 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0070491	repressing transcription factor binding	1	7.329938e-3	1.000000e+0	1.000000e+0	1.364268e+2	7.329938e-3	1	7.329938e-3	1.000000e+0	1	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	PRDM5
GO Molecular Function	GO:0008168	methyltransferase activity	2	1.710242e-2	1.000000e+0	1.000000e+0	5.847126e+1	1.710242e-2	1	1.710242e-2	1.000000e+0	3	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	PRDM5
GO Molecular Function	GO:0016741	transferase activity, transferring one-carbon groups	3	1.739575e-2	1.000000e+0	1.000000e+0	5.748529e+1	1.739575e-2	1	1.739575e-2	1.000000e+0	4	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	PRDM5
GO Molecular Function	GO:0000976	transcription regulatory region sequence-specific DNA binding	4	2.600217e-2	1.000000e+0	1.000000e+0	3.845833e+1	2.600217e-2	1	2.600217e-2	1.000000e+0	2	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	PRDM5
GO Molecular Function	GO:0044212	transcription regulatory region DNA binding	5	5.123854e-2	1.000000e+0	1.000000e+0	1.951656e+1	5.123854e-2	1	5.123854e-2	1.000000e+0	5	3.951200e-2	1.000000e+0	1.000000e+0	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	PRDM5
GO Molecular Function	GO:0000975	regulatory region DNA binding	6	5.212165e-2	1.000000e+0	1.000000e+0	1.918589e+1	5.212165e-2	1	5.212165e-2	1.000000e+0	6	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	PRDM5
GO Molecular Function	GO:0008134	transcription factor binding	7	5.376409e-2	1.000000e+0	1.000000e+0	1.859977e+1	5.376409e-2	1	5.376409e-2	1.000000e+0	7	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	PRDM5
GO Molecular Function	GO:0042803	protein homodimerization activity	8	6.175957e-2	1.000000e+0	1.000000e+0	1.619182e+1	6.175957e-2	1	6.175957e-2	1.000000e+0	8	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	MAD2L1
GO Molecular Function	GO:0043565	sequence-specific DNA binding	9	9.345854e-2	1.000000e+0	1.000000e+0	1.069993e+1	9.345854e-2	1	9.345854e-2	1.000000e+0	9	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	PRDM5
GO Molecular Function	GO:0042802	identical protein binding	10	9.800114e-2	1.000000e+0	1.000000e+0	1.020396e+1	9.800114e-2	1	9.800114e-2	1.000000e+0	10	1.043301e-1	1.000000e+0	1.000000e+0	9.328335e+0	1.072003e-1	1	967	5.000000e-1	1.034126e-3	unnamed	MAD2L1
GO Molecular Function	GO:0046983	protein dimerization activity	11	1.038803e-1	1.000000e+0	1.000000e+0	9.626466e+0	1.038803e-1	1	1.038803e-1	1.000000e+0	11	1.064273e-1	1.000000e+0	1.000000e+0	9.139311e+0	1.094174e-1	1	987	5.000000e-1	1.013171e-3	unnamed	MAD2L1
GO Molecular Function	GO:0016740	transferase activity	12	1.774445e-1	1.000000e+0	1.000000e+0	5.635566e+0	1.774445e-1	1	1.774445e-1	1.000000e+0	12	1.943792e-1	1.000000e+0	1.000000e+0	4.881223e+0	2.048667e-1	1	1848	5.000000e-1	5.411255e-4	unnamed	PRDM5
GO Molecular Function	GO:0003677	DNA binding	13	2.170876e-1	1.000000e+0	1.000000e+0	4.606435e+0	2.170876e-1	1	2.170876e-1	1.000000e+0	14	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	PRDM5
GO Molecular Function	GO:0003676	nucleic acid binding	14	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	15	3.411408e-1	1.000000e+0	1.000000e+0	2.655431e+0	3.765867e-1	1	3397	5.000000e-1	2.943774e-4	unnamed	PRDM5
GO Molecular Function	GO:0046872	metal ion binding	15	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	16	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	PRDM5
GO Molecular Function	GO:0043169	cation binding	16	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	17	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	PRDM5
GO Molecular Function	GO:1901363	heterocyclic compound binding	17	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	19	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	PRDM5
GO Molecular Function	GO:0097159	organic cyclic compound binding	18	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	20	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	PRDM5
GO Molecular Function	GO:0003824	catalytic activity	19	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	21	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	PRDM5
GO Molecular Function	GO:0043167	ion binding	20	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	22	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	PRDM5
GO Molecular Function	GO:0005515	protein binding	21	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	13	1.964729e-1	1.000000e+0	1.000000e+0	2.255971e+0	8.865362e-1	2	7997	1.000000e+0	2.500938e-4	unnamed	MAD2L1,PRDM5
GO Molecular Function	GO:0005488	binding	22	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	18	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0090267	positive regulation of mitotic cell cycle spindle assembly checkpoint	1	5.616445e-4	1.000000e+0	1.000000e+0	1.780486e+3	5.616445e-4	1	5.616445e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MAD2L1
GO Biological Process	GO:0060564	negative regulation of mitotic anaphase-promoting complex activity	2	6.584597e-4	1.000000e+0	1.000000e+0	1.518696e+3	6.584597e-4	1	6.584597e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MAD2L1
GO Biological Process	GO:0090232	positive regulation of spindle checkpoint	3	6.940652e-4	1.000000e+0	1.000000e+0	1.440787e+3	6.940652e-4	1	6.940652e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MAD2L1
GO Biological Process	GO:0090266	regulation of mitotic cell cycle spindle assembly checkpoint	4	7.464300e-4	1.000000e+0	1.000000e+0	1.339710e+3	7.464300e-4	1	7.464300e-4	1.000000e+0	4	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MAD2L1
GO Biological Process	GO:0051567	histone H3-K9 methylation	5	8.643234e-4	1.000000e+0	1.000000e+0	1.156974e+3	8.643234e-4	1	8.643234e-4	1.000000e+0	6	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PRDM5
GO Biological Process	GO:1901978	positive regulation of cell cycle checkpoint	6	1.145764e-3	1.000000e+0	1.000000e+0	8.727801e+2	1.145764e-3	1	1.145764e-3	1.000000e+0	4	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MAD2L1
GO Biological Process	GO:0090231	regulation of spindle checkpoint	7	1.323202e-3	1.000000e+0	1.000000e+0	7.557423e+2	1.323202e-3	1	1.323202e-3	1.000000e+0	6	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	MAD2L1
GO Biological Process	GO:1901976	regulation of cell cycle checkpoint	8	2.064282e-3	1.000000e+0	1.000000e+0	4.844299e+2	2.064282e-3	1	2.064282e-3	1.000000e+0	11	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	MAD2L1
GO Biological Process	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	9	2.776732e-3	1.000000e+0	1.000000e+0	3.601356e+2	2.776732e-3	1	2.776732e-3	1.000000e+0	10	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	MAD2L1
GO Biological Process	GO:1901799	negative regulation of proteasomal protein catabolic process	10	2.798072e-3	1.000000e+0	1.000000e+0	3.573889e+2	2.798072e-3	1	2.798072e-3	1.000000e+0	11	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	MAD2L1
GO Biological Process	GO:0007094	mitotic spindle assembly checkpoint	11	2.956144e-3	1.000000e+0	1.000000e+0	3.382785e+2	2.956144e-3	1	2.956144e-3	1.000000e+0	14	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	MAD2L1
GO Biological Process	GO:0071173	spindle assembly checkpoint	12	2.998038e-3	1.000000e+0	1.000000e+0	3.335515e+2	2.998038e-3	1	2.998038e-3	1.000000e+0	15	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	MAD2L1
GO Biological Process	GO:0071174	mitotic spindle checkpoint	13	3.075749e-3	1.000000e+0	1.000000e+0	3.251241e+2	3.075749e-3	1	3.075749e-3	1.000000e+0	18	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	MAD2L1
GO Biological Process	GO:0031577	spindle checkpoint	14	3.129759e-3	1.000000e+0	1.000000e+0	3.195134e+2	3.129759e-3	1	3.129759e-3	1.000000e+0	19	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	MAD2L1
GO Biological Process	GO:0045841	negative regulation of mitotic metaphase/anaphase transition	15	3.153498e-3	1.000000e+0	1.000000e+0	3.171082e+2	3.153498e-3	1	3.153498e-3	1.000000e+0	16	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	MAD2L1
GO Biological Process	GO:0016575	histone deacetylation	16	3.215267e-3	1.000000e+0	1.000000e+0	3.110162e+2	3.215267e-3	1	3.215267e-3	1.000000e+0	13	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PRDM5
GO Biological Process	GO:0006476	protein deacetylation	17	3.357681e-3	1.000000e+0	1.000000e+0	2.978246e+2	3.357681e-3	1	3.357681e-3	1.000000e+0	16	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	PRDM5
GO Biological Process	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	18	3.764559e-3	1.000000e+0	1.000000e+0	2.656354e+2	3.764559e-3	1	3.764559e-3	1.000000e+0	32	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MAD2L1
GO Biological Process	GO:0030071	regulation of mitotic metaphase/anaphase transition	19	3.769373e-3	1.000000e+0	1.000000e+0	2.652961e+2	3.769373e-3	1	3.769373e-3	1.000000e+0	23	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	MAD2L1
GO Biological Process	GO:0035601	protein deacylation	20	3.986122e-3	1.000000e+0	1.000000e+0	2.508704e+2	3.986122e-3	1	3.986122e-3	1.000000e+0	19	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PRDM5
GO Biological Process	GO:0045861	negative regulation of proteolysis	21	4.230838e-3	1.000000e+0	1.000000e+0	2.363598e+2	4.230838e-3	1	4.230838e-3	1.000000e+0	21	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	MAD2L1
GO Biological Process	GO:0051444	negative regulation of ubiquitin-protein ligase activity	22	4.280052e-3	1.000000e+0	1.000000e+0	2.336420e+2	4.280052e-3	1	4.280052e-3	1.000000e+0	36	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	MAD2L1
GO Biological Process	GO:0045839	negative regulation of mitosis	23	4.691826e-3	1.000000e+0	1.000000e+0	2.131366e+2	4.691826e-3	1	4.691826e-3	1.000000e+0	23	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	MAD2L1
GO Biological Process	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	24	4.736877e-3	1.000000e+0	1.000000e+0	2.111096e+2	4.736877e-3	1	4.736877e-3	1.000000e+0	38	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	MAD2L1
GO Biological Process	GO:0031145	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	25	4.839373e-3	1.000000e+0	1.000000e+0	2.066383e+2	4.839373e-3	1	4.839373e-3	1.000000e+0	39	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	MAD2L1
GO Biological Process	GO:0000070	mitotic sister chromatid segregation	26	4.998462e-3	1.000000e+0	1.000000e+0	2.000615e+2	4.998462e-3	1	4.998462e-3	1.000000e+0	26	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MAD2L1
GO Biological Process	GO:0000819	sister chromatid segregation	27	5.177963e-3	1.000000e+0	1.000000e+0	1.931261e+2	5.177963e-3	1	5.177963e-3	1.000000e+0	27	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MAD2L1
GO Biological Process	GO:0034968	histone lysine methylation	28	5.695836e-3	1.000000e+0	1.000000e+0	1.755668e+2	5.695836e-3	1	5.695836e-3	1.000000e+0	28	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	PRDM5
GO Biological Process	GO:0042177	negative regulation of protein catabolic process	29	6.089343e-3	1.000000e+0	1.000000e+0	1.642213e+2	6.089343e-3	1	6.089343e-3	1.000000e+0	25	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	MAD2L1
GO Biological Process	GO:0031397	negative regulation of protein ubiquitination	30	7.097623e-3	1.000000e+0	1.000000e+0	1.408922e+2	7.097623e-3	1	7.097623e-3	1.000000e+0	43	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	MAD2L1
GO Biological Process	GO:0016571	histone methylation	31	7.325998e-3	1.000000e+0	1.000000e+0	1.365002e+2	7.325998e-3	1	7.325998e-3	1.000000e+0	34	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	PRDM5
GO Biological Process	GO:0051438	regulation of ubiquitin-protein ligase activity	32	7.332637e-3	1.000000e+0	1.000000e+0	1.363766e+2	7.332637e-3	1	7.332637e-3	1.000000e+0	41	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	MAD2L1
GO Biological Process	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	33	7.532037e-3	1.000000e+0	1.000000e+0	1.327662e+2	7.532037e-3	1	7.532037e-3	1.000000e+0	31	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	MAD2L1
GO Biological Process	GO:0031330	negative regulation of cellular catabolic process	34	7.810914e-3	1.000000e+0	1.000000e+0	1.280260e+2	7.810914e-3	1	7.810914e-3	1.000000e+0	32	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MAD2L1
GO Biological Process	GO:0051340	regulation of ligase activity	35	8.022775e-3	1.000000e+0	1.000000e+0	1.246451e+2	8.022775e-3	1	8.022775e-3	1.000000e+0	44	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	MAD2L1
GO Biological Process	GO:0061136	regulation of proteasomal protein catabolic process	36	8.190721e-3	1.000000e+0	1.000000e+0	1.220894e+2	8.190721e-3	1	8.190721e-3	1.000000e+0	37	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	MAD2L1
GO Biological Process	GO:0007088	regulation of mitosis	37	9.100903e-3	1.000000e+0	1.000000e+0	1.098792e+2	9.100903e-3	1	9.100903e-3	1.000000e+0	44	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	MAD2L1
GO Biological Process	GO:0006479	protein methylation	38	9.181411e-3	1.000000e+0	1.000000e+0	1.089157e+2	9.181411e-3	1	9.181411e-3	1.000000e+0	40	1.050413e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	95	5.000000e-1	1.052632e-2	unnamed	PRDM5
GO Biological Process	GO:0007093	mitotic cell cycle checkpoint	39	1.093625e-2	1.000000e+0	1.000000e+0	9.143898e+1	1.093625e-2	1	1.093625e-2	1.000000e+0	48	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	MAD2L1
GO Biological Process	GO:0009895	negative regulation of catabolic process	40	1.141093e-2	1.000000e+0	1.000000e+0	8.763526e+1	1.141093e-2	1	1.141093e-2	1.000000e+0	41	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	MAD2L1
GO Biological Process	GO:0007059	chromosome segregation	41	1.265936e-2	1.000000e+0	1.000000e+0	7.899292e+1	1.265936e-2	1	1.265936e-2	1.000000e+0	47	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	MAD2L1
GO Biological Process	GO:1901991	negative regulation of mitotic cell cycle phase transition	42	1.328035e-2	1.000000e+0	1.000000e+0	7.529923e+1	1.328035e-2	1	1.328035e-2	1.000000e+0	50	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	MAD2L1
GO Biological Process	GO:0043414	macromolecule methylation	43	1.335436e-2	1.000000e+0	1.000000e+0	7.488190e+1	1.335436e-2	1	1.335436e-2	1.000000e+0	49	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PRDM5
GO Biological Process	GO:1901988	negative regulation of cell cycle phase transition	44	1.409885e-2	1.000000e+0	1.000000e+0	7.092777e+1	1.409885e-2	1	1.409885e-2	1.000000e+0	51	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	MAD2L1
GO Biological Process	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	45	1.471616e-2	1.000000e+0	1.000000e+0	6.795252e+1	1.471616e-2	1	1.471616e-2	1.000000e+0	57	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	MAD2L1
GO Biological Process	GO:0010498	proteasomal protein catabolic process	46	1.551154e-2	1.000000e+0	1.000000e+0	6.446814e+1	1.551154e-2	1	1.551154e-2	1.000000e+0	58	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
GO Biological Process	GO:0000075	cell cycle checkpoint	47	1.587902e-2	1.000000e+0	1.000000e+0	6.297617e+1	1.587902e-2	1	1.587902e-2	1.000000e+0	60	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	MAD2L1
GO Biological Process	GO:0030162	regulation of proteolysis	48	1.596185e-2	1.000000e+0	1.000000e+0	6.264936e+1	1.596185e-2	1	1.596185e-2	1.000000e+0	53	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	MAD2L1
GO Biological Process	GO:0031396	regulation of protein ubiquitination	49	1.662564e-2	1.000000e+0	1.000000e+0	6.014805e+1	1.662564e-2	1	1.662564e-2	1.000000e+0	55	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MAD2L1
GO Biological Process	GO:0090068	positive regulation of cell cycle process	50	1.754374e-2	1.000000e+0	1.000000e+0	5.700040e+1	1.754374e-2	1	1.754374e-2	1.000000e+0	54	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	MAD2L1
GO Biological Process	GO:1901990	regulation of mitotic cell cycle phase transition	51	1.910917e-2	1.000000e+0	1.000000e+0	5.233089e+1	1.910917e-2	1	1.910917e-2	1.000000e+0	59	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	MAD2L1
GO Biological Process	GO:0010948	negative regulation of cell cycle process	52	1.920177e-2	1.000000e+0	1.000000e+0	5.207854e+1	1.920177e-2	1	1.920177e-2	1.000000e+0	62	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	MAD2L1
GO Biological Process	GO:0010639	negative regulation of organelle organization	53	1.964405e-2	1.000000e+0	1.000000e+0	5.090601e+1	1.964405e-2	1	1.964405e-2	1.000000e+0	56	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MAD2L1
GO Biological Process	GO:1901987	regulation of cell cycle phase transition	54	1.998785e-2	1.000000e+0	1.000000e+0	5.003040e+1	1.998785e-2	1	1.998785e-2	1.000000e+0	61	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	MAD2L1
GO Biological Process	GO:0042176	regulation of protein catabolic process	55	2.132785e-2	1.000000e+0	1.000000e+0	4.688705e+1	2.132785e-2	1	2.132785e-2	1.000000e+0	52	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	MAD2L1
GO Biological Process	GO:0032259	methylation	56	2.161420e-2	1.000000e+0	1.000000e+0	4.626587e+1	2.161420e-2	1	2.161420e-2	1.000000e+0	65	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	PRDM5
GO Biological Process	GO:0016570	histone modification	57	2.701510e-2	1.000000e+0	1.000000e+0	3.701633e+1	2.701510e-2	1	2.701510e-2	1.000000e+0	67	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	PRDM5
GO Biological Process	GO:0016569	covalent chromatin modification	58	2.730858e-2	1.000000e+0	1.000000e+0	3.661852e+1	2.730858e-2	1	2.730858e-2	1.000000e+0	68	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	PRDM5
GO Biological Process	GO:0007067	mitosis	59	2.800485e-2	1.000000e+0	1.000000e+0	3.570810e+1	2.800485e-2	1	2.800485e-2	1.000000e+0	69	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	MAD2L1
GO Biological Process	GO:0045786	negative regulation of cell cycle	60	2.832384e-2	1.000000e+0	1.000000e+0	3.530595e+1	2.832384e-2	1	2.832384e-2	1.000000e+0	64	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	MAD2L1
GO Biological Process	GO:0048285	organelle fission	61	3.075653e-2	1.000000e+0	1.000000e+0	3.251342e+1	3.075653e-2	1	3.075653e-2	1.000000e+0	72	3.668503e-2	1.000000e+0	1.000000e+0	2.700749e+1	3.702677e-2	1	334	5.000000e-1	2.994012e-3	unnamed	MAD2L1
GO Biological Process	GO:0006511	ubiquitin-dependent protein catabolic process	62	3.147311e-2	1.000000e+0	1.000000e+0	3.177316e+1	3.147311e-2	1	3.147311e-2	1.000000e+0	76	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	MAD2L1
GO Biological Process	GO:0019941	modification-dependent protein catabolic process	63	3.156297e-2	1.000000e+0	1.000000e+0	3.168270e+1	3.156297e-2	1	3.156297e-2	1.000000e+0	77	4.233480e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	MAD2L1
GO Biological Process	GO:0007346	regulation of mitotic cell cycle	64	3.175872e-2	1.000000e+0	1.000000e+0	3.148741e+1	3.175872e-2	1	3.175872e-2	1.000000e+0	71	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	MAD2L1
GO Biological Process	GO:0043632	modification-dependent macromolecule catabolic process	65	3.188266e-2	1.000000e+0	1.000000e+0	3.136501e+1	3.188266e-2	1	3.188266e-2	1.000000e+0	78	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	MAD2L1
GO Biological Process	GO:0051603	proteolysis involved in cellular protein catabolic process	66	3.352040e-2	1.000000e+0	1.000000e+0	2.983258e+1	3.352040e-2	1	3.352040e-2	1.000000e+0	80	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	MAD2L1
GO Biological Process	GO:0044257	cellular protein catabolic process	67	3.517714e-2	1.000000e+0	1.000000e+0	2.842755e+1	3.517714e-2	1	3.517714e-2	1.000000e+0	81	4.612818e-2	1.000000e+0	1.000000e+0	2.142637e+1	4.667147e-2	1	421	5.000000e-1	2.375297e-3	unnamed	MAD2L1
GO Biological Process	GO:0031400	negative regulation of protein modification process	68	3.726288e-2	1.000000e+0	1.000000e+0	2.683636e+1	3.726288e-2	1	3.726288e-2	1.000000e+0	74	3.994654e-2	1.000000e+0	1.000000e+0	2.478159e+1	4.035253e-2	1	364	5.000000e-1	2.747253e-3	unnamed	MAD2L1
GO Biological Process	GO:0030163	protein catabolic process	69	3.843880e-2	1.000000e+0	1.000000e+0	2.601538e+1	3.843880e-2	1	3.843880e-2	1.000000e+0	85	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	MAD2L1
GO Biological Process	GO:0010564	regulation of cell cycle process	70	3.998440e-2	1.000000e+0	1.000000e+0	2.500975e+1	3.998440e-2	1	3.998440e-2	1.000000e+0	79	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	MAD2L1
GO Biological Process	GO:0051129	negative regulation of cellular component organization	71	4.357565e-2	1.000000e+0	1.000000e+0	2.294860e+1	4.357565e-2	1	4.357565e-2	1.000000e+0	75	4.048959e-2	1.000000e+0	1.000000e+0	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	MAD2L1
GO Biological Process	GO:0051301	cell division	72	4.487060e-2	1.000000e+0	1.000000e+0	2.228631e+1	4.487060e-2	1	4.487060e-2	1.000000e+0	82	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	MAD2L1
GO Biological Process	GO:0032269	negative regulation of cellular protein metabolic process	73	4.649340e-2	1.000000e+0	1.000000e+0	2.150843e+1	4.649340e-2	1	4.649340e-2	1.000000e+0	86	5.164219e-2	1.000000e+0	1.000000e+0	1.911123e+1	5.232526e-2	1	472	5.000000e-1	2.118644e-3	unnamed	MAD2L1
GO Biological Process	GO:0016568	chromatin modification	74	4.683645e-2	1.000000e+0	1.000000e+0	2.135089e+1	4.683645e-2	1	4.683645e-2	1.000000e+0	84	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	PRDM5
GO Biological Process	GO:0051248	negative regulation of protein metabolic process	75	5.347675e-2	1.000000e+0	1.000000e+0	1.869971e+1	5.347675e-2	1	5.347675e-2	1.000000e+0	88	5.843155e-2	1.000000e+0	1.000000e+0	1.686075e+1	5.930935e-2	1	535	5.000000e-1	1.869159e-3	unnamed	MAD2L1
GO Biological Process	GO:0044265	cellular macromolecule catabolic process	76	5.355610e-2	1.000000e+0	1.000000e+0	1.867201e+1	5.355610e-2	1	5.355610e-2	1.000000e+0	99	7.620416e-2	1.000000e+0	1.000000e+0	1.286805e+1	7.771188e-2	1	701	5.000000e-1	1.426534e-3	unnamed	MAD2L1
GO Biological Process	GO:0006325	chromatin organization	77	5.364312e-2	1.000000e+0	1.000000e+0	1.864172e+1	5.364312e-2	1	5.364312e-2	1.000000e+0	89	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	PRDM5
GO Biological Process	GO:0000278	mitotic cell cycle	78	5.694180e-2	1.000000e+0	1.000000e+0	1.756179e+1	5.694180e-2	1	5.694180e-2	1.000000e+0	8	1.328294e-3	1.000000e+0	1.000000e+0	2.741793e+1	7.294496e-2	2	658	1.000000e+0	3.039514e-3	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0043086	negative regulation of catalytic activity	79	5.840041e-2	1.000000e+0	1.000000e+0	1.712317e+1	5.840041e-2	1	5.840041e-2	1.000000e+0	93	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	MAD2L1
GO Biological Process	GO:0033043	regulation of organelle organization	80	6.090903e-2	1.000000e+0	1.000000e+0	1.641793e+1	6.090903e-2	1	6.090903e-2	1.000000e+0	90	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	MAD2L1
GO Biological Process	GO:0009057	macromolecule catabolic process	81	6.409408e-2	1.000000e+0	1.000000e+0	1.560207e+1	6.409408e-2	1	6.409408e-2	1.000000e+0	103	8.905220e-2	1.000000e+0	1.000000e+0	1.097384e+1	9.112577e-2	1	822	5.000000e-1	1.216545e-3	unnamed	MAD2L1
GO Biological Process	GO:0051276	chromosome organization	82	6.817619e-2	1.000000e+0	1.000000e+0	1.466788e+1	6.817619e-2	1	6.817619e-2	1.000000e+0	9	1.749126e-3	1.000000e+0	1.000000e+0	2.389536e+1	8.369824e-2	2	755	1.000000e+0	2.649007e-3	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0043066	negative regulation of apoptotic process	83	7.076490e-2	1.000000e+0	1.000000e+0	1.413130e+1	7.076490e-2	1	7.076490e-2	1.000000e+0	94	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	MAD2L1
GO Biological Process	GO:0031329	regulation of cellular catabolic process	84	7.096721e-2	1.000000e+0	1.000000e+0	1.409101e+1	7.096721e-2	1	7.096721e-2	1.000000e+0	92	6.808832e-2	1.000000e+0	1.000000e+0	1.443280e+1	6.928662e-2	1	625	5.000000e-1	1.600000e-3	unnamed	MAD2L1
GO Biological Process	GO:0043069	negative regulation of programmed cell death	85	7.183207e-2	1.000000e+0	1.000000e+0	1.392136e+1	7.183207e-2	1	7.183207e-2	1.000000e+0	95	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	MAD2L1
GO Biological Process	GO:0051726	regulation of cell cycle	86	7.419191e-2	1.000000e+0	1.000000e+0	1.347856e+1	7.419191e-2	1	7.419191e-2	1.000000e+0	101	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	MAD2L1
GO Biological Process	GO:0006508	proteolysis	87	7.467204e-2	1.000000e+0	1.000000e+0	1.339189e+1	7.467204e-2	1	7.467204e-2	1.000000e+0	106	9.570606e-2	1.000000e+0	1.000000e+0	1.019266e+1	9.810986e-2	1	885	5.000000e-1	1.129944e-3	unnamed	MAD2L1
GO Biological Process	GO:0060548	negative regulation of cell death	88	7.699389e-2	1.000000e+0	1.000000e+0	1.298804e+1	7.699389e-2	1	7.699389e-2	1.000000e+0	97	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	MAD2L1
GO Biological Process	GO:0044092	negative regulation of molecular function	89	7.795078e-2	1.000000e+0	1.000000e+0	1.282861e+1	7.795078e-2	1	7.795078e-2	1.000000e+0	102	8.640502e-2	1.000000e+0	1.000000e+0	1.131807e+1	8.835430e-2	1	797	5.000000e-1	1.254705e-3	unnamed	MAD2L1
GO Biological Process	GO:0009894	regulation of catabolic process	90	8.103014e-2	1.000000e+0	1.000000e+0	1.234109e+1	8.103014e-2	1	8.103014e-2	1.000000e+0	98	7.599104e-2	1.000000e+0	1.000000e+0	1.290486e+1	7.749016e-2	1	699	5.000000e-1	1.430615e-3	unnamed	MAD2L1
GO Biological Process	GO:0022402	cell cycle process	91	8.847677e-2	1.000000e+0	1.000000e+0	1.130240e+1	8.847677e-2	1	8.847677e-2	1.000000e+0	110	1.077891e-1	1.000000e+0	1.000000e+0	9.020500e+0	1.108586e-1	1	1000	5.000000e-1	1.000000e-3	unnamed	MAD2L1
GO Biological Process	GO:0007049	cell cycle	92	1.078728e-1	1.000000e+0	1.000000e+0	9.270177e+0	1.078728e-1	1	1.078728e-1	1.000000e+0	22	4.682578e-3	1.000000e+0	1.000000e+0	1.460810e+1	1.369104e-1	2	1235	1.000000e+0	1.619433e-3	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0045892	negative regulation of transcription, DNA-dependent	93	1.104440e-1	1.000000e+0	1.000000e+0	9.054358e+0	1.104440e-1	1	1.104440e-1	1.000000e+0	105	9.517887e-2	1.000000e+0	1.000000e+0	1.025057e+1	9.755557e-2	1	880	5.000000e-1	1.136364e-3	unnamed	PRDM5
GO Biological Process	GO:0051253	negative regulation of RNA metabolic process	94	1.131743e-1	1.000000e+0	1.000000e+0	8.835931e+0	1.131743e-1	1	1.131743e-1	1.000000e+0	107	9.918168e-2	1.000000e+0	1.000000e+0	9.826253e+0	1.017682e-1	1	918	5.000000e-1	1.089325e-3	unnamed	PRDM5
GO Biological Process	GO:0031399	regulation of protein modification process	95	1.170270e-1	1.000000e+0	1.000000e+0	8.545037e+0	1.170270e-1	1	1.170270e-1	1.000000e+0	117	1.196868e-1	1.000000e+0	1.000000e+0	8.097397e+0	1.234965e-1	1	1114	5.000000e-1	8.976661e-4	unnamed	MAD2L1
GO Biological Process	GO:2000113	negative regulation of cellular macromolecule biosynthetic process	96	1.195916e-1	1.000000e+0	1.000000e+0	8.361790e+0	1.195916e-1	1	1.195916e-1	1.000000e+0	109	1.065321e-1	1.000000e+0	1.000000e+0	9.130061e+0	1.095283e-1	1	988	5.000000e-1	1.012146e-3	unnamed	PRDM5
GO Biological Process	GO:0010629	negative regulation of gene expression	97	1.196382e-1	1.000000e+0	1.000000e+0	8.358535e+0	1.196382e-1	1	1.196382e-1	1.000000e+0	108	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	PRDM5
GO Biological Process	GO:0042981	regulation of apoptotic process	98	1.200175e-1	1.000000e+0	1.000000e+0	8.332116e+0	1.200175e-1	1	1.200175e-1	1.000000e+0	118	1.243613e-1	1.000000e+0	1.000000e+0	7.783003e+0	1.284851e-1	1	1159	5.000000e-1	8.628128e-4	unnamed	MAD2L1
GO Biological Process	GO:0043067	regulation of programmed cell death	99	1.213630e-1	1.000000e+0	1.000000e+0	8.239741e+0	1.213630e-1	1	1.213630e-1	1.000000e+0	119	1.256058e-1	1.000000e+0	1.000000e+0	7.703245e+0	1.298154e-1	1	1171	5.000000e-1	8.539710e-4	unnamed	MAD2L1
GO Biological Process	GO:0010558	negative regulation of macromolecule biosynthetic process	100	1.230904e-1	1.000000e+0	1.000000e+0	8.124112e+0	1.230904e-1	1	1.230904e-1	1.000000e+0	113	1.108233e-1	1.000000e+0	1.000000e+0	8.766278e+0	1.140735e-1	1	1029	5.000000e-1	9.718173e-4	unnamed	PRDM5
GO Biological Process	GO:0045934	negative regulation of nucleobase-containing compound metabolic process	101	1.236988e-1	1.000000e+0	1.000000e+0	8.084155e+0	1.236988e-1	1	1.236988e-1	1.000000e+0	111	1.087313e-1	1.000000e+0	1.000000e+0	8.940040e+0	1.118563e-1	1	1009	5.000000e-1	9.910803e-4	unnamed	PRDM5
GO Biological Process	GO:0044248	cellular catabolic process	102	1.236997e-1	1.000000e+0	1.000000e+0	8.084094e+0	1.236997e-1	1	1.236997e-1	1.000000e+0	124	1.690077e-1	1.000000e+0	1.000000e+0	5.655486e+0	1.768195e-1	1	1595	5.000000e-1	6.269592e-4	unnamed	MAD2L1
GO Biological Process	GO:0051172	negative regulation of nitrogen compound metabolic process	103	1.247094e-1	1.000000e+0	1.000000e+0	8.018640e+0	1.247094e-1	1	1.247094e-1	1.000000e+0	112	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	PRDM5
GO Biological Process	GO:0010941	regulation of cell death	104	1.261875e-1	1.000000e+0	1.000000e+0	7.924714e+0	1.261875e-1	1	1.261875e-1	1.000000e+0	120	1.296441e-1	1.000000e+0	1.000000e+0	7.454959e+0	1.341389e-1	1	1210	5.000000e-1	8.264463e-4	unnamed	MAD2L1
GO Biological Process	GO:0031327	negative regulation of cellular biosynthetic process	105	1.294140e-1	1.000000e+0	1.000000e+0	7.727141e+0	1.294140e-1	1	1.294140e-1	1.000000e+0	114	1.157298e-1	1.000000e+0	1.000000e+0	8.383364e+0	1.192839e-1	1	1076	5.000000e-1	9.293680e-4	unnamed	PRDM5
GO Biological Process	GO:0009890	negative regulation of biosynthetic process	106	1.306849e-1	1.000000e+0	1.000000e+0	7.651996e+0	1.306849e-1	1	1.306849e-1	1.000000e+0	116	1.172929e-1	1.000000e+0	1.000000e+0	8.268103e+0	1.209467e-1	1	1091	5.000000e-1	9.165903e-4	unnamed	PRDM5
GO Biological Process	GO:1901575	organic substance catabolic process	107	1.333602e-1	1.000000e+0	1.000000e+0	7.498488e+0	1.333602e-1	1	1.333602e-1	1.000000e+0	126	1.828954e-1	1.000000e+0	1.000000e+0	5.205136e+0	1.921180e-1	1	1733	5.000000e-1	5.770340e-4	unnamed	MAD2L1
GO Biological Process	GO:0032268	regulation of cellular protein metabolic process	108	1.389785e-1	1.000000e+0	1.000000e+0	7.195356e+0	1.389785e-1	1	1.389785e-1	1.000000e+0	123	1.498997e-1	1.000000e+0	1.000000e+0	6.411158e+0	1.559780e-1	1	1407	5.000000e-1	7.107321e-4	unnamed	MAD2L1
GO Biological Process	GO:0009056	catabolic process	109	1.498546e-1	1.000000e+0	1.000000e+0	6.673137e+0	1.498546e-1	1	1.498546e-1	1.000000e+0	128	2.035077e-1	1.000000e+0	1.000000e+0	4.649742e+0	2.150657e-1	1	1940	5.000000e-1	5.154639e-4	unnamed	MAD2L1
GO Biological Process	GO:0051246	regulation of protein metabolic process	110	1.559232e-1	1.000000e+0	1.000000e+0	6.413414e+0	1.559232e-1	1	1.559232e-1	1.000000e+0	125	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	MAD2L1
GO Biological Process	GO:0051128	regulation of cellular component organization	111	1.583941e-1	1.000000e+0	1.000000e+0	6.313365e+0	1.583941e-1	1	1.583941e-1	1.000000e+0	122	1.493886e-1	1.000000e+0	1.000000e+0	6.434023e+0	1.554238e-1	1	1402	5.000000e-1	7.132668e-4	unnamed	MAD2L1
GO Biological Process	GO:0010605	negative regulation of macromolecule metabolic process	112	1.635114e-1	1.000000e+0	1.000000e+0	6.115780e+0	1.635114e-1	1	1.635114e-1	1.000000e+0	30	6.725627e-3	1.000000e+0	1.000000e+0	1.218986e+1	1.640707e-1	2	1480	1.000000e+0	1.351351e-3	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0031324	negative regulation of cellular metabolic process	113	1.637788e-1	1.000000e+0	1.000000e+0	6.105797e+0	1.637788e-1	1	1.637788e-1	1.000000e+0	29	6.671187e-3	1.000000e+0	1.000000e+0	1.223948e+1	1.634056e-1	2	1474	1.000000e+0	1.356852e-3	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0009892	negative regulation of metabolic process	114	1.743568e-1	1.000000e+0	1.000000e+0	5.735367e+0	1.743568e-1	1	1.743568e-1	1.000000e+0	35	7.772669e-3	1.000000e+0	1.000000e+0	1.133941e+1	1.763760e-1	2	1591	1.000000e+0	1.257071e-3	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0050790	regulation of catalytic activity	115	1.756788e-1	1.000000e+0	1.000000e+0	5.692208e+0	1.756788e-1	1	1.756788e-1	1.000000e+0	127	1.830959e-1	1.000000e+0	1.000000e+0	5.199135e+0	1.923397e-1	1	1735	5.000000e-1	5.763689e-4	unnamed	MAD2L1
GO Biological Process	GO:0006996	organelle organization	116	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	46	1.530018e-2	1.000000e+0	1.000000e+0	8.082885e+0	2.474364e-1	2	2232	1.000000e+0	8.960573e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0006464	cellular protein modification process	117	2.092214e-1	1.000000e+0	1.000000e+0	4.779626e+0	2.092214e-1	1	2.092214e-1	1.000000e+0	133	2.280507e-1	1.000000e+0	1.000000e+0	4.118950e+0	2.427803e-1	1	2190	5.000000e-1	4.566210e-4	unnamed	PRDM5
GO Biological Process	GO:0065009	regulation of molecular function	118	2.156945e-1	1.000000e+0	1.000000e+0	4.636187e+0	2.156945e-1	1	2.156945e-1	1.000000e+0	131	2.197492e-1	1.000000e+0	1.000000e+0	4.285273e+0	2.333574e-1	1	2105	5.000000e-1	4.750594e-4	unnamed	MAD2L1
GO Biological Process	GO:0043412	macromolecule modification	119	2.160048e-1	1.000000e+0	1.000000e+0	4.629527e+0	2.160048e-1	1	2.160048e-1	1.000000e+0	134	2.399849e-1	1.000000e+0	1.000000e+0	3.899914e+0	2.564159e-1	1	2313	5.000000e-1	4.323390e-4	unnamed	PRDM5
GO Biological Process	GO:0006351	transcription, DNA-dependent	120	2.234119e-1	1.000000e+0	1.000000e+0	4.476036e+0	2.234119e-1	1	2.234119e-1	1.000000e+0	136	2.497150e-1	1.000000e+0	1.000000e+0	3.736744e+0	2.676127e-1	1	2414	5.000000e-1	4.142502e-4	unnamed	PRDM5
GO Biological Process	GO:0032774	RNA biosynthetic process	121	2.268650e-1	1.000000e+0	1.000000e+0	4.407908e+0	2.268650e-1	1	2.268650e-1	1.000000e+0	137	2.585235e-1	1.000000e+0	1.000000e+0	3.599561e+0	2.778117e-1	1	2506	5.000000e-1	3.990423e-4	unnamed	PRDM5
GO Biological Process	GO:0034654	nucleobase-containing compound biosynthetic process	122	2.447967e-1	1.000000e+0	1.000000e+0	4.085022e+0	2.447967e-1	1	2.447967e-1	1.000000e+0	140	2.799409e-1	1.000000e+0	1.000000e+0	3.301794e+0	3.028657e-1	1	2732	5.000000e-1	3.660322e-4	unnamed	PRDM5
GO Biological Process	GO:0018130	heterocycle biosynthetic process	123	2.497654e-1	1.000000e+0	1.000000e+0	4.003758e+0	2.497654e-1	1	2.497654e-1	1.000000e+0	141	2.868855e-1	1.000000e+0	1.000000e+0	3.214718e+0	3.110692e-1	1	2806	5.000000e-1	3.563792e-4	unnamed	PRDM5
GO Biological Process	GO:0019438	aromatic compound biosynthetic process	124	2.512206e-1	1.000000e+0	1.000000e+0	3.980565e+0	2.512206e-1	1	2.512206e-1	1.000000e+0	142	2.869791e-1	1.000000e+0	1.000000e+0	3.213573e+0	3.111801e-1	1	2807	5.000000e-1	3.562522e-4	unnamed	PRDM5
GO Biological Process	GO:0044271	cellular nitrogen compound biosynthetic process	125	2.531794e-1	1.000000e+0	1.000000e+0	3.949768e+0	2.531794e-1	1	2.531794e-1	1.000000e+0	143	2.917453e-1	1.000000e+0	1.000000e+0	3.156228e+0	3.168339e-1	1	2858	5.000000e-1	3.498950e-4	unnamed	PRDM5
GO Biological Process	GO:0044267	cellular protein metabolic process	126	2.533433e-1	1.000000e+0	1.000000e+0	3.947214e+0	2.533433e-1	1	2.533433e-1	1.000000e+0	63	2.645886e-2	1.000000e+0	1.000000e+0	6.146848e+0	3.253700e-1	2	2935	1.000000e+0	6.814310e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:1901362	organic cyclic compound biosynthetic process	127	2.593182e-1	1.000000e+0	1.000000e+0	3.856266e+0	2.593182e-1	1	2.593182e-1	1.000000e+0	144	2.978897e-1	1.000000e+0	1.000000e+0	3.084986e+0	3.241505e-1	1	2924	5.000000e-1	3.419973e-4	unnamed	PRDM5
GO Biological Process	GO:0016070	RNA metabolic process	128	2.686590e-1	1.000000e+0	1.000000e+0	3.722190e+0	2.686590e-1	1	2.686590e-1	1.000000e+0	147	3.211950e-1	1.000000e+0	1.000000e+0	2.839314e+0	3.521978e-1	1	3177	5.000000e-1	3.147624e-4	unnamed	PRDM5
GO Biological Process	GO:0010467	gene expression	129	2.836887e-1	1.000000e+0	1.000000e+0	3.524990e+0	2.836887e-1	1	2.836887e-1	1.000000e+0	154	3.441967e-1	1.000000e+0	1.000000e+0	2.629117e+0	3.803559e-1	1	3431	5.000000e-1	2.914602e-4	unnamed	PRDM5
GO Biological Process	GO:0034645	cellular macromolecule biosynthetic process	130	2.892943e-1	1.000000e+0	1.000000e+0	3.456687e+0	2.892943e-1	1	2.892943e-1	1.000000e+0	151	3.331981e-1	1.000000e+0	1.000000e+0	2.726050e+0	3.668311e-1	1	3309	5.000000e-1	3.022061e-4	unnamed	PRDM5
GO Biological Process	GO:0009059	macromolecule biosynthetic process	131	2.955002e-1	1.000000e+0	1.000000e+0	3.384092e+0	2.955002e-1	1	2.955002e-1	1.000000e+0	153	3.377168e-1	1.000000e+0	1.000000e+0	2.685472e+0	3.723740e-1	1	3359	5.000000e-1	2.977077e-4	unnamed	PRDM5
GO Biological Process	GO:0019538	protein metabolic process	132	2.975455e-1	1.000000e+0	1.000000e+0	3.360830e+0	2.975455e-1	1	2.975455e-1	1.000000e+0	73	3.773592e-2	1.000000e+0	1.000000e+0	5.147218e+0	3.885594e-1	2	3505	1.000000e+0	5.706134e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0006355	regulation of transcription, DNA-dependent	133	3.043461e-1	1.000000e+0	1.000000e+0	3.285733e+0	3.043461e-1	1	3.043461e-1	1.000000e+0	148	3.260273e-1	1.000000e+0	1.000000e+0	2.792724e+0	3.580733e-1	1	3230	5.000000e-1	3.095975e-4	unnamed	PRDM5
GO Biological Process	GO:2001141	regulation of RNA biosynthetic process	134	3.046463e-1	1.000000e+0	1.000000e+0	3.282495e+0	3.046463e-1	1	3.046463e-1	1.000000e+0	149	3.275736e-1	1.000000e+0	1.000000e+0	2.778103e+0	3.599579e-1	1	3247	5.000000e-1	3.079766e-4	unnamed	PRDM5
GO Biological Process	GO:0090304	nucleic acid metabolic process	135	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	161	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	PRDM5
GO Biological Process	GO:0051252	regulation of RNA metabolic process	136	3.113245e-1	1.000000e+0	1.000000e+0	3.212082e+0	3.113245e-1	1	3.113245e-1	1.000000e+0	152	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	PRDM5
GO Biological Process	GO:0048523	negative regulation of cellular process	137	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	66	2.844225e-2	1.000000e+0	1.000000e+0	5.928689e+0	3.373427e-1	2	3043	1.000000e+0	6.572461e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:2000112	regulation of cellular macromolecule biosynthetic process	138	3.236874e-1	1.000000e+0	1.000000e+0	3.089400e+0	3.236874e-1	1	3.236874e-1	1.000000e+0	155	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	PRDM5
GO Biological Process	GO:0010556	regulation of macromolecule biosynthetic process	139	3.285042e-1	1.000000e+0	1.000000e+0	3.044101e+0	3.285042e-1	1	3.285042e-1	1.000000e+0	156	3.578608e-1	1.000000e+0	1.000000e+0	2.516881e+0	3.973172e-1	1	3584	5.000000e-1	2.790179e-4	unnamed	PRDM5
GO Biological Process	GO:0048519	negative regulation of biological process	140	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	70	3.385698e-2	1.000000e+0	1.000000e+0	5.434036e+0	3.680506e-1	2	3320	1.000000e+0	6.024096e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0048522	positive regulation of cellular process	141	3.411192e-1	1.000000e+0	1.000000e+0	2.931526e+0	3.411192e-1	1	3.411192e-1	1.000000e+0	150	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	MAD2L1
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	142	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	158	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	PRDM5
GO Biological Process	GO:0010468	regulation of gene expression	143	3.434880e-1	1.000000e+0	1.000000e+0	2.911310e+0	3.434880e-1	1	3.434880e-1	1.000000e+0	159	3.723475e-1	1.000000e+0	1.000000e+0	2.406750e+0	4.154980e-1	1	3748	5.000000e-1	2.668090e-4	unnamed	PRDM5
GO Biological Process	GO:0009889	regulation of biosynthetic process	144	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	160	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	PRDM5
GO Biological Process	GO:0044249	cellular biosynthetic process	145	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	165	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	PRDM5
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	146	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	168	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	PRDM5
GO Biological Process	GO:1901576	organic substance biosynthetic process	147	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	166	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	PRDM5
GO Biological Process	GO:0009058	biosynthetic process	148	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	167	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	PRDM5
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	149	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	163	3.879706e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	3927	5.000000e-1	2.546473e-4	unnamed	PRDM5
GO Biological Process	GO:0046483	heterocycle metabolic process	150	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	169	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	PRDM5
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	151	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	170	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	PRDM5
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	152	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	164	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	PRDM5
GO Biological Process	GO:0048518	positive regulation of biological process	153	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	157	3.689175e-1	1.000000e+0	1.000000e+0	2.432057e+0	4.111745e-1	1	3709	5.000000e-1	2.696145e-4	unnamed	MAD2L1
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	154	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	171	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	PRDM5
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	155	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	172	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	PRDM5
GO Biological Process	GO:0016043	cellular component organization	156	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	83	4.979004e-2	1.000000e+0	1.000000e+0	4.481123e+0	4.463167e-1	2	4026	1.000000e+0	4.967710e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0071840	cellular component organization or biogenesis	157	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	87	5.287922e-2	1.000000e+0	1.000000e+0	4.348277e+0	4.599523e-1	2	4149	1.000000e+0	4.820439e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	158	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	91	6.596616e-2	1.000000e+0	1.000000e+0	3.893181e+0	5.137188e-1	2	4634	1.000000e+0	4.315926e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0006807	nitrogen compound metabolic process	159	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	173	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	PRDM5
GO Biological Process	GO:0080090	regulation of primary metabolic process	160	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	96	7.451216e-2	1.000000e+0	1.000000e+0	3.663147e+0	5.459786e-1	2	4925	1.000000e+0	4.060914e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0031323	regulation of cellular metabolic process	161	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	100	7.624706e-2	1.000000e+0	1.000000e+0	3.621236e+0	5.522975e-1	2	4982	1.000000e+0	4.014452e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0019222	regulation of metabolic process	162	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	104	9.333456e-2	1.000000e+0	1.000000e+0	3.273041e+0	6.110526e-1	2	5512	1.000000e+0	3.628447e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	163	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	115	1.170645e-1	1.000000e+0	1.000000e+0	2.922566e+0	6.843301e-1	2	6173	1.000000e+0	3.239916e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0043170	macromolecule metabolic process	164	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	121	1.412623e-1	1.000000e+0	1.000000e+0	2.660522e+0	7.517322e-1	2	6781	1.000000e+0	2.949417e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0044237	cellular metabolic process	165	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	129	2.082916e-1	1.000000e+0	1.000000e+0	2.191037e+0	9.128097e-1	2	8234	1.000000e+0	2.428953e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0044238	primary metabolic process	166	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	130	2.124101e-1	1.000000e+0	1.000000e+0	2.169693e+0	9.217893e-1	2	8315	1.000000e+0	2.405292e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0071704	organic substance metabolic process	167	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	132	2.252177e-1	1.000000e+0	1.000000e+0	2.107101e+0	9.491713e-1	2	8562	1.000000e+0	2.335903e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0008152	metabolic process	168	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	138	2.598086e-1	1.000000e+0	1.000000e+0	1.961831e+0	1.019456e+0	2	9196	1.000000e+0	2.174859e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0050794	regulation of cellular process	169	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	135	2.408423e-1	1.000000e+0	1.000000e+0	2.037610e+0	9.815420e-1	2	8854	1.000000e+0	2.258866e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0050789	regulation of biological process	170	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	139	2.673785e-1	1.000000e+0	1.000000e+0	1.933862e+0	1.034200e+0	2	9329	1.000000e+0	2.143853e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0065007	biological regulation	171	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	145	2.982605e-1	1.000000e+0	1.000000e+0	1.831016e+0	1.092290e+0	2	9853	1.000000e+0	2.029839e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0044763	single-organism cellular process	172	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	146	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0044699	single-organism process	173	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	162	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	MAD2L1,PRDM5
GO Biological Process	GO:0009987	cellular process	174	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	174	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0072686	mitotic spindle	1	2.326302e-3	1.000000e+0	1.000000e+0	4.298668e+2	2.326302e-3	1	2.326302e-3	1.000000e+0	1	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	MAD2L1
GO Cellular Component	GO:0005643	nuclear pore	2	5.350099e-3	1.000000e+0	1.000000e+0	1.869124e+2	5.350099e-3	1	5.350099e-3	1.000000e+0	2	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MAD2L1
GO Cellular Component	GO:0046930	pore complex	3	6.576552e-3	1.000000e+0	1.000000e+0	1.520554e+2	6.576552e-3	1	6.576552e-3	1.000000e+0	3	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	MAD2L1
GO Cellular Component	GO:0000777	condensed chromosome kinetochore	4	7.951056e-3	1.000000e+0	1.000000e+0	1.257695e+2	7.951056e-3	1	7.951056e-3	1.000000e+0	4	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	MAD2L1
GO Cellular Component	GO:0000779	condensed chromosome, centromeric region	5	8.063526e-3	1.000000e+0	1.000000e+0	1.240152e+2	8.063526e-3	1	8.063526e-3	1.000000e+0	5	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	MAD2L1
GO Cellular Component	GO:0000776	kinetochore	6	9.231094e-3	1.000000e+0	1.000000e+0	1.083295e+2	9.231094e-3	1	9.231094e-3	1.000000e+0	7	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	MAD2L1
GO Cellular Component	GO:0000922	spindle pole	7	9.779420e-3	1.000000e+0	1.000000e+0	1.022556e+2	9.779420e-3	1	9.779420e-3	1.000000e+0	6	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	MAD2L1
GO Cellular Component	GO:0000775	chromosome, centromeric region	8	1.314800e-2	1.000000e+0	1.000000e+0	7.605720e+1	1.314800e-2	1	1.314800e-2	1.000000e+0	8	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	MAD2L1
GO Cellular Component	GO:0000793	condensed chromosome	9	1.418418e-2	1.000000e+0	1.000000e+0	7.050105e+1	1.418418e-2	1	1.418418e-2	1.000000e+0	9	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	MAD2L1
GO Cellular Component	GO:0032993	protein-DNA complex	10	2.130231e-2	1.000000e+0	1.000000e+0	4.694326e+1	2.130231e-2	1	2.130231e-2	1.000000e+0	11	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	MAD2L1
GO Cellular Component	GO:0005819	spindle	11	2.347518e-2	1.000000e+0	1.000000e+0	4.259817e+1	2.347518e-2	1	2.347518e-2	1.000000e+0	10	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	MAD2L1
GO Cellular Component	GO:0005635	nuclear envelope	12	3.163396e-2	1.000000e+0	1.000000e+0	3.161160e+1	3.163396e-2	1	3.163396e-2	1.000000e+0	12	3.494330e-2	1.000000e+0	1.000000e+0	2.836635e+1	3.525303e-2	1	318	5.000000e-1	3.144654e-3	unnamed	MAD2L1
GO Cellular Component	GO:0048471	perinuclear region of cytoplasm	13	4.831620e-2	1.000000e+0	1.000000e+0	2.069699e+1	4.831620e-2	1	4.831620e-2	1.000000e+0	13	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	MAD2L1
GO Cellular Component	GO:0044427	chromosomal part	14	4.834754e-2	1.000000e+0	1.000000e+0	2.068358e+1	4.834754e-2	1	4.834754e-2	1.000000e+0	14	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	MAD2L1
GO Cellular Component	GO:0005694	chromosome	15	5.644203e-2	1.000000e+0	1.000000e+0	1.771729e+1	5.644203e-2	1	5.644203e-2	1.000000e+0	15	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	MAD2L1
GO Cellular Component	GO:0031967	organelle envelope	16	6.812257e-2	1.000000e+0	1.000000e+0	1.467942e+1	6.812257e-2	1	6.812257e-2	1.000000e+0	16	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	MAD2L1
GO Cellular Component	GO:0031975	envelope	17	6.827720e-2	1.000000e+0	1.000000e+0	1.464618e+1	6.827720e-2	1	6.827720e-2	1.000000e+0	17	9.401850e-2	1.000000e+0	1.000000e+0	1.038032e+1	9.633612e-2	1	869	5.000000e-1	1.150748e-3	unnamed	MAD2L1
GO Cellular Component	GO:0015630	microtubule cytoskeleton	18	8.547273e-2	1.000000e+0	1.000000e+0	1.169964e+1	8.547273e-2	1	8.547273e-2	1.000000e+0	18	1.006542e-1	1.000000e+0	1.000000e+0	9.678648e+0	1.033202e-1	1	932	5.000000e-1	1.072961e-3	unnamed	MAD2L1
GO Cellular Component	GO:0044430	cytoskeletal part	19	1.208518e-1	1.000000e+0	1.000000e+0	8.274597e+0	1.208518e-1	1	1.208518e-1	1.000000e+0	20	1.458062e-1	1.000000e+0	1.000000e+0	6.598756e+0	1.515437e-1	1	1367	5.000000e-1	7.315289e-4	unnamed	MAD2L1
GO Cellular Component	GO:0012505	endomembrane system	20	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	21	1.741537e-1	1.000000e+0	1.000000e+0	5.480255e+0	1.824733e-1	1	1646	5.000000e-1	6.075334e-4	unnamed	MAD2L1
GO Cellular Component	GO:0005856	cytoskeleton	21	1.730861e-1	1.000000e+0	1.000000e+0	5.777472e+0	1.730861e-1	1	1.730861e-1	1.000000e+0	22	1.976595e-1	1.000000e+0	1.000000e+0	4.795587e+0	2.085250e-1	1	1881	5.000000e-1	5.316321e-4	unnamed	MAD2L1
GO Cellular Component	GO:0044428	nuclear part	22	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	23	2.552742e-1	1.000000e+0	1.000000e+0	3.649070e+0	2.740425e-1	1	2472	5.000000e-1	4.045307e-4	unnamed	MAD2L1
GO Cellular Component	GO:0005829	cytosol	23	2.084988e-1	1.000000e+0	1.000000e+0	4.796191e+0	2.084988e-1	1	2.084988e-1	1.000000e+0	24	2.663307e-1	1.000000e+0	1.000000e+0	3.485510e+0	2.869021e-1	1	2588	5.000000e-1	3.863988e-4	unnamed	MAD2L1
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	24	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	27	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	MAD2L1
GO Cellular Component	GO:0043234	protein complex	25	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	28	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	MAD2L1
GO Cellular Component	GO:0032991	macromolecular complex	26	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	31	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	MAD2L1
GO Cellular Component	GO:0016021	integral to membrane	27	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	33	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	MAD2L1
GO Cellular Component	GO:0031224	intrinsic to membrane	28	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	35	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	MAD2L1
GO Cellular Component	GO:0044446	intracellular organelle part	29	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	37	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	MAD2L1
GO Cellular Component	GO:0005634	nucleus	30	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	19	1.133394e-1	1.000000e+0	1.000000e+0	2.970201e+0	6.733551e-1	2	6074	1.000000e+0	3.292723e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0044422	organelle part	31	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	38	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	MAD2L1
GO Cellular Component	GO:0044444	cytoplasmic part	32	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	39	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	MAD2L1
GO Cellular Component	GO:0044425	membrane part	33	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	36	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	MAD2L1
GO Cellular Component	GO:0016020	membrane	34	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	42	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	MAD2L1
GO Cellular Component	GO:0005737	cytoplasm	35	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	43	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	MAD2L1
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	36	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	25	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0043227	membrane-bounded organelle	37	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	26	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0043229	intracellular organelle	38	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	29	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0043226	organelle	39	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	30	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0044424	intracellular part	40	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	32	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0005622	intracellular	41	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	34	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0044464	cell part	42	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	40	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	MAD2L1,PRDM5
GO Cellular Component	GO:0005623	cell	43	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	41	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	MAD2L1,PRDM5
Mouse Phenotype	MP:0010965	decreased compact bone volume	1	7.064674e-4	1.000000e+0	1.000000e+0	1.415493e+3	7.064674e-4	1	7.064674e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PRDM5
Mouse Phenotype	MP:0011642	abnormal bone collagen fibril morphology	2	7.994187e-4	1.000000e+0	1.000000e+0	1.250909e+3	7.994187e-4	1	7.994187e-4	1.000000e+0	2	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PRDM5
Mouse Phenotype	MP:0009762	abnormal mitotic spindle assembly checkpoint	3	8.504348e-4	1.000000e+0	1.000000e+0	1.175869e+3	8.504348e-4	1	8.504348e-4	1.000000e+0	3	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MAD2L1
Mouse Phenotype	MP:0003815	hairless	4	1.333841e-3	1.000000e+0	1.000000e+0	7.497147e+2	1.333841e-3	1	1.333841e-3	1.000000e+0	6	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0010963	abnormal compact bone volume	5	1.382646e-3	1.000000e+0	1.000000e+0	7.232507e+2	1.382646e-3	1	1.382646e-3	1.000000e+0	5	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	PRDM5
Mouse Phenotype	MP:0011194	abnormal hair follicle physiology	6	2.421193e-3	1.000000e+0	1.000000e+0	4.130194e+2	2.421193e-3	1	2.421193e-3	1.000000e+0	4	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	MAD2L1
Mouse Phenotype	MP:0010681	abnormal hair follicle bulb morphology	7	2.447069e-3	1.000000e+0	1.000000e+0	4.086521e+2	2.447069e-3	1	2.447069e-3	1.000000e+0	6	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0010380	abnormal inner cell mass apoptosis	8	2.638796e-3	1.000000e+0	1.000000e+0	3.789606e+2	2.638796e-3	1	2.638796e-3	1.000000e+0	8	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0012114	absent inner cell mass proliferation	9	3.095246e-3	1.000000e+0	1.000000e+0	3.230761e+2	3.095246e-3	1	3.095246e-3	1.000000e+0	12	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0008481	increased spleen germinal center number	10	3.145485e-3	1.000000e+0	1.000000e+0	3.179160e+2	3.145485e-3	1	3.145485e-3	1.000000e+0	9	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0004965	inner cell mass degeneration	11	3.358718e-3	1.000000e+0	1.000000e+0	2.977326e+2	3.358718e-3	1	3.358718e-3	1.000000e+0	10	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0004045	abnormal cell cycle checkpoint function	12	4.183364e-3	1.000000e+0	1.000000e+0	2.390421e+2	4.183364e-3	1	4.183364e-3	1.000000e+0	14	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0004024	aneuploidy	13	4.788014e-3	1.000000e+0	1.000000e+0	2.088548e+2	4.788014e-3	1	4.788014e-3	1.000000e+0	13	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0010879	decreased trabecular bone volume	14	4.880221e-3	1.000000e+0	1.000000e+0	2.049088e+2	4.880221e-3	1	4.880221e-3	1.000000e+0	11	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	PRDM5
Mouse Phenotype	MP:0004028	chromosome breakage	15	5.508062e-3	1.000000e+0	1.000000e+0	1.815520e+2	5.508062e-3	1	5.508062e-3	1.000000e+0	17	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0004966	abnormal inner cell mass proliferation	16	5.621959e-3	1.000000e+0	1.000000e+0	1.778739e+2	5.621959e-3	1	5.621959e-3	1.000000e+0	15	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0004023	abnormal chromosome number	17	5.908002e-3	1.000000e+0	1.000000e+0	1.692619e+2	5.908002e-3	1	5.908002e-3	1.000000e+0	20	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0002027	lung adenocarcinoma	18	6.674635e-3	1.000000e+0	1.000000e+0	1.498209e+2	6.674635e-3	1	6.674635e-3	1.000000e+0	19	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0008716	lung non-small cell carcinoma	19	7.123287e-3	1.000000e+0	1.000000e+0	1.403846e+2	7.123287e-3	1	7.123287e-3	1.000000e+0	21	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0010877	abnormal trabecular bone volume	20	7.865759e-3	1.000000e+0	1.000000e+0	1.271333e+2	7.865759e-3	1	7.865759e-3	1.000000e+0	18	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PRDM5
Mouse Phenotype	MP:0002718	abnormal inner cell mass morphology	21	8.027305e-3	1.000000e+0	1.000000e+0	1.245748e+2	8.027305e-3	1	8.027305e-3	1.000000e+0	22	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0008714	lung carcinoma	22	8.130735e-3	1.000000e+0	1.000000e+0	1.229901e+2	8.130735e-3	1	8.130735e-3	1.000000e+0	24	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	MAD2L1
Mouse Phenotype	MP:0001242	hyperkeratosis	23	8.825531e-3	1.000000e+0	1.000000e+0	1.133076e+2	8.825531e-3	1	8.825531e-3	1.000000e+0	26	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010876	decreased bone volume	24	8.886798e-3	1.000000e+0	1.000000e+0	1.125265e+2	8.886798e-3	1	8.886798e-3	1.000000e+0	15	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PRDM5
Mouse Phenotype	MP:0008866	chromosomal instability	25	9.832341e-3	1.000000e+0	1.000000e+0	1.017052e+2	9.832341e-3	1	9.832341e-3	1.000000e+0	28	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010094	abnormal chromosome stability	26	9.881449e-3	1.000000e+0	1.000000e+0	1.011997e+2	9.881449e-3	1	9.881449e-3	1.000000e+0	31	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002359	abnormal spleen germinal center morphology	27	1.043890e-2	1.000000e+0	1.000000e+0	9.579557e+1	1.043890e-2	1	1.043890e-2	1.000000e+0	33	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010124	decreased bone mineral content	28	1.059161e-2	1.000000e+0	1.000000e+0	9.441437e+1	1.059161e-2	1	1.059161e-2	1.000000e+0	23	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PRDM5
Mouse Phenotype	MP:0008472	abnormal spleen secondary B follicle morphology	29	1.097142e-2	1.000000e+0	1.000000e+0	9.114588e+1	1.097142e-2	1	1.097142e-2	1.000000e+0	34	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0004046	abnormal mitosis	30	1.141663e-2	1.000000e+0	1.000000e+0	8.759154e+1	1.141663e-2	1	1.141663e-2	1.000000e+0	28	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0008014	increased lung tumor incidence	31	1.298326e-2	1.000000e+0	1.000000e+0	7.702228e+1	1.298326e-2	1	1.298326e-2	1.000000e+0	36	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0001240	abnormal epidermis stratum corneum morphology	32	1.317503e-2	1.000000e+0	1.000000e+0	7.590113e+1	1.317503e-2	1	1.317503e-2	1.000000e+0	40	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0003111	abnormal cell nucleus morphology	33	1.402786e-2	1.000000e+0	1.000000e+0	7.128670e+1	1.402786e-2	1	1.402786e-2	1.000000e+0	39	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010874	abnormal bone volume	34	1.409555e-2	1.000000e+0	1.000000e+0	7.094437e+1	1.409555e-2	1	1.409555e-2	1.000000e+0	27	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	PRDM5
Mouse Phenotype	MP:0010122	abnormal bone mineral content	35	1.416982e-2	1.000000e+0	1.000000e+0	7.057253e+1	1.416982e-2	1	1.416982e-2	1.000000e+0	30	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	PRDM5
Mouse Phenotype	MP:0008470	abnormal spleen B cell follicle morphology	36	1.488894e-2	1.000000e+0	1.000000e+0	6.716396e+1	1.488894e-2	1	1.488894e-2	1.000000e+0	43	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0009308	adenocarcinoma	37	1.492238e-2	1.000000e+0	1.000000e+0	6.701344e+1	1.492238e-2	1	1.492238e-2	1.000000e+0	41	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0008932	abnormal embryonic tissue physiology	38	1.493424e-2	1.000000e+0	1.000000e+0	6.696020e+1	1.493424e-2	1	1.493424e-2	1.000000e+0	25	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002021	increased incidence of induced tumors	39	1.567887e-2	1.000000e+0	1.000000e+0	6.378010e+1	1.567887e-2	1	1.567887e-2	1.000000e+0	38	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0003797	abnormal compact bone morphology	40	1.717998e-2	1.000000e+0	1.000000e+0	5.820730e+1	1.717998e-2	1	1.717998e-2	1.000000e+0	37	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	PRDM5
Mouse Phenotype	MP:0004986	abnormal osteoblast morphology	41	1.836525e-2	1.000000e+0	1.000000e+0	5.445067e+1	1.836525e-2	1	1.836525e-2	1.000000e+0	35	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	PRDM5
Mouse Phenotype	MP:0000060	delayed bone ossification	42	1.872413e-2	1.000000e+0	1.000000e+0	5.340702e+1	1.872413e-2	1	1.872413e-2	1.000000e+0	31	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	PRDM5
Mouse Phenotype	MP:0010680	abnormal skin adnexa physiology	43	2.001286e-2	1.000000e+0	1.000000e+0	4.996788e+1	2.001286e-2	1	2.001286e-2	1.000000e+0	42	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0004957	abnormal blastocyst morphology	44	2.026522e-2	1.000000e+0	1.000000e+0	4.934563e+1	2.026522e-2	1	2.026522e-2	1.000000e+0	46	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0003077	abnormal cell cycle	45	2.376361e-2	1.000000e+0	1.000000e+0	4.208115e+1	2.376361e-2	1	2.376361e-2	1.000000e+0	48	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000377	abnormal hair follicle morphology	46	2.441363e-2	1.000000e+0	1.000000e+0	4.096073e+1	2.441363e-2	1	2.441363e-2	1.000000e+0	44	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000063	decreased bone mineral density	47	2.503843e-2	1.000000e+0	1.000000e+0	3.993860e+1	2.503843e-2	1	2.503843e-2	1.000000e+0	45	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PRDM5
Mouse Phenotype	MP:0011096	complete embryonic lethality between implantation and somite formation	48	2.707518e-2	1.000000e+0	1.000000e+0	3.693420e+1	2.707518e-2	1	2.707518e-2	1.000000e+0	52	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002038	carcinoma	49	2.714825e-2	1.000000e+0	1.000000e+0	3.683478e+1	2.714825e-2	1	2.714825e-2	1.000000e+0	51	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002357	abnormal spleen white pulp morphology	50	2.859597e-2	1.000000e+0	1.000000e+0	3.496997e+1	2.859597e-2	1	2.859597e-2	1.000000e+0	56	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0006205	embryonic lethality between implantation and somite formation	51	2.974573e-2	1.000000e+0	1.000000e+0	3.361827e+1	2.974573e-2	1	2.974573e-2	1.000000e+0	54	3.287295e-2	1.000000e+0	1.000000e+0	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0005501	abnormal skin physiology	52	2.990313e-2	1.000000e+0	1.000000e+0	3.344131e+1	2.990313e-2	1	2.990313e-2	1.000000e+0	53	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000130	abnormal trabecular bone morphology	53	2.999890e-2	1.000000e+0	1.000000e+0	3.333456e+1	2.999890e-2	1	2.999890e-2	1.000000e+0	47	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	PRDM5
Mouse Phenotype	MP:0009781	abnormal preimplantation embryo development	54	3.036362e-2	1.000000e+0	1.000000e+0	3.293415e+1	3.036362e-2	1	3.036362e-2	1.000000e+0	56	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0001216	abnormal epidermal layer morphology	55	3.084585e-2	1.000000e+0	1.000000e+0	3.241927e+1	3.084585e-2	1	3.084585e-2	1.000000e+0	55	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010119	abnormal bone mineral density	56	3.282881e-2	1.000000e+0	1.000000e+0	3.046105e+1	3.282881e-2	1	3.282881e-2	1.000000e+0	48	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	PRDM5
Mouse Phenotype	MP:0002073	abnormal hair growth	57	3.323816e-2	1.000000e+0	1.000000e+0	3.008590e+1	3.323816e-2	1	3.323816e-2	1.000000e+0	50	2.938103e-2	1.000000e+0	1.000000e+0	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002018	malignant tumors	58	3.474739e-2	1.000000e+0	1.000000e+0	2.877914e+1	3.474739e-2	1	3.474739e-2	1.000000e+0	58	3.646740e-2	1.000000e+0	1.000000e+0	2.717018e+1	3.680506e-2	1	332	5.000000e-1	3.012048e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000358	abnormal cell morphology	59	3.732183e-2	1.000000e+0	1.000000e+0	2.679397e+1	3.732183e-2	1	3.732183e-2	1.000000e+0	60	4.385306e-2	1.000000e+0	1.000000e+0	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0009850	embryonic lethality between implantation and placentation	60	4.196084e-2	1.000000e+0	1.000000e+0	2.383174e+1	4.196084e-2	1	4.196084e-2	1.000000e+0	61	4.699418e-2	1.000000e+0	1.000000e+0	2.102681e+1	4.755834e-2	1	429	5.000000e-1	2.331002e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010273	increased classified tumor incidence	61	5.452900e-2	1.000000e+0	1.000000e+0	1.833887e+1	5.452900e-2	1	5.452900e-2	1.000000e+0	64	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0008271	abnormal bone ossification	62	5.470209e-2	1.000000e+0	1.000000e+0	1.828084e+1	5.470209e-2	1	5.470209e-2	1.000000e+0	59	3.918602e-2	1.000000e+0	1.000000e+0	2.526751e+1	3.957652e-2	1	357	5.000000e-1	2.801120e-3	unnamed	PRDM5
Mouse Phenotype	MP:0001510	abnormal coat appearance	63	5.881193e-2	1.000000e+0	1.000000e+0	1.700335e+1	5.881193e-2	1	5.881193e-2	1.000000e+0	62	5.250568e-2	1.000000e+0	1.000000e+0	1.879271e+1	5.321213e-2	1	480	5.000000e-1	2.083333e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	64	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	65	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000367	abnormal coat/ hair morphology	65	6.170842e-2	1.000000e+0	1.000000e+0	1.620524e+1	6.170842e-2	1	6.170842e-2	1.000000e+0	63	5.455490e-2	1.000000e+0	1.000000e+0	1.807715e+1	5.531844e-2	1	499	5.000000e-1	2.004008e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0001698	decreased embryo size	66	6.752872e-2	1.000000e+0	1.000000e+0	1.480851e+1	6.752872e-2	1	6.752872e-2	1.000000e+0	66	6.133380e-2	1.000000e+0	1.000000e+0	1.605071e+1	6.230253e-2	1	562	5.000000e-1	1.779359e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0001697	abnormal embryo size	67	6.914308e-2	1.000000e+0	1.000000e+0	1.446276e+1	6.914308e-2	1	6.914308e-2	1.000000e+0	68	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002020	increased tumor incidence	68	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	70	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0003795	abnormal bone structure	69	7.209275e-2	1.000000e+0	1.000000e+0	1.387102e+1	7.209275e-2	1	7.209275e-2	1.000000e+0	67	6.165600e-2	1.000000e+0	1.000000e+0	1.596549e+1	6.263511e-2	1	565	5.000000e-1	1.769912e-3	unnamed	PRDM5
Mouse Phenotype	MP:0001533	abnormal skeleton physiology	70	7.413401e-2	1.000000e+0	1.000000e+0	1.348909e+1	7.413401e-2	1	7.413401e-2	1.000000e+0	69	6.272959e-2	1.000000e+0	1.000000e+0	1.568783e+1	6.374369e-2	1	575	5.000000e-1	1.739130e-3	unnamed	PRDM5
Mouse Phenotype	MP:0002019	abnormal tumor incidence	71	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	72	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002166	altered tumor susceptibility	72	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	74	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000689	abnormal spleen morphology	73	8.333506e-2	1.000000e+0	1.000000e+0	1.199975e+1	8.333506e-2	1	8.333506e-2	1.000000e+0	80	8.979273e-2	1.000000e+0	1.000000e+0	1.088118e+1	9.190178e-2	1	829	5.000000e-1	1.206273e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0006042	increased apoptosis	74	8.429662e-2	1.000000e+0	1.000000e+0	1.186287e+1	8.429662e-2	1	8.429662e-2	1.000000e+0	75	7.939802e-2	1.000000e+0	1.000000e+0	1.233995e+1	8.103764e-2	1	731	5.000000e-1	1.367989e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010866	abnormal prenatal body size	75	8.435389e-2	1.000000e+0	1.000000e+0	1.185482e+1	8.435389e-2	1	8.435389e-2	1.000000e+0	71	7.663033e-2	1.000000e+0	1.000000e+0	1.279504e+1	7.815531e-2	1	705	5.000000e-1	1.418440e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002060	abnormal skin morphology	76	8.538698e-2	1.000000e+0	1.000000e+0	1.171139e+1	8.538698e-2	1	8.538698e-2	1.000000e+0	77	8.428452e-2	1.000000e+0	1.000000e+0	1.160940e+1	8.613713e-2	1	777	5.000000e-1	1.287001e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002006	tumorigenesis	77	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	78	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0010678	abnormal skin adnexa morphology	78	9.474627e-2	1.000000e+0	1.000000e+0	1.055450e+1	9.474627e-2	1	9.474627e-2	1.000000e+0	76	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0000350	abnormal cell proliferation	79	9.545087e-2	1.000000e+0	1.000000e+0	1.047659e+1	9.545087e-2	1	9.545087e-2	1.000000e+0	81	9.021575e-2	1.000000e+0	1.000000e+0	1.082893e+1	9.234521e-2	1	833	5.000000e-1	1.200480e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002088	abnormal embryonic growth/weight/body size	80	9.953028e-2	1.000000e+0	1.000000e+0	1.004719e+1	9.953028e-2	1	9.953028e-2	1.000000e+0	79	8.947540e-2	1.000000e+0	1.000000e+0	1.092070e+1	9.156920e-2	1	826	5.000000e-1	1.210654e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0011086	partial postnatal lethality	81	1.002907e-1	1.000000e+0	1.000000e+0	9.971019e+0	1.002907e-1	1	1.002907e-1	1.000000e+0	73	7.822758e-2	1.000000e+0	1.000000e+0	1.252847e+1	7.981819e-2	1	720	5.000000e-1	1.388889e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0002722	abnormal immune system organ morphology	82	1.102968e-1	1.000000e+0	1.000000e+0	9.066446e+0	1.102968e-1	1	1.102968e-1	1.000000e+0	84	1.202068e-1	1.000000e+0	1.000000e+0	8.061215e+0	1.240508e-1	1	1119	5.000000e-1	8.936550e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0002085	abnormal embryonic tissue morphology	83	1.131386e-1	1.000000e+0	1.000000e+0	8.838720e+0	1.131386e-1	1	1.131386e-1	1.000000e+0	82	9.391298e-2	1.000000e+0	1.000000e+0	1.039228e+1	9.622526e-2	1	868	5.000000e-1	1.152074e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0004196	abnormal prenatal growth/weight/body size	84	1.174251e-1	1.000000e+0	1.000000e+0	8.516069e+0	1.174251e-1	1	1.174251e-1	1.000000e+0	83	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	MAD2L1
Mouse Phenotype	MP:0001648	abnormal apoptosis	85	1.225891e-1	1.000000e+0	1.000000e+0	8.157331e+0	1.225891e-1	1	1.225891e-1	1.000000e+0	85	1.205188e-1	1.000000e+0	1.000000e+0	8.039661e+0	1.243833e-1	1	1122	5.000000e-1	8.912656e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0000313	abnormal cell death	86	1.373532e-1	1.000000e+0	1.000000e+0	7.280503e+0	1.373532e-1	1	1.373532e-1	1.000000e+0	87	1.377955e-1	1.000000e+0	1.000000e+0	6.998061e+0	1.428967e-1	1	1289	5.000000e-1	7.757952e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0008762	embryonic lethality	87	1.587123e-1	1.000000e+0	1.000000e+0	6.300711e+0	1.587123e-1	1	1.587123e-1	1.000000e+0	92	1.667828e-1	1.000000e+0	1.000000e+0	5.734584e+0	1.743806e-1	1	1573	5.000000e-1	6.357279e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0002082	postnatal lethality	88	1.637535e-1	1.000000e+0	1.000000e+0	6.106739e+0	1.637535e-1	1	1.637535e-1	1.000000e+0	86	1.329505e-1	1.000000e+0	1.000000e+0	7.262882e+0	1.376864e-1	1	1242	5.000000e-1	8.051530e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005508	abnormal skeleton morphology	89	1.720465e-1	1.000000e+0	1.000000e+0	5.812383e+0	1.720465e-1	1	1.720465e-1	1.000000e+0	88	1.447813e-1	1.000000e+0	1.000000e+0	6.647384e+0	1.504351e-1	1	1357	5.000000e-1	7.369197e-4	unnamed	PRDM5
Mouse Phenotype	MP:0010771	integument phenotype	90	1.731215e-1	1.000000e+0	1.000000e+0	5.776291e+0	1.731215e-1	1	1.731215e-1	1.000000e+0	90	1.570398e-1	1.000000e+0	1.000000e+0	6.107312e+0	1.637382e-1	1	1477	5.000000e-1	6.770481e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0001672	abnormal embryogenesis/ development	91	1.759787e-1	1.000000e+0	1.000000e+0	5.682507e+0	1.759787e-1	1	1.759787e-1	1.000000e+0	91	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005390	skeleton phenotype	92	1.793833e-1	1.000000e+0	1.000000e+0	5.574655e+0	1.793833e-1	1	1.793833e-1	1.000000e+0	89	1.554104e-1	1.000000e+0	1.000000e+0	6.174196e+0	1.619644e-1	1	1461	5.000000e-1	6.844627e-4	unnamed	PRDM5
Mouse Phenotype	MP:0000685	abnormal immune system morphology	93	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	94	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	94	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	97	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	95	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	98	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0002080	prenatal lethality	96	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	95	2.134693e-1	1.000000e+0	1.000000e+0	4.419647e+0	2.262624e-1	1	2041	5.000000e-1	4.899559e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005387	immune system phenotype	97	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	99	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	98	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	96	2.188676e-1	1.000000e+0	1.000000e+0	4.303674e+0	2.323596e-1	1	2096	5.000000e-1	4.770992e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005621	abnormal cell physiology	99	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	100	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005384	cellular phenotype	100	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	101	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0005378	growth/size phenotype	101	3.447235e-1	1.000000e+0	1.000000e+0	2.900875e+0	3.447235e-1	1	3.447235e-1	1.000000e+0	102	3.172618e-1	1.000000e+0	1.000000e+0	2.878271e+0	3.474309e-1	1	3134	5.000000e-1	3.190810e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0010770	preweaning lethality	102	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	103	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0010769	abnormal survival	103	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	104	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0010768	mortality/aging	104	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	105	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	MAD2L1
Mouse Phenotype	MP:0000001	mammalian phenotype	105	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	93	1.739173e-1	1.000000e+0	1.000000e+0	2.397794e+0	8.341001e-1	2	7524	1.000000e+0	2.658161e-4	unnamed	MAD2L1,PRDM5
Human Phenotype	HP:0007720	Flat cornea	1	3.845211e-4	1.000000e+0	1.000000e+0	2.600638e+3	3.845211e-4	1	3.845211e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PRDM5
Human Phenotype	HP:0001119	Keratoglobus	2	5.100898e-4	1.000000e+0	1.000000e+0	1.960439e+3	5.100898e-4	1	5.100898e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PRDM5
Human Phenotype	HP:0000563	Keratoconus	3	1.754214e-3	1.000000e+0	1.000000e+0	5.700557e+2	1.754214e-3	1	1.754214e-3	1.000000e+0	3	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PRDM5
Human Phenotype	HP:0000485	Megalocornea	4	2.611587e-3	1.000000e+0	1.000000e+0	3.829090e+2	2.611587e-3	1	2.611587e-3	1.000000e+0	3	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PRDM5
Human Phenotype	HP:0000647	Sclerocornea	5	3.330285e-3	1.000000e+0	1.000000e+0	3.002746e+2	3.330285e-3	1	3.330285e-3	1.000000e+0	5	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PRDM5
Human Phenotype	HP:0200020	Corneal erosions	6	3.432359e-3	1.000000e+0	1.000000e+0	2.913448e+2	3.432359e-3	1	3.432359e-3	1.000000e+0	6	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PRDM5
Human Phenotype	HP:0000592	Blue sclerae	7	4.242106e-3	1.000000e+0	1.000000e+0	2.357320e+2	4.242106e-3	1	4.242106e-3	1.000000e+0	7	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PRDM5
Human Phenotype	HP:0000591	Abnormality of the sclera	8	4.512551e-3	1.000000e+0	1.000000e+0	2.216041e+2	4.512551e-3	1	4.512551e-3	1.000000e+0	9	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PRDM5
Human Phenotype	HP:0011495	Abnormality of corneal epithelium	9	4.625993e-3	1.000000e+0	1.000000e+0	2.161698e+2	4.625993e-3	1	4.625993e-3	1.000000e+0	11	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	PRDM5
Human Phenotype	HP:0001131	Corneal dystrophy	10	4.644812e-3	1.000000e+0	1.000000e+0	2.152940e+2	4.644812e-3	1	4.644812e-3	1.000000e+0	8	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	PRDM5
Human Phenotype	HP:0003326	Myalgia	11	5.298781e-3	1.000000e+0	1.000000e+0	1.887226e+2	5.298781e-3	1	5.298781e-3	1.000000e+0	11	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	PRDM5
Human Phenotype	HP:0000541	Retinal detachment	12	6.431379e-3	1.000000e+0	1.000000e+0	1.554876e+2	6.431379e-3	1	6.431379e-3	1.000000e+0	10	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PRDM5
Human Phenotype	HP:0100689	Decreased corneal thickness	13	7.132799e-3	1.000000e+0	1.000000e+0	1.401974e+2	7.132799e-3	1	7.132799e-3	1.000000e+0	18	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	PRDM5
Human Phenotype	HP:0011486	Abnormality of corneal thickness	14	7.410583e-3	1.000000e+0	1.000000e+0	1.349422e+2	7.410583e-3	1	7.410583e-3	1.000000e+0	19	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PRDM5
Human Phenotype	HP:0000978	Bruising susceptibility	15	7.665722e-3	1.000000e+0	1.000000e+0	1.304509e+2	7.665722e-3	1	7.665722e-3	1.000000e+0	17	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PRDM5
Human Phenotype	HP:0100691	Abnormality of the curvature of the cornea	16	8.639857e-3	1.000000e+0	1.000000e+0	1.157427e+2	8.639857e-3	1	8.639857e-3	1.000000e+0	14	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	PRDM5
Human Phenotype	HP:0001633	Abnormality of the mitral valve	17	9.002976e-3	1.000000e+0	1.000000e+0	1.110744e+2	9.002976e-3	1	9.002976e-3	1.000000e+0	13	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PRDM5
Human Phenotype	HP:0000987	Atypical scarring of skin	18	9.492875e-3	1.000000e+0	1.000000e+0	1.053422e+2	9.492875e-3	1	9.492875e-3	1.000000e+0	21	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	PRDM5
Human Phenotype	HP:0006705	Abnormality of the atrioventricular valves	19	9.578845e-3	1.000000e+0	1.000000e+0	1.043967e+2	9.578845e-3	1	9.578845e-3	1.000000e+0	16	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	PRDM5
Human Phenotype	HP:0001933	Subcutaneous hemorrhage	20	9.738658e-3	1.000000e+0	1.000000e+0	1.026836e+2	9.738658e-3	1	9.738658e-3	1.000000e+0	24	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	PRDM5
Human Phenotype	HP:0001641	Abnormality of the pulmonary valve	21	9.779826e-3	1.000000e+0	1.000000e+0	1.022513e+2	9.779826e-3	1	9.779826e-3	1.000000e+0	15	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	PRDM5
Human Phenotype	HP:0100699	Scarring	22	9.917120e-3	1.000000e+0	1.000000e+0	1.008357e+2	9.917120e-3	1	9.917120e-3	1.000000e+0	23	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PRDM5
Human Phenotype	HP:0002757	Recurrent fractures	23	1.262127e-2	1.000000e+0	1.000000e+0	7.923132e+1	1.262127e-2	1	1.262127e-2	1.000000e+0	21	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	PRDM5
Human Phenotype	HP:0002659	Increased susceptibility to fractures	24	1.442513e-2	1.000000e+0	1.000000e+0	6.932347e+1	1.442513e-2	1	1.442513e-2	1.000000e+0	25	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	PRDM5
Human Phenotype	HP:0001120	Abnormality of corneal size	25	1.479072e-2	1.000000e+0	1.000000e+0	6.760998e+1	1.479072e-2	1	1.479072e-2	1.000000e+0	20	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	PRDM5
Human Phenotype	HP:0000405	Conductive hearing impairment	26	1.627022e-2	1.000000e+0	1.000000e+0	6.146199e+1	1.627022e-2	1	1.627022e-2	1.000000e+0	26	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	PRDM5
Human Phenotype	HP:0007957	Corneal opacity	27	1.637968e-2	1.000000e+0	1.000000e+0	6.105125e+1	1.637968e-2	1	1.637968e-2	1.000000e+0	31	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	PRDM5
Human Phenotype	HP:0001654	Abnormality of the heart valves	28	1.669885e-2	1.000000e+0	1.000000e+0	5.988435e+1	1.669885e-2	1	1.669885e-2	1.000000e+0	28	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	PRDM5
Human Phenotype	HP:0011452	Functional abnormality of the middle ear	29	1.678248e-2	1.000000e+0	1.000000e+0	5.958595e+1	1.678248e-2	1	1.678248e-2	1.000000e+0	27	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	PRDM5
Human Phenotype	HP:0001892	Abnormal bleeding	30	1.685969e-2	1.000000e+0	1.000000e+0	5.931306e+1	1.685969e-2	1	1.685969e-2	1.000000e+0	34	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	PRDM5
Human Phenotype	HP:0005930	Abnormality of the epiphyses	31	1.752650e-2	1.000000e+0	1.000000e+0	5.705644e+1	1.752650e-2	1	1.752650e-2	1.000000e+0	30	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	PRDM5
Human Phenotype	HP:0001382	Joint hypermobility	32	1.780788e-2	1.000000e+0	1.000000e+0	5.615492e+1	1.780788e-2	1	1.780788e-2	1.000000e+0	29	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PRDM5
Human Phenotype	HP:0011276	Vascular skin abnormality	33	1.939619e-2	1.000000e+0	1.000000e+0	5.155651e+1	1.939619e-2	1	1.939619e-2	1.000000e+0	40	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	PRDM5
Human Phenotype	HP:0000501	Glaucoma	34	2.135653e-2	1.000000e+0	1.000000e+0	4.682408e+1	2.135653e-2	1	2.135653e-2	1.000000e+0	33	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PRDM5
Human Phenotype	HP:0000545	Myopia	35	2.321840e-2	1.000000e+0	1.000000e+0	4.306928e+1	2.321840e-2	1	2.321840e-2	1.000000e+0	32	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PRDM5
Human Phenotype	HP:0000370	Abnormality of the middle ear	36	2.356312e-2	1.000000e+0	1.000000e+0	4.243920e+1	2.356312e-2	1	2.356312e-2	1.000000e+0	37	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	PRDM5
Human Phenotype	HP:0004349	Reduced bone mineral density	37	2.455397e-2	1.000000e+0	1.000000e+0	4.072661e+1	2.455397e-2	1	2.455397e-2	1.000000e+0	36	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	PRDM5
Human Phenotype	HP:0003272	Abnormality of the hip bone	38	2.734385e-2	1.000000e+0	1.000000e+0	3.657130e+1	2.734385e-2	1	2.734385e-2	1.000000e+0	35	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	PRDM5
Human Phenotype	HP:0000539	Abnormality of refraction	39	2.887770e-2	1.000000e+0	1.000000e+0	3.462879e+1	2.887770e-2	1	2.887770e-2	1.000000e+0	37	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	PRDM5
Human Phenotype	HP:0004348	Abnormality of bone mineral density	40	3.181401e-2	1.000000e+0	1.000000e+0	3.143270e+1	3.181401e-2	1	3.181401e-2	1.000000e+0	45	3.145511e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	286	5.000000e-1	3.496503e-3	unnamed	PRDM5
Human Phenotype	HP:0011843	Abnormality of skeletal physiology	41	3.183243e-2	1.000000e+0	1.000000e+0	3.141451e+1	3.183243e-2	1	3.183243e-2	1.000000e+0	44	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	PRDM5
Human Phenotype	HP:0002644	Abnormality of pelvic girdle bone morphology	42	3.309154e-2	1.000000e+0	1.000000e+0	3.021920e+1	3.309154e-2	1	3.309154e-2	1.000000e+0	41	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	PRDM5
Human Phenotype	HP:0100790	Hernia	43	3.328132e-2	1.000000e+0	1.000000e+0	3.004688e+1	3.328132e-2	1	3.328132e-2	1.000000e+0	39	2.621103e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	PRDM5
Human Phenotype	HP:0000175	Cleft palate	44	3.555289e-2	1.000000e+0	1.000000e+0	2.812711e+1	3.555289e-2	1	3.555289e-2	1.000000e+0	42	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	PRDM5
Human Phenotype	HP:0100737	Abnormality of the hard palate	45	3.615159e-2	1.000000e+0	1.000000e+0	2.766130e+1	3.615159e-2	1	3.615159e-2	1.000000e+0	43	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	PRDM5
Human Phenotype	HP:0011314	Abnormality of long bone morphology	46	3.664344e-2	1.000000e+0	1.000000e+0	2.729001e+1	3.664344e-2	1	3.664344e-2	1.000000e+0	46	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	PRDM5
Human Phenotype	HP:0001288	Gait disturbance	47	3.682158e-2	1.000000e+0	1.000000e+0	2.715798e+1	3.682158e-2	1	3.682158e-2	1.000000e+0	48	3.603207e-2	1.000000e+0	1.000000e+0	2.750152e+1	3.636162e-2	1	328	5.000000e-1	3.048780e-3	unnamed	PRDM5
Human Phenotype	HP:0000481	Abnormality of the cornea	48	3.847321e-2	1.000000e+0	1.000000e+0	2.599211e+1	3.847321e-2	1	3.847321e-2	1.000000e+0	50	3.994654e-2	1.000000e+0	1.000000e+0	2.478159e+1	4.035253e-2	1	364	5.000000e-1	2.747253e-3	unnamed	PRDM5
Human Phenotype	HP:0100491	Abnormality of the joints of the lower limbs	49	3.853177e-2	1.000000e+0	1.000000e+0	2.595261e+1	3.853177e-2	1	3.853177e-2	1.000000e+0	48	3.603207e-2	1.000000e+0	1.000000e+0	2.750152e+1	3.636162e-2	1	328	5.000000e-1	3.048780e-3	unnamed	PRDM5
Human Phenotype	HP:0000202	Oral cleft	50	4.063484e-2	1.000000e+0	1.000000e+0	2.460943e+1	4.063484e-2	1	4.063484e-2	1.000000e+0	47	3.396288e-2	1.000000e+0	1.000000e+0	2.919256e+1	3.425531e-2	1	309	5.000000e-1	3.236246e-3	unnamed	PRDM5
Human Phenotype	HP:0003330	Abnormal bone structure	51	4.132243e-2	1.000000e+0	1.000000e+0	2.419993e+1	4.132243e-2	1	4.132243e-2	1.000000e+0	51	4.081535e-2	1.000000e+0	1.000000e+0	2.424866e+1	4.123940e-2	1	372	5.000000e-1	2.688172e-3	unnamed	PRDM5
Human Phenotype	HP:0000479	Abnormality of the retina	52	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	55	4.829244e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	441	5.000000e-1	2.267574e-3	unnamed	PRDM5
Human Phenotype	HP:0002650	Scoliosis	53	4.610557e-2	1.000000e+0	1.000000e+0	2.168935e+1	4.610557e-2	1	4.610557e-2	1.000000e+0	52	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	PRDM5
Human Phenotype	HP:0000505	Visual impairment	54	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	57	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	PRDM5
Human Phenotype	HP:0000407	Sensorineural hearing impairment	55	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	54	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	PRDM5
Human Phenotype	HP:0000504	Abnormality of vision	56	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	61	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	PRDM5
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	57	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	59	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	PRDM5
Human Phenotype	HP:0010674	Abnormality of the curvature of the vertebral column	58	5.014164e-2	1.000000e+0	1.000000e+0	1.994351e+1	5.014164e-2	1	5.014164e-2	1.000000e+0	58	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	PRDM5
Human Phenotype	HP:0000359	Abnormality of the inner ear	59	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	60	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	PRDM5
Human Phenotype	HP:0000164	Abnormality of the teeth	60	5.299708e-2	1.000000e+0	1.000000e+0	1.886896e+1	5.299708e-2	1	5.299708e-2	1.000000e+0	53	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	PRDM5
Human Phenotype	HP:0000174	Abnormality of the palate	61	5.471904e-2	1.000000e+0	1.000000e+0	1.827517e+1	5.471904e-2	1	5.471904e-2	1.000000e+0	56	4.840059e-2	1.000000e+0	1.000000e+0	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	PRDM5
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	62	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	75	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	PRDM5
Human Phenotype	HP:0001098	Abnormality of the fundus	63	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	63	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	PRDM5
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	64	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	64	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	PRDM5
Human Phenotype	HP:0011729	Abnormality of joint mobility	65	6.014038e-2	1.000000e+0	1.000000e+0	1.662776e+1	6.014038e-2	1	6.014038e-2	1.000000e+0	62	5.670958e-2	1.000000e+0	1.000000e+0	1.738054e+1	5.753561e-2	1	519	5.000000e-1	1.926782e-3	unnamed	PRDM5
Human Phenotype	HP:0004328	Abnormality of the anterior segment of the eye	66	6.610995e-2	1.000000e+0	1.000000e+0	1.512632e+1	6.610995e-2	1	6.610995e-2	1.000000e+0	66	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	PRDM5
Human Phenotype	HP:0000925	Abnormality of the vertebral column	67	6.929502e-2	1.000000e+0	1.000000e+0	1.443105e+1	6.929502e-2	1	6.929502e-2	1.000000e+0	65	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	PRDM5
Human Phenotype	HP:0003549	Abnormality of connective tissue	68	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	66	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	PRDM5
Human Phenotype	HP:0100022	Abnormality of movement	69	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	70	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	PRDM5
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	70	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	68	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	PRDM5
Human Phenotype	HP:0000365	Hearing impairment	71	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	71	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	PRDM5
Human Phenotype	HP:0001627	Abnormality of the heart	72	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	69	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	PRDM5
Human Phenotype	HP:0000364	Hearing abnormality	73	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	72	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	PRDM5
Human Phenotype	HP:0001367	Abnormal joint morphology	74	7.644753e-2	1.000000e+0	1.000000e+0	1.308087e+1	7.644753e-2	1	7.644753e-2	1.000000e+0	74	7.545814e-2	1.000000e+0	1.000000e+0	1.299784e+1	7.693587e-2	1	694	5.000000e-1	1.440922e-3	unnamed	PRDM5
Human Phenotype	HP:0011354	Generalized abnormality of skin	75	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	77	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	PRDM5
Human Phenotype	HP:0002814	Abnormality of the lower limb	76	8.121304e-2	1.000000e+0	1.000000e+0	1.231329e+1	8.121304e-2	1	8.121304e-2	1.000000e+0	72	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	PRDM5
Human Phenotype	HP:0000163	Abnormality of the oral cavity	77	8.862539e-2	1.000000e+0	1.000000e+0	1.128345e+1	8.862539e-2	1	8.862539e-2	1.000000e+0	76	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	PRDM5
Human Phenotype	HP:0011804	Abnormality of muscle physiology	78	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	81	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	PRDM5
Human Phenotype	HP:0000951	Abnormality of the skin	79	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	83	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	PRDM5
Human Phenotype	HP:0002813	Abnormality of limb bone morphology	80	1.016983e-1	1.000000e+0	1.000000e+0	9.833005e+0	1.016983e-1	1	1.016983e-1	1.000000e+0	78	9.665462e-2	1.000000e+0	1.000000e+0	1.009004e+1	9.910759e-2	1	894	5.000000e-1	1.118568e-3	unnamed	PRDM5
Human Phenotype	HP:0011844	Abnormal appendicular skeleton morphology	81	1.019563e-1	1.000000e+0	1.000000e+0	9.808128e+0	1.019563e-1	1	1.019563e-1	1.000000e+0	79	9.728672e-2	1.000000e+0	1.000000e+0	1.002278e+1	9.977274e-2	1	900	5.000000e-1	1.111111e-3	unnamed	PRDM5
Human Phenotype	HP:0000153	Abnormality of the mouth	82	1.037371e-1	1.000000e+0	1.000000e+0	9.639755e+0	1.037371e-1	1	1.037371e-1	1.000000e+0	80	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	PRDM5
Human Phenotype	HP:0000598	Abnormality of the ear	83	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	82	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	PRDM5
Human Phenotype	HP:0012373	Abnormal eye physiology	84	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	85	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	PRDM5
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	85	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	84	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	PRDM5
Human Phenotype	HP:0012374	Abnormality of the globe	86	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	86	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	PRDM5
Human Phenotype	HP:0012372	Abnormal eye morphology	87	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	87	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	PRDM5
Human Phenotype	HP:0003011	Abnormality of the musculature	88	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	89	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	PRDM5
Human Phenotype	HP:0001574	Abnormality of the integument	89	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	90	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	PRDM5
Human Phenotype	HP:0009121	Abnormal axial skeleton morphology	90	1.232157e-1	1.000000e+0	1.000000e+0	8.115849e+0	1.232157e-1	1	1.232157e-1	1.000000e+0	88	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	PRDM5
Human Phenotype	HP:0000271	Abnormality of the face	91	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	91	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	PRDM5
Human Phenotype	HP:0000007	Autosomal recessive inheritance	92	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	97	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	PRDM5
Human Phenotype	HP:0000478	Abnormality of the eye	93	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	92	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	PRDM5
Human Phenotype	HP:0000234	Abnormality of the head	94	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	94	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	PRDM5
Human Phenotype	HP:0000152	Abnormality of head and neck	95	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	95	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	PRDM5
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	96	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	93	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	PRDM5
Human Phenotype	HP:0000924	Abnormality of the skeletal system	97	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	96	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	PRDM5
Human Phenotype	HP:0000707	Abnormality of the nervous system	98	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	98	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	PRDM5
Human Phenotype	HP:0000005	Mode of inheritance	99	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	99	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	PRDM5
Human Phenotype	HP:0000118	Phenotypic abnormality	100	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	100	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	PRDM5
Human Phenotype	HP:0000001	All	101	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	101	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	PRDM5
Disease Ontology	DOID:3676	renal malignant neoplasm	1	5.662120e-3	1.000000e+0	1.000000e+0	1.766123e+2	5.662120e-3	1	5.662120e-3	1.000000e+0	1	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	MAD2L1
Disease Ontology	DOID:263	kidney neoplasm	2	6.920750e-3	1.000000e+0	1.000000e+0	1.444930e+2	6.920750e-3	1	6.920750e-3	1.000000e+0	2	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	MAD2L1
Disease Ontology	DOID:9206	Barrett's esophagus	3	7.581585e-3	1.000000e+0	1.000000e+0	1.318985e+2	7.581585e-3	1	7.581585e-3	1.000000e+0	3	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	MAD2L1
Disease Ontology	DOID:6050	esophageal disease	4	1.204297e-2	1.000000e+0	1.000000e+0	8.303600e+1	1.204297e-2	1	1.204297e-2	1.000000e+0	4	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	MAD2L1
Disease Ontology	DOID:3008	ductal breast carcinoma	5	1.452768e-2	1.000000e+0	1.000000e+0	6.883410e+1	1.452768e-2	1	1.452768e-2	1.000000e+0	5	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	MAD2L1
Disease Ontology	DOID:3113	papillary carcinoma	6	1.563409e-2	1.000000e+0	1.000000e+0	6.396281e+1	1.563409e-2	1	1.563409e-2	1.000000e+0	6	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	MAD2L1
Disease Ontology	DOID:3458	breast adenocarcinoma	7	1.662071e-2	1.000000e+0	1.000000e+0	6.016589e+1	1.662071e-2	1	1.662071e-2	1.000000e+0	7	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	MAD2L1
Disease Ontology	DOID:3169	papillary epithelial neoplasm	8	1.746725e-2	1.000000e+0	1.000000e+0	5.724999e+1	1.746725e-2	1	1.746725e-2	1.000000e+0	8	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	MAD2L1
Disease Ontology	DOID:3007	ductal carcinoma	9	2.482786e-2	1.000000e+0	1.000000e+0	4.027733e+1	2.482786e-2	1	2.482786e-2	1.000000e+0	9	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
Disease Ontology	DOID:3996	cancer of urinary tract	10	2.754903e-2	1.000000e+0	1.000000e+0	3.629892e+1	2.754903e-2	1	2.754903e-2	1.000000e+0	10	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	MAD2L1
Disease Ontology	DOID:2620	ductal, lobular, and medullary neoplasm	11	2.916543e-2	1.000000e+0	1.000000e+0	3.428716e+1	2.916543e-2	1	2.916543e-2	1.000000e+0	11	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	MAD2L1
Disease Ontology	DOID:10008	malignant neoplasm of thyroid	12	2.959106e-2	1.000000e+0	1.000000e+0	3.379399e+1	2.959106e-2	1	2.959106e-2	1.000000e+0	12	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	MAD2L1
Disease Ontology	DOID:1781	thyroid neoplasm	13	2.994908e-2	1.000000e+0	1.000000e+0	3.339000e+1	2.994908e-2	1	2.994908e-2	1.000000e+0	13	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	MAD2L1
Disease Ontology	DOID:10009	malignant neoplasm of endocrine gland	14	3.234190e-2	1.000000e+0	1.000000e+0	3.091964e+1	3.234190e-2	1	3.234190e-2	1.000000e+0	14	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	MAD2L1
Disease Ontology	DOID:731	urologic neoplasm	15	3.752395e-2	1.000000e+0	1.000000e+0	2.664965e+1	3.752395e-2	1	3.752395e-2	1.000000e+0	15	3.657622e-2	1.000000e+0	1.000000e+0	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	MAD2L1
Disease Ontology	DOID:4451	renal carcinoma	16	3.907764e-2	1.000000e+0	1.000000e+0	2.559008e+1	3.907764e-2	1	3.907764e-2	1.000000e+0	16	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	MAD2L1
Disease Ontology	DOID:50	thyroid gland disease	17	4.014086e-2	1.000000e+0	1.000000e+0	2.491227e+1	4.014086e-2	1	4.014086e-2	1.000000e+0	18	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	MAD2L1
Disease Ontology	DOID:1112	neck cancer	18	4.017075e-2	1.000000e+0	1.000000e+0	2.489373e+1	4.017075e-2	1	4.017075e-2	1.000000e+0	17	4.124960e-2	1.000000e+0	1.000000e+0	2.399069e+1	4.168283e-2	1	376	5.000000e-1	2.659574e-3	unnamed	MAD2L1
Disease Ontology	DOID:4725	neck neoplasm	19	4.031124e-2	1.000000e+0	1.000000e+0	2.480698e+1	4.031124e-2	1	4.031124e-2	1.000000e+0	19	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	MAD2L1
Disease Ontology	DOID:3459	breast carcinoma	20	4.496474e-2	1.000000e+0	1.000000e+0	2.223965e+1	4.496474e-2	1	4.496474e-2	1.000000e+0	20	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	MAD2L1
Disease Ontology	DOID:769	neuroblastoma	21	5.857072e-2	1.000000e+0	1.000000e+0	1.707338e+1	5.857072e-2	1	5.857072e-2	1.000000e+0	21	4.861687e-2	1.000000e+0	1.000000e+0	2.031644e+1	4.922122e-2	1	444	5.000000e-1	2.252252e-3	unnamed	MAD2L1
Disease Ontology	DOID:3369	Ewings sarcoma	22	5.884188e-2	1.000000e+0	1.000000e+0	1.699470e+1	5.884188e-2	1	5.884188e-2	1.000000e+0	22	4.883312e-2	1.000000e+0	1.000000e+0	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	MAD2L1
Disease Ontology	DOID:2438	tumor of dermis	23	6.071436e-2	1.000000e+0	1.000000e+0	1.647057e+1	6.071436e-2	1	6.071436e-2	1.000000e+0	23	5.002208e-2	1.000000e+0	1.000000e+0	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	MAD2L1
Disease Ontology	DOID:4159	skin cancer	24	6.228896e-2	1.000000e+0	1.000000e+0	1.605421e+1	6.228896e-2	1	6.228896e-2	1.000000e+0	25	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	MAD2L1
Disease Ontology	DOID:1192	peripheral nervous system neoplasm	25	6.432174e-2	1.000000e+0	1.000000e+0	1.554684e+1	6.432174e-2	1	6.432174e-2	1.000000e+0	24	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	MAD2L1
Disease Ontology	DOID:168	primitive neuroectodermal tumor	26	6.935969e-2	1.000000e+0	1.000000e+0	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	26	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	MAD2L1
Disease Ontology	DOID:688	embryonal cancer	27	7.040036e-2	1.000000e+0	1.000000e+0	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	27	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	MAD2L1
Disease Ontology	DOID:3347	osteosarcoma	28	7.547113e-2	1.000000e+0	1.000000e+0	1.325010e+1	7.547113e-2	1	7.547113e-2	1.000000e+0	28	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	MAD2L1
Disease Ontology	DOID:183	bone tissue neoplasm	29	7.606199e-2	1.000000e+0	1.000000e+0	1.314717e+1	7.606199e-2	1	7.606199e-2	1.000000e+0	29	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	MAD2L1
Disease Ontology	DOID:9256	colorectal cancer	30	8.071500e-2	1.000000e+0	1.000000e+0	1.238927e+1	8.071500e-2	1	8.071500e-2	1.000000e+0	31	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	MAD2L1
Disease Ontology	DOID:3168	squamous cell neoplasm	31	8.073938e-2	1.000000e+0	1.000000e+0	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	35	8.492093e-2	1.000000e+0	1.000000e+0	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	MAD2L1
Disease Ontology	DOID:201	connective tissue neoplasm	32	8.800066e-2	1.000000e+0	1.000000e+0	1.136355e+1	8.800066e-2	1	8.800066e-2	1.000000e+0	30	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	MAD2L1
Disease Ontology	DOID:1994	large Intestine carcinoma	33	8.851868e-2	1.000000e+0	1.000000e+0	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	36	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	MAD2L1
Disease Ontology	DOID:684	hepatocellular carcinoma	34	9.124792e-2	1.000000e+0	1.000000e+0	1.095915e+1	9.124792e-2	1	9.124792e-2	1.000000e+0	39	9.211812e-2	1.000000e+0	1.000000e+0	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	MAD2L1
Disease Ontology	DOID:284	malignant neoplasm of abdomen	35	9.133327e-2	1.000000e+0	1.000000e+0	1.094891e+1	9.133327e-2	1	9.133327e-2	1.000000e+0	38	9.063867e-2	1.000000e+0	1.000000e+0	1.077718e+1	9.278865e-2	1	837	5.000000e-1	1.194743e-3	unnamed	MAD2L1
Disease Ontology	DOID:686	liver and intrahepatic biliary tract carcinoma	36	9.251093e-2	1.000000e+0	1.000000e+0	1.080953e+1	9.251093e-2	1	9.251093e-2	1.000000e+0	40	9.338526e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	863	5.000000e-1	1.158749e-3	unnamed	MAD2L1
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	37	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	33	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	MAD2L1
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	38	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	34	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	MAD2L1
Disease Ontology	DOID:3070	malignant glioma	39	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	37	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	MAD2L1
Disease Ontology	DOID:1265	genitourinary cancer	40	1.098597e-1	1.000000e+0	1.000000e+0	9.102521e+0	1.098597e-1	1	1.098597e-1	1.000000e+0	45	1.099868e-1	1.000000e+0	1.000000e+0	8.834966e+0	1.131866e-1	1	1021	5.000000e-1	9.794319e-4	unnamed	MAD2L1
Disease Ontology	DOID:122	abdominal cancer	41	1.132547e-1	1.000000e+0	1.000000e+0	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	47	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	MAD2L1
Disease Ontology	DOID:170	endocrine gland cancer	42	1.163017e-1	1.000000e+0	1.000000e+0	8.598327e+0	1.163017e-1	1	1.163017e-1	1.000000e+0	41	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	MAD2L1
Disease Ontology	DOID:3165	skin neoplasm	43	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	43	1.090453e-1	1.000000e+0	1.000000e+0	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	MAD2L1
Disease Ontology	DOID:0050117	disease by infectious agent	44	1.209421e-1	1.000000e+0	1.000000e+0	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	56	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	PRDM5
Disease Ontology	DOID:65	connective tissue disease	45	1.230503e-1	1.000000e+0	1.000000e+0	8.126760e+0	1.230503e-1	1	1.230503e-1	1.000000e+0	50	1.217659e-1	1.000000e+0	1.000000e+0	7.954586e+0	1.257137e-1	1	1134	5.000000e-1	8.818342e-4	unnamed	MAD2L1
Disease Ontology	DOID:2627	glioma	46	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	42	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	MAD2L1
Disease Ontology	DOID:1319	brain neoplasm	47	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	44	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	MAD2L1
Disease Ontology	DOID:3620	central nervous system neoplasm	48	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	46	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	MAD2L1
Disease Ontology	DOID:171	neuroectodermal tumor	49	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	48	1.187505e-1	1.000000e+0	1.000000e+0	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	MAD2L1
Disease Ontology	DOID:3095	germ cell and embryonal cancer	50	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	49	1.204148e-1	1.000000e+0	1.000000e+0	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	MAD2L1
Disease Ontology	DOID:2994	germ cell cancer	51	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	51	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	MAD2L1
Disease Ontology	DOID:28	endocrine system disease	52	1.359578e-1	1.000000e+0	1.000000e+0	7.355222e+0	1.359578e-1	1	1.359578e-1	1.000000e+0	54	1.392361e-1	1.000000e+0	1.000000e+0	6.922870e+0	1.444488e-1	1	1303	5.000000e-1	7.674597e-4	unnamed	MAD2L1
Disease Ontology	DOID:177	soft tissue neoplasm	53	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	52	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	MAD2L1
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	54	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	53	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	MAD2L1
Disease Ontology	DOID:1115	sarcoma	55	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	55	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	MAD2L1
Disease Ontology	DOID:77	gastrointestinal system disease	56	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	62	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	MAD2L1
Disease Ontology	DOID:3094	neuroepithelial neoplasm	57	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	57	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	MAD2L1
Disease Ontology	DOID:3195	neural neoplasm	58	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	58	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	MAD2L1
Disease Ontology	DOID:299	adenocarcinoma	59	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	60	1.699169e-1	1.000000e+0	1.000000e+0	5.623753e+0	1.778172e-1	1	1604	5.000000e-1	6.234414e-4	unnamed	MAD2L1
Disease Ontology	DOID:3093	nervous system cancer	60	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	59	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	MAD2L1
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	61	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	63	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	MAD2L1
Disease Ontology	DOID:936	brain disease	62	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	61	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	MAD2L1
Disease Ontology	DOID:17	musculoskeletal system disease	63	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	66	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	MAD2L1
Disease Ontology	DOID:157	epithelial carcinoma	64	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	67	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	MAD2L1
Disease Ontology	DOID:155	glandular and epithelial neoplasm	65	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	65	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	MAD2L1
Disease Ontology	DOID:331	central nervous system disease	66	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	68	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	MAD2L1
Disease Ontology	DOID:863	nervous system disease	67	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	69	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	MAD2L1
Disease Ontology	DOID:557	kidney disease	68	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	70	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	MAD2L1
Disease Ontology	DOID:18	urinary system disease	69	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	71	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	MAD2L1
Disease Ontology	DOID:305	carcinoma	70	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	72	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	MAD2L1
Disease Ontology	DOID:462	cancer by anatomical entity	71	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	73	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	MAD2L1
Disease Ontology	DOID:162	cancer	72	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	32	7.990207e-2	1.000000e+0	1.000000e+0	3.537451e+0	5.653789e-1	2	5100	1.000000e+0	3.921569e-4	unnamed	MAD2L1,PRDM5
Disease Ontology	DOID:7	disease of anatomical entity	73	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	74	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	MAD2L1
Disease Ontology	DOID:4	disease	74	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	64	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	MAD2L1,PRDM5
MSigDB Cancer Neighborhood	GNF2_MSH6	Neighborhood of MSH6	1	2.513529e-3	1.000000e+0	1.000000e+0	3.978471e+2	2.513529e-3	1	2.513529e-3	1.000000e+0	1	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MAD2L1
MSigDB Cancer Neighborhood	GNF2_ESPL1	Neighborhood of ESPL1	2	2.616518e-3	1.000000e+0	5.586266e-1	3.821873e+2	2.616518e-3	1	2.616518e-3	1.000000e+0	2	3.987038e-3	1.000000e+0	8.512326e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	MAD2L1
MSigDB Cancer Neighborhood	GNF2_MCM4	Neighborhood of MCM4	3	3.710211e-3	1.000000e+0	5.280867e-1	2.695265e+2	3.710211e-3	1	3.710211e-3	1.000000e+0	3	5.867038e-3	1.000000e+0	8.350751e-1	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	MAD2L1
MSigDB Cancer Neighborhood	MORF_CCNF	Neighborhood of CCNF	4	6.811518e-3	1.000000e+0	7.271295e-1	1.468102e+2	6.811518e-3	1	6.811518e-3	1.000000e+0	4	8.297342e-3	1.000000e+0	8.857413e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	MAD2L1
MSigDB Cancer Neighborhood	MORF_BRCA1	Neighborhood of BRCA1	5	2.868559e-2	1.000000e+0	1.000000e+0	3.486070e+1	2.868559e-2	1	2.868559e-2	1.000000e+0	5	2.927180e-2	1.000000e+0	1.000000e+0	3.391165e+1	2.948839e-2	1	266	5.000000e-1	3.759398e-3	unnamed	MAD2L1
MSigDB Pathway	REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1	1.667200e-3	1.000000e+0	1.000000e+0	5.998082e+2	1.667200e-3	1	1.667200e-3	1.000000e+0	1	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	MAD2L1
MSigDB Pathway	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	Genes involved in APC-Cdc20 mediated degradation of Nek2A	2	1.835749e-3	1.000000e+0	1.000000e+0	5.447369e+2	1.835749e-3	1	1.835749e-3	1.000000e+0	2	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	MAD2L1
MSigDB Pathway	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins	3	4.227258e-3	1.000000e+0	1.000000e+0	2.365599e+2	4.227258e-3	1	4.227258e-3	1.000000e+0	3	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MAD2L1
MSigDB Pathway	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	Genes involved in Regulation of mitotic cell cycle	4	5.209239e-3	1.000000e+0	1.000000e+0	1.919666e+2	5.209239e-3	1	5.209239e-3	1.000000e+0	4	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	MAD2L1
MSigDB Pathway	REACTOME_CELL_CYCLE_CHECKPOINTS	Genes involved in Cell Cycle Checkpoints	5	6.869192e-3	1.000000e+0	1.000000e+0	1.455775e+2	6.869192e-3	1	6.869192e-3	1.000000e+0	8	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	MAD2L1
MSigDB Pathway	REACTOME_MITOTIC_PROMETAPHASE	Genes involved in Mitotic Prometaphase	6	7.753048e-3	1.000000e+0	1.000000e+0	1.289815e+2	7.753048e-3	1	7.753048e-3	1.000000e+0	5	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	MAD2L1
MSigDB Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	Progesterone-mediated oocyte maturation	7	1.005217e-2	1.000000e+0	1.000000e+0	9.948097e+1	1.005217e-2	1	1.005217e-2	1.000000e+0	5	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	MAD2L1
MSigDB Pathway	KEGG_CELL_CYCLE	Cell cycle	8	1.071370e-2	1.000000e+0	1.000000e+0	9.333840e+1	1.071370e-2	1	1.071370e-2	1.000000e+0	9	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	MAD2L1
MSigDB Pathway	REACTOME_MITOTIC_M_M_G1_PHASES	Genes involved in Mitotic M-M/G1 phases	9	1.239876e-2	1.000000e+0	1.000000e+0	8.065323e+1	1.239876e-2	1	1.239876e-2	1.000000e+0	10	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	MAD2L1
MSigDB Pathway	KEGG_OOCYTE_MEIOSIS	Oocyte meiosis	10	1.242915e-2	1.000000e+0	1.000000e+0	8.045600e+1	1.242915e-2	1	1.242915e-2	1.000000e+0	7	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	MAD2L1
MSigDB Pathway	REACTOME_DNA_REPLICATION	Genes involved in DNA Replication	11	1.363027e-2	1.000000e+0	1.000000e+0	7.336610e+1	1.363027e-2	1	1.363027e-2	1.000000e+0	11	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MAD2L1
MSigDB Pathway	REACTOME_CELL_CYCLE_MITOTIC	Genes involved in Cell Cycle, Mitotic	12	2.320406e-2	1.000000e+0	1.000000e+0	4.309591e+1	2.320406e-2	1	2.320406e-2	1.000000e+0	12	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	MAD2L1
MSigDB Pathway	REACTOME_CELL_CYCLE	Genes involved in Cell Cycle	13	2.729338e-2	1.000000e+0	1.000000e+0	3.663892e+1	2.729338e-2	1	2.729338e-2	1.000000e+0	13	4.406985e-2	1.000000e+0	1.000000e+0	2.243905e+1	4.456516e-2	1	402	5.000000e-1	2.487562e-3	unnamed	MAD2L1
MGI Expression: Detected	16929	TS17_nephric duct, metanephric portion	1	1.604991e-2	1.000000e+0	1.000000e+0	6.230563e+1	1.604991e-2	1	1.604991e-2	1.000000e+0	20	1.127592e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	PRDM5
MGI Expression: Detected	2377	TS17_mesonephros tubule	2	1.681660e-2	1.000000e+0	1.000000e+0	5.946505e+1	1.681660e-2	1	1.681660e-2	1.000000e+0	19	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	PRDM5
MGI Expression: Detected	15733	TS17_metanephric mesenchyme	3	2.083405e-2	1.000000e+0	1.000000e+0	4.799835e+1	2.083405e-2	1	2.083405e-2	1.000000e+0	22	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PRDM5
MGI Expression: Detected	2375	TS17_mesonephros mesenchyme	4	2.294296e-2	1.000000e+0	1.000000e+0	4.358636e+1	2.294296e-2	1	2.294296e-2	1.000000e+0	22	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PRDM5
MGI Expression: Detected	2373	TS17_nephric duct	5	2.386658e-2	1.000000e+0	1.000000e+0	4.189960e+1	2.386658e-2	1	2.386658e-2	1.000000e+0	24	1.656012e-2	1.000000e+0	1.000000e+0	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	PRDM5
MGI Expression: Detected	9	TS2_two-cell stage embryo	6	4.499198e-2	1.000000e+0	1.000000e+0	2.222618e+1	4.499198e-2	1	4.499198e-2	1.000000e+0	35	4.016378e-2	1.000000e+0	1.000000e+0	2.464617e+1	4.057425e-2	1	366	5.000000e-1	2.732240e-3	unnamed	PRDM5
MGI Expression: Detected	5356	TS21_olfactory lobe	7	4.757455e-2	1.000000e+0	1.000000e+0	2.101964e+1	4.757455e-2	1	4.757455e-2	1.000000e+0	34	3.690264e-2	1.000000e+0	1.000000e+0	2.684673e+1	3.724849e-2	1	336	5.000000e-1	2.976190e-3	unnamed	MAD2L1
MGI Expression: Detected	2374	TS17_mesonephros	8	4.920020e-2	1.000000e+0	1.000000e+0	2.032512e+1	4.920020e-2	1	4.920020e-2	1.000000e+0	36	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	PRDM5
MGI Expression: Detected	5322	TS21_hypothalamus	9	5.721094e-2	1.000000e+0	1.000000e+0	1.747918e+1	5.721094e-2	1	5.721094e-2	1.000000e+0	33	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	MAD2L1
MGI Expression: Detected	14670	TS21_brain ventricular layer	10	5.977790e-2	1.000000e+0	1.000000e+0	1.672859e+1	5.977790e-2	1	5.977790e-2	1.000000e+0	42	5.681724e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	520	5.000000e-1	1.923077e-3	unnamed	MAD2L1
MGI Expression: Detected	5326	TS21_thalamus	11	6.354174e-2	1.000000e+0	1.000000e+0	1.573769e+1	6.354174e-2	1	6.354174e-2	1.000000e+0	37	4.211781e-2	1.000000e+0	1.000000e+0	2.349089e+1	4.256970e-2	1	384	5.000000e-1	2.604167e-3	unnamed	MAD2L1
MGI Expression: Detected	4974	TS21_retina	12	6.682573e-2	1.000000e+0	1.000000e+0	1.496429e+1	6.682573e-2	1	6.682573e-2	1.000000e+0	44	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	MAD2L1
MGI Expression: Detected	5400	TS21_midbrain	13	6.883740e-2	1.000000e+0	1.000000e+0	1.452699e+1	6.883740e-2	1	6.883740e-2	1.000000e+0	38	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	MAD2L1
MGI Expression: Detected	5351	TS21_corpus striatum	14	6.973793e-2	1.000000e+0	1.000000e+0	1.433940e+1	6.973793e-2	1	6.973793e-2	1.000000e+0	43	5.896934e-2	1.000000e+0	1.000000e+0	1.670463e+1	5.986364e-2	1	540	5.000000e-1	1.851852e-3	unnamed	MAD2L1
MGI Expression: Detected	1820	TS16_central nervous system	15	7.114798e-2	1.000000e+0	1.000000e+0	1.405521e+1	7.114798e-2	1	7.114798e-2	1.000000e+0	39	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	PRDM5
MGI Expression: Detected	1819	TS16_nervous system	16	7.228284e-2	1.000000e+0	1.000000e+0	1.383454e+1	7.228284e-2	1	7.228284e-2	1.000000e+0	40	5.131828e-2	1.000000e+0	1.000000e+0	1.923348e+1	5.199268e-2	1	469	5.000000e-1	2.132196e-3	unnamed	PRDM5
MGI Expression: Detected	16133	TS23_ureteric tip	17	8.171085e-2	1.000000e+0	1.000000e+0	1.223828e+1	8.171085e-2	1	8.171085e-2	1.000000e+0	2	2.280412e-3	1.000000e+0	1.000000e+0	2.092923e+1	9.556011e-2	2	862	1.000000e+0	2.320186e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	16285	TS23_ureteric trunk	18	8.207453e-2	1.000000e+0	1.000000e+0	1.218405e+1	8.207453e-2	1	8.207453e-2	1.000000e+0	1	2.254018e-3	1.000000e+0	1.000000e+0	2.105134e+1	9.500582e-2	2	857	1.000000e+0	2.333722e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	4966	TS21_eye	19	8.346019e-2	1.000000e+0	1.000000e+0	1.198176e+1	8.346019e-2	1	8.346019e-2	1.000000e+0	47	6.947907e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	638	5.000000e-1	1.567398e-3	unnamed	MAD2L1
MGI Expression: Detected	5297	TS21_diencephalon	20	8.372466e-2	1.000000e+0	1.000000e+0	1.194391e+1	8.372466e-2	1	8.372466e-2	1.000000e+0	41	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	MAD2L1
MGI Expression: Detected	15389	TS3_4-cell stage embryo	21	8.656099e-2	1.000000e+0	1.000000e+0	1.155255e+1	8.656099e-2	1	8.656099e-2	1.000000e+0	56	9.517887e-2	1.000000e+0	1.000000e+0	1.025057e+1	9.755557e-2	1	880	5.000000e-1	1.136364e-3	unnamed	PRDM5
MGI Expression: Detected	2371	TS17_urogenital system	22	8.727913e-2	1.000000e+0	1.000000e+0	1.145749e+1	8.727913e-2	1	8.727913e-2	1.000000e+0	46	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	PRDM5
MGI Expression: Detected	16777	TS23_late tubule	23	8.864057e-2	1.000000e+0	1.000000e+0	1.128152e+1	8.864057e-2	1	8.864057e-2	1.000000e+0	5	2.740985e-3	1.000000e+0	1.000000e+0	1.909101e+1	1.047614e-1	2	945	1.000000e+0	2.116402e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	16773	TS23_cap mesenchyme	24	8.911767e-2	1.000000e+0	1.000000e+0	1.122112e+1	8.911767e-2	1	8.911767e-2	1.000000e+0	4	2.603456e-3	1.000000e+0	1.000000e+0	1.958849e+1	1.021008e-1	2	921	1.000000e+0	2.171553e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	1619	TS16_organ system	25	9.308949e-2	1.000000e+0	1.000000e+0	1.074235e+1	9.308949e-2	1	9.308949e-2	1.000000e+0	45	6.744608e-2	1.000000e+0	1.000000e+0	1.457270e+1	6.862147e-2	1	619	5.000000e-1	1.615509e-3	unnamed	PRDM5
MGI Expression: Detected	16776	TS23_early tubule	26	9.390834e-2	1.000000e+0	1.000000e+0	1.064868e+1	9.390834e-2	1	9.390834e-2	1.000000e+0	8	3.014475e-3	1.000000e+0	1.000000e+0	1.820484e+1	1.098609e-1	2	991	1.000000e+0	2.018163e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	16132	TS23_collecting duct	27	9.428660e-2	1.000000e+0	1.000000e+0	1.060596e+1	9.428660e-2	1	9.428660e-2	1.000000e+0	6	2.758425e-3	1.000000e+0	1.000000e+0	1.903059e+1	1.050940e-1	2	948	1.000000e+0	2.109705e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	5344	TS21_cerebral cortex	28	9.691622e-2	1.000000e+0	1.000000e+0	1.031819e+1	9.691622e-2	1	9.691622e-2	1.000000e+0	48	7.865328e-2	1.000000e+0	1.000000e+0	1.245925e+1	8.026163e-2	1	724	5.000000e-1	1.381215e-3	unnamed	MAD2L1
MGI Expression: Detected	16772	TS23_renal blood vessel	29	9.875875e-2	1.000000e+0	1.000000e+0	1.012569e+1	9.875875e-2	1	9.875875e-2	1.000000e+0	9	3.294602e-3	1.000000e+0	1.000000e+0	1.741409e+1	1.148495e-1	2	1036	1.000000e+0	1.930502e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	15997	TS23_nephrogenic zone	30	9.983179e-2	1.000000e+0	1.000000e+0	1.001685e+1	9.983179e-2	1	9.983179e-2	1.000000e+0	7	2.996242e-3	1.000000e+0	1.000000e+0	1.826012e+1	1.095283e-1	2	988	1.000000e+0	2.024291e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	5361	TS21_hindbrain	31	1.084484e-1	1.000000e+0	1.000000e+0	9.220974e+0	1.084484e-1	1	1.084484e-1	1.000000e+0	49	8.809966e-2	1.000000e+0	1.000000e+0	1.109533e+1	9.012804e-2	1	813	5.000000e-1	1.230012e-3	unnamed	MAD2L1
MGI Expression: Detected	13	TS3_4-8 cell stage embryo	32	1.090635e-1	1.000000e+0	1.000000e+0	9.168968e+0	1.090635e-1	1	1.090635e-1	1.000000e+0	60	1.203108e-1	1.000000e+0	1.000000e+0	8.054018e+0	1.241616e-1	1	1120	5.000000e-1	8.928571e-4	unnamed	PRDM5
MGI Expression: Detected	16778	TS23_renal interstitium	33	1.097768e-1	1.000000e+0	1.000000e+0	9.109396e+0	1.097768e-1	1	1.097768e-1	1.000000e+0	10	3.397202e-3	1.000000e+0	1.000000e+0	1.714924e+1	1.166232e-1	2	1052	1.000000e+0	1.901141e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	5430	TS21_spinal cord	34	1.106298e-1	1.000000e+0	1.000000e+0	9.039157e+0	1.106298e-1	1	1.106298e-1	1.000000e+0	50	9.116718e-2	1.000000e+0	1.000000e+0	1.071318e+1	9.334294e-2	1	842	5.000000e-1	1.187648e-3	unnamed	MAD2L1
MGI Expression: Detected	9185	TS23_ovary	35	1.112863e-1	1.000000e+0	1.000000e+0	8.985836e+0	1.112863e-1	1	1.112863e-1	1.000000e+0	12	3.727965e-3	1.000000e+0	1.000000e+0	1.637114e+1	1.221662e-1	2	1102	1.000000e+0	1.814882e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	10	Theiler_stage_3	36	1.114448e-1	1.000000e+0	1.000000e+0	8.973053e+0	1.114448e-1	1	1.114448e-1	1.000000e+0	61	1.228046e-1	1.000000e+0	1.000000e+0	7.885052e+0	1.268222e-1	1	1144	5.000000e-1	8.741259e-4	unnamed	PRDM5
MGI Expression: Detected	7163	TS21_head	37	1.120297e-1	1.000000e+0	1.000000e+0	8.926202e+0	1.120297e-1	1	1.120297e-1	1.000000e+0	3	2.333660e-3	1.000000e+0	1.000000e+0	2.068922e+1	9.666870e-2	2	872	1.000000e+0	2.293578e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	17324	TS23_male reproductive structure	38	1.150712e-1	1.000000e+0	1.000000e+0	8.690273e+0	1.150712e-1	1	1.150712e-1	1.000000e+0	59	1.119728e-1	1.000000e+0	1.000000e+0	8.673558e+0	1.152929e-1	1	1040	5.000000e-1	9.615385e-4	unnamed	PRDM5
MGI Expression: Detected	10313	TS23_ureter	39	1.164252e-1	1.000000e+0	1.000000e+0	8.589207e+0	1.164252e-1	1	1.164252e-1	1.000000e+0	58	1.106142e-1	1.000000e+0	1.000000e+0	8.783350e+0	1.138518e-1	1	1027	5.000000e-1	9.737098e-4	unnamed	PRDM5
MGI Expression: Detected	6	Theiler_stage_2	40	1.175007e-1	1.000000e+0	1.000000e+0	8.510587e+0	1.175007e-1	1	1.175007e-1	1.000000e+0	63	1.238426e-1	1.000000e+0	1.000000e+0	7.816724e+0	1.279308e-1	1	1154	5.000000e-1	8.665511e-4	unnamed	PRDM5
MGI Expression: Detected	1477	TS16_embryo	41	1.175447e-1	1.000000e+0	1.000000e+0	8.507400e+0	1.175447e-1	1	1.175447e-1	1.000000e+0	51	9.327970e-2	1.000000e+0	1.000000e+0	1.046462e+1	9.556011e-2	1	862	5.000000e-1	1.160093e-3	unnamed	PRDM5
MGI Expression: Detected	1476	Theiler_stage_16	42	1.180180e-1	1.000000e+0	1.000000e+0	8.473285e+0	1.180180e-1	1	1.180180e-1	1.000000e+0	52	9.422953e-2	1.000000e+0	1.000000e+0	1.035649e+1	9.655784e-2	1	871	5.000000e-1	1.148106e-3	unnamed	PRDM5
MGI Expression: Detected	17326	TS23_female reproductive structure	43	1.201198e-1	1.000000e+0	1.000000e+0	8.325019e+0	1.201198e-1	1	1.201198e-1	1.000000e+0	11	3.620449e-3	1.000000e+0	1.000000e+0	1.661234e+1	1.203924e-1	2	1086	1.000000e+0	1.841621e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	4911	TS21_sensory organ	44	1.206280e-1	1.000000e+0	1.000000e+0	8.289951e+0	1.206280e-1	1	1.206280e-1	1.000000e+0	54	9.486248e-2	1.000000e+0	1.000000e+0	1.028563e+1	9.722299e-2	1	877	5.000000e-1	1.140251e-3	unnamed	MAD2L1
MGI Expression: Detected	2297	TS17_visceral organ	45	1.256993e-1	1.000000e+0	1.000000e+0	7.955495e+0	1.256993e-1	1	1.256993e-1	1.000000e+0	53	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	PRDM5
MGI Expression: Detected	15433	TS23_renal cortex	46	1.301941e-1	1.000000e+0	1.000000e+0	7.680839e+0	1.301941e-1	1	1.301941e-1	1.000000e+0	14	4.998776e-3	1.000000e+0	1.000000e+0	1.413871e+1	1.414556e-1	2	1276	1.000000e+0	1.567398e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	17232	TS23_urethra of female	47	1.302071e-1	1.000000e+0	1.000000e+0	7.680074e+0	1.302071e-1	1	1.302071e-1	1.000000e+0	13	3.768688e-3	1.000000e+0	1.000000e+0	1.628249e+1	1.228313e-1	2	1108	1.000000e+0	1.805054e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	17245	TS23_urethra of male	48	1.342634e-1	1.000000e+0	1.000000e+0	7.448047e+0	1.342634e-1	1	1.342634e-1	1.000000e+0	64	1.246725e-1	1.000000e+0	1.000000e+0	7.762909e+0	1.288177e-1	1	1162	5.000000e-1	8.605852e-4	unnamed	PRDM5
MGI Expression: Detected	5334	TS21_telencephalon	49	1.398156e-1	1.000000e+0	1.000000e+0	7.152278e+0	1.398156e-1	1	1.398156e-1	1.000000e+0	57	1.085220e-1	1.000000e+0	1.000000e+0	8.957795e+0	1.116346e-1	1	1007	5.000000e-1	9.930487e-4	unnamed	MAD2L1
MGI Expression: Detected	8255	TS23_female reproductive system	50	1.442732e-1	1.000000e+0	1.000000e+0	6.931293e+0	1.442732e-1	1	1.442732e-1	1.000000e+0	15	5.373957e-3	1.000000e+0	1.000000e+0	1.363643e+1	1.466659e-1	2	1323	1.000000e+0	1.511716e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	9169	TS23_drainage component	51	1.457842e-1	1.000000e+0	1.000000e+0	6.859453e+0	1.457842e-1	1	1.457842e-1	1.000000e+0	66	1.384131e-1	1.000000e+0	1.000000e+0	6.965637e+0	1.435619e-1	1	1295	5.000000e-1	7.722008e-4	unnamed	PRDM5
MGI Expression: Detected	5296	TS21_forebrain	52	1.605913e-1	1.000000e+0	1.000000e+0	6.226989e+0	1.605913e-1	1	1.605913e-1	1.000000e+0	62	1.231160e-1	1.000000e+0	1.000000e+0	7.864429e+0	1.271548e-1	1	1147	5.000000e-1	8.718396e-4	unnamed	MAD2L1
MGI Expression: Detected	6443	TS22_cerebellum	53	1.613687e-1	1.000000e+0	1.000000e+0	6.196990e+0	1.613687e-1	1	1.613687e-1	1.000000e+0	65	1.280920e-1	1.000000e+0	1.000000e+0	7.548536e+0	1.324760e-1	1	1195	5.000000e-1	8.368201e-4	unnamed	MAD2L1
MGI Expression: Detected	9198	TS23_testis	54	1.636246e-1	1.000000e+0	1.000000e+0	6.111550e+0	1.636246e-1	1	1.636246e-1	1.000000e+0	71	1.707248e-1	1.000000e+0	1.000000e+0	5.595844e+0	1.787041e-1	1	1612	5.000000e-1	6.203474e-4	unnamed	PRDM5
MGI Expression: Detected	17231	TS23_urethra	55	1.733427e-1	1.000000e+0	1.000000e+0	5.768919e+0	1.733427e-1	1	1.733427e-1	1.000000e+0	16	7.539866e-3	1.000000e+0	1.000000e+0	1.151308e+1	1.737154e-1	2	1567	1.000000e+0	1.276324e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	8416	TS23_urinary bladder	56	1.763697e-1	1.000000e+0	1.000000e+0	5.669908e+0	1.763697e-1	1	1.763697e-1	1.000000e+0	17	7.684953e-3	1.000000e+0	1.000000e+0	1.140392e+1	1.753783e-1	2	1582	1.000000e+0	1.264223e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	5295	TS21_brain	57	1.940984e-1	1.000000e+0	1.000000e+0	5.152025e+0	1.940984e-1	1	1.940984e-1	1.000000e+0	67	1.547990e-1	1.000000e+0	1.000000e+0	6.199656e+0	1.612993e-1	1	1455	5.000000e-1	6.872852e-4	unnamed	MAD2L1
MGI Expression: Detected	6438	TS22_metencephalon lateral wall	58	1.987443e-1	1.000000e+0	1.000000e+0	5.031590e+0	1.987443e-1	1	1.987443e-1	1.000000e+0	68	1.618169e-1	1.000000e+0	1.000000e+0	5.918963e+0	1.689485e-1	1	1524	5.000000e-1	6.561680e-4	unnamed	MAD2L1
MGI Expression: Detected	6437	TS22_metencephalon	59	1.993050e-1	1.000000e+0	1.000000e+0	5.017434e+0	1.993050e-1	1	1.993050e-1	1.000000e+0	69	1.621214e-1	1.000000e+0	1.000000e+0	5.907335e+0	1.692811e-1	1	1527	5.000000e-1	6.548788e-4	unnamed	MAD2L1
MGI Expression: Detected	5281	TS21_central nervous system	60	2.095049e-1	1.000000e+0	1.000000e+0	4.773158e+0	2.095049e-1	1	2.095049e-1	1.000000e+0	70	1.678956e-1	1.000000e+0	1.000000e+0	5.694760e+0	1.756000e-1	1	1584	5.000000e-1	6.313131e-4	unnamed	MAD2L1
MGI Expression: Detected	5280	TS21_nervous system	61	2.120967e-1	1.000000e+0	1.000000e+0	4.714830e+0	2.120967e-1	1	2.120967e-1	1.000000e+0	72	1.710276e-1	1.000000e+0	1.000000e+0	5.585449e+0	1.790366e-1	1	1615	5.000000e-1	6.191950e-4	unnamed	MAD2L1
MGI Expression: Detected	6434	TS22_hindbrain	62	2.130295e-1	1.000000e+0	1.000000e+0	4.694185e+0	2.130295e-1	1	2.130295e-1	1.000000e+0	73	1.769722e-1	1.000000e+0	1.000000e+0	5.388590e+0	1.855773e-1	1	1674	5.000000e-1	5.973716e-4	unnamed	MAD2L1
MGI Expression: Detected	2413	TS17_central nervous system	63	2.230048e-1	1.000000e+0	1.000000e+0	4.484208e+0	2.230048e-1	1	2.230048e-1	1.000000e+0	18	1.110952e-2	1.000000e+0	1.000000e+0	9.485279e+0	2.108531e-1	2	1902	1.000000e+0	1.051525e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	8259	TS23_male reproductive system	64	2.246603e-1	1.000000e+0	1.000000e+0	4.451166e+0	2.246603e-1	1	2.246603e-1	1.000000e+0	75	2.139608e-1	1.000000e+0	1.000000e+0	4.408847e+0	2.268167e-1	1	2046	5.000000e-1	4.887586e-4	unnamed	PRDM5
MGI Expression: Detected	2412	TS17_nervous system	65	2.273547e-1	1.000000e+0	1.000000e+0	4.398414e+0	2.273547e-1	1	2.273547e-1	1.000000e+0	21	1.148659e-2	1.000000e+0	1.000000e+0	9.328335e+0	2.144005e-1	2	1934	1.000000e+0	1.034126e-3	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	7648	TS23_reproductive system	66	2.726454e-1	1.000000e+0	1.000000e+0	3.667768e+0	2.726454e-1	1	2.726454e-1	1.000000e+0	25	2.049196e-2	1.000000e+0	1.000000e+0	6.984514e+0	2.863478e-1	2	2583	1.000000e+0	7.742935e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	8013	TS23_metanephros	67	2.993178e-1	1.000000e+0	1.000000e+0	3.340931e+0	2.993178e-1	1	2.993178e-1	1.000000e+0	27	2.475601e-2	1.000000e+0	1.000000e+0	6.354702e+0	3.147276e-1	2	2839	1.000000e+0	7.044734e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	2165	TS17_organ system	68	3.004442e-1	1.000000e+0	1.000000e+0	3.328405e+0	3.004442e-1	1	3.004442e-1	1.000000e+0	26	2.098688e-2	1.000000e+0	1.000000e+0	6.901683e+0	2.897844e-1	2	2614	1.000000e+0	7.651109e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	4799	TS21_organ system	69	3.222661e-1	1.000000e+0	1.000000e+0	3.103025e+0	3.222661e-1	1	3.222661e-1	1.000000e+0	78	2.733407e-1	1.000000e+0	1.000000e+0	3.388618e+0	2.951056e-1	1	2662	5.000000e-1	3.756574e-4	unnamed	MAD2L1
MGI Expression: Detected	6365	TS22_brain	70	3.486991e-1	1.000000e+0	1.000000e+0	2.867802e+0	3.486991e-1	1	3.486991e-1	1.000000e+0	79	2.970534e-1	1.000000e+0	1.000000e+0	3.094511e+0	3.231528e-1	1	2915	5.000000e-1	3.430532e-4	unnamed	MAD2L1
MGI Expression: Detected	7644	TS23_renal-urinary system	71	3.497890e-1	1.000000e+0	1.000000e+0	2.858867e+0	3.497890e-1	1	3.497890e-1	1.000000e+0	32	3.471915e-2	1.000000e+0	1.000000e+0	5.366151e+0	3.727066e-1	2	3362	1.000000e+0	5.948840e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	2023	TS17_embryo	72	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	30	3.250405e-2	1.000000e+0	1.000000e+0	5.545958e+0	3.606230e-1	2	3253	1.000000e+0	6.148171e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	2022	Theiler_stage_17	73	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	31	3.300565e-2	1.000000e+0	1.000000e+0	5.503661e+0	3.633945e-1	2	3278	1.000000e+0	6.101281e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	6351	TS22_central nervous system	74	3.611614e-1	1.000000e+0	1.000000e+0	2.768845e+0	3.611614e-1	1	3.611614e-1	1.000000e+0	80	3.110186e-1	1.000000e+0	1.000000e+0	2.942107e+0	3.398925e-1	1	3066	5.000000e-1	3.261579e-4	unnamed	MAD2L1
MGI Expression: Detected	4761	TS21_embryo	75	3.653552e-1	1.000000e+0	1.000000e+0	2.737062e+0	3.653552e-1	1	3.653552e-1	1.000000e+0	28	3.065241e-2	1.000000e+0	1.000000e+0	5.710984e+0	3.502023e-1	2	3159	1.000000e+0	6.331117e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	4760	Theiler_stage_21	76	3.661005e-1	1.000000e+0	1.000000e+0	2.731490e+0	3.661005e-1	1	3.661005e-1	1.000000e+0	29	3.086628e-2	1.000000e+0	1.000000e+0	5.691167e+0	3.514218e-1	2	3170	1.000000e+0	6.309148e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	6350	TS22_nervous system	77	3.685477e-1	1.000000e+0	1.000000e+0	2.713353e+0	3.685477e-1	1	3.685477e-1	1.000000e+0	81	3.206469e-1	1.000000e+0	1.000000e+0	2.844686e+0	3.515326e-1	1	3171	5.000000e-1	3.153579e-4	unnamed	MAD2L1
MGI Expression: Detected	3341	TS19_embryo	78	3.699199e-1	1.000000e+0	1.000000e+0	2.703288e+0	3.699199e-1	1	3.699199e-1	1.000000e+0	82	3.257542e-1	1.000000e+0	1.000000e+0	2.795321e+0	3.577407e-1	1	3227	5.000000e-1	3.098853e-4	unnamed	PRDM5
MGI Expression: Detected	3340	Theiler_stage_19	79	3.711587e-1	1.000000e+0	1.000000e+0	2.694265e+0	3.711587e-1	1	3.711587e-1	1.000000e+0	83	3.271190e-1	1.000000e+0	1.000000e+0	2.782387e+0	3.594036e-1	1	3242	5.000000e-1	3.084516e-4	unnamed	PRDM5
MGI Expression: Detected	5784	TS22_organ system	80	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	84	4.454434e-1	1.000000e+0	1.000000e+0	1.958424e+0	5.106147e-1	1	4606	5.000000e-1	2.171081e-4	unnamed	MAD2L1
MGI Expression: Detected	5741	TS22_embryo	81	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	85	4.751674e-1	1.000000e+0	1.000000e+0	1.814625e+0	5.510781e-1	1	4971	5.000000e-1	2.011668e-4	unnamed	MAD2L1
MGI Expression: Detected	5740	Theiler_stage_22	82	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	86	4.770932e-1	1.000000e+0	1.000000e+0	1.805906e+0	5.537387e-1	1	4995	5.000000e-1	2.002002e-4	unnamed	MAD2L1
MGI Expression: Detected	7489	TS23_visceral organ	83	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	55	9.506987e-2	1.000000e+0	1.000000e+0	3.243034e+0	6.167064e-1	2	5563	1.000000e+0	3.595182e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	7445	TS23_organ system	84	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	74	1.994819e-1	1.000000e+0	1.000000e+0	2.238893e+0	8.932986e-1	2	8058	1.000000e+0	2.482005e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	6925	TS23_embryo	85	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	76	2.342505e-1	1.000000e+0	1.000000e+0	2.066079e+0	9.680173e-1	2	8732	1.000000e+0	2.290426e-4	unnamed	MAD2L1,PRDM5
MGI Expression: Detected	6924	Theiler_stage_23	86	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	77	2.344115e-1	1.000000e+0	1.000000e+0	2.065369e+0	9.683499e-1	2	8735	1.000000e+0	2.289639e-4	unnamed	MAD2L1,PRDM5
MSigDB Perturbation	MANN_RESPONSE_TO_AMIFOSTINE_DN	Genes down-regulated in HCT116 cells (colon cancer) after treatment with amifostine [PubChem=2141] depending on the presence of TP53 [GeneID=7157]: TP53-positive vs TP53-null cells.	1	1.048562e-3	1.000000e+0	1.000000e+0	9.536871e+2	1.048562e-3	1	1.048562e-3	1.000000e+0	1	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MAD2L1
MSigDB Perturbation	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	Genes down-regulated in DU-145 cells (prostate cancer) in the absence and presence of a dominant negative form of AKT1 [GeneID=207] upon exposure to HGF [GeneID=3082] for 48 h.	2	1.855008e-3	1.000000e+0	1.000000e+0	5.390812e+2	1.855008e-3	1	1.855008e-3	1.000000e+0	2	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	MAD2L1
MSigDB Perturbation	FARMER_BREAST_CANCER_CLUSTER_2	Cluster 2: selected proliferation and 8q amplicon genes clustered together across breast cancer samples.	3	2.677558e-3	1.000000e+0	1.000000e+0	3.734747e+2	2.677558e-3	1	2.677558e-3	1.000000e+0	4	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	MAD2L1
MSigDB Perturbation	CHEN_ETV5_TARGETS_TESTIS	Genes down-regulated in testis from 4 week old ETV5 [GeneID=2119] knockout mice.	4	2.871529e-3	1.000000e+0	1.000000e+0	3.482465e+2	2.871529e-3	1	2.871529e-3	1.000000e+0	3	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	MAD2L1
MSigDB Perturbation	HOFMANN_CELL_LYMPHOMA_DN	Genes down-regulated in lymph nodes from patients with mantle cell lymphoma (MCL) compared to the non-malignant hyperplastic lymph nodes.	5	3.084300e-3	1.000000e+0	1.000000e+0	3.242227e+2	3.084300e-3	1	3.084300e-3	1.000000e+0	6	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	MAD2L1
MSigDB Perturbation	AMUNDSON_GAMMA_RADIATION_RESPONSE	Genes down-regulated across the entire panel of NCI-60 cell lines in response to gamma radiation.	6	3.370142e-3	1.000000e+0	1.000000e+0	2.967234e+2	3.370142e-3	1	3.370142e-3	1.000000e+0	7	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	MAD2L1
MSigDB Perturbation	GREENBAUM_E2A_TARGETS_UP	Genes up-regulated in pre-B lymphocytes upon Cre-Lox knockout of E2A [GeneID=6929].	7	3.682848e-3	1.000000e+0	1.000000e+0	2.715290e+2	3.682848e-3	1	3.682848e-3	1.000000e+0	4	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	MAD2L1
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_MS_DN	Top 50 down-regulated genes in cluster MS of multiple myeloma samples with characteristic expression spike of WHSC1 [GeneID=7468].	8	3.930399e-3	1.000000e+0	1.000000e+0	2.544271e+2	3.930399e-3	1	3.930399e-3	1.000000e+0	9	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PRDM5
MSigDB Perturbation	KAMMINGA_EZH2_TARGETS	Putative targets or partners of EZH2 [GeneID=2146] in hematopoietic stem cells.	9	4.101541e-3	1.000000e+0	1.000000e+0	2.438108e+2	4.101541e-3	1	4.101541e-3	1.000000e+0	8	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	MAD2L1
MSigDB Perturbation	KANG_DOXORUBICIN_RESISTANCE_UP	Genes up-regulated in gastric cancer cell lines: doxorubicin [PubChem=31703] resistant vs sensitive.	10	4.372260e-3	1.000000e+0	1.000000e+0	2.287147e+2	4.372260e-3	1	4.372260e-3	1.000000e+0	13	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MAD2L1
MSigDB Perturbation	RHODES_UNDIFFERENTIATED_CANCER	Genes commonly up-regulated in undifferentiated cancer relative to well-differentiated cancer, based on the meta-analysis of the OncoMine gene expression database.	11	4.493587e-3	1.000000e+0	1.000000e+0	2.225394e+2	4.493587e-3	1	4.493587e-3	1.000000e+0	21	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	MAD2L1
MSigDB Perturbation	LEE_LIVER_CANCER_MYC_E2F1_UP	Genes up-regulated in hepatocellular carcinoma (HCC) from MYC and E2F1 [GeneID=4609;1869] double transgenic mice.	12	4.608519e-3	1.000000e+0	1.000000e+0	2.169895e+2	4.608519e-3	1	4.608519e-3	1.000000e+0	14	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	MAD2L1
MSigDB Perturbation	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	Down-regulated genes predicting response of patients with hepatocellular carcinoma (HCC) to combination chemotherapy with 5-fluorouracil (5-FU) [PubChem=3385] and IFN1@ [GeneID=3438].	13	5.071923e-3	1.000000e+0	1.000000e+0	1.971639e+2	5.071923e-3	1	5.071923e-3	1.000000e+0	10	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	MAD2L1
MSigDB Perturbation	RAMASWAMY_METASTASIS_UP	Up-regulated genes in metastatic vs primary solid tumors.	14	5.298113e-3	1.000000e+0	1.000000e+0	1.887464e+2	5.298113e-3	1	5.298113e-3	1.000000e+0	18	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	MAD2L1
MSigDB Perturbation	OLSSON_E2F3_TARGETS_DN	Genes down-regulated in the 5637 cell line (bladder cancer) after knockdown of E2F3 [GeneID=1871] by RNAi.	15	5.298588e-3	1.000000e+0	1.000000e+0	1.887295e+2	5.298588e-3	1	5.298588e-3	1.000000e+0	20	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MAD2L1
MSigDB Perturbation	REN_BOUND_BY_E2F	Genes whose promoters were bound by E2F1 and E2F4 [GeneID=1869;1874] in the primary fibroblasts WI-38, by ChIP on chip assay.	16	5.473169e-3	1.000000e+0	1.000000e+0	1.827095e+2	5.473169e-3	1	5.473169e-3	1.000000e+0	22	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	MAD2L1
MSigDB Perturbation	KAUFFMANN_MELANOMA_RELAPSE_UP	DNA repair and replication genes up-regulated in melanoma patients who will relapse vs patients who will not.	17	5.549016e-3	1.000000e+0	1.000000e+0	1.802121e+2	5.549016e-3	1	5.549016e-3	1.000000e+0	15	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MAD2L1
MSigDB Perturbation	SONG_TARGETS_OF_IE86_CMV_PROTEIN	Cellular genes up-regulated in forskin fibroblasts by expression of CMV EI86 protein off an adenovirus vector.	18	5.686757e-3	1.000000e+0	1.000000e+0	1.758472e+2	5.686757e-3	1	5.686757e-3	1.000000e+0	15	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MAD2L1
MSigDB Perturbation	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	Cell cycle genes significantly (p =&lt; 0.05) changed in fibroblast cells at 6 h after exposure to ionizing radiation.	19	5.746122e-3	1.000000e+0	1.000000e+0	1.740304e+2	5.746122e-3	1	5.746122e-3	1.000000e+0	23	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	MAD2L1
MSigDB Perturbation	MALONEY_RESPONSE_TO_17AAG_DN	Down-regulated genes in A2780 cells (ovarian cancer) treated with 17AAG [PubChem=6440175], a chemical with anticancer properties.	20	6.058576e-3	1.000000e+0	1.000000e+0	1.650553e+2	6.058576e-3	1	6.058576e-3	1.000000e+0	26	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	MAD2L1
MSigDB Perturbation	RIZKI_TUMOR_INVASIVENESS_2D_DN	Genes down-regulated in monolayer (2D) cultures of preinvasive (S3-C) vs invasive (T4-2) breast cancer cells.	21	6.190037e-3	1.000000e+0	9.915850e-1	1.615499e+2	6.190037e-3	1	6.190037e-3	1.000000e+0	19	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	MAD2L1
MSigDB Perturbation	GEORGES_CELL_CYCLE_MIR192_TARGETS	Experimentally validated direct targets of MIR192 [GeneID=406967] microRNA; MIR192 caused cell cycle arrest in HCT116 cells (colon cancer).	22	7.232983e-3	1.000000e+0	1.000000e+0	1.382555e+2	7.232983e-3	1	7.232983e-3	1.000000e+0	17	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	MAD2L1
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_CD2_UP	Top 50 up-regulated genes in cluster CD-2 of multiple myeloma samples with the characteristic expression spike of CCND3 [GeneID=896].	23	7.319232e-3	1.000000e+0	1.000000e+0	1.366264e+2	7.319232e-3	1	7.319232e-3	1.000000e+0	11	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	PRDM5
MSigDB Perturbation	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	Genes down-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.	24	7.721462e-3	1.000000e+0	1.000000e+0	1.295092e+2	7.721462e-3	1	7.721462e-3	1.000000e+0	25	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	MAD2L1
MSigDB Perturbation	CROONQUIST_IL6_DEPRIVATION_DN	Genes down-regulated in the ANBL-6 cell line (multiple myeloma, MM) after withdrawal of IL6 [GeneID=3569].	25	8.409895e-3	1.000000e+0	1.000000e+0	1.189075e+2	8.409895e-3	1	8.409895e-3	1.000000e+0	27	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	MAD2L1
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	Genes down-regulated in CD-1 compared to CD-2 cluster of multiple myeloma samples.	26	8.579997e-3	1.000000e+0	1.000000e+0	1.165502e+2	8.579997e-3	1	8.579997e-3	1.000000e+0	12	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	PRDM5
MSigDB Perturbation	LEE_AGING_CEREBELLUM_DN	Downregulated in the cerebellum of aged adult mice (30-month) vs young adult (5-month)	27	8.958958e-3	1.000000e+0	1.000000e+0	1.116201e+2	8.958958e-3	1	8.958958e-3	1.000000e+0	24	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	PRDM5
MSigDB Perturbation	BURTON_ADIPOGENESIS_3	Strongly up-regulated at 16-24 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.	28	9.482842e-3	1.000000e+0	1.000000e+0	1.054536e+2	9.482842e-3	1	9.482842e-3	1.000000e+0	28	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	MAD2L1
MSigDB Perturbation	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	Up-regulated genes whose expression correlated with histologic grade of invasive breast cancer tumors: comparison of grade 1 vs grade 3.	29	9.817439e-3	1.000000e+0	1.000000e+0	1.018596e+2	9.817439e-3	1	9.817439e-3	1.000000e+0	42	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	MAD2L1
MSigDB Perturbation	BASSO_B_LYMPHOCYTE_NETWORK	Genes which comprise the top 1% of highly interconnected genes (major hubs) that account for most of gene interactions in the reconstructed regulatory networks from expression profiles in B lymphocytes.	30	1.057384e-2	1.000000e+0	1.000000e+0	9.457301e+1	1.057384e-2	1	1.057384e-2	1.000000e+0	36	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	MAD2L1
MSigDB Perturbation	PUJANA_BRCA_CENTERED_NETWORK	Genes constituting the BRCA-centered network (BCN).	31	1.065216e-2	1.000000e+0	1.000000e+0	9.387771e+1	1.065216e-2	1	1.065216e-2	1.000000e+0	30	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	MAD2L1
MSigDB Perturbation	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.	32	1.069990e-2	1.000000e+0	1.000000e+0	9.345884e+1	1.069990e-2	1	1.069990e-2	1.000000e+0	37	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	MAD2L1
MSigDB Perturbation	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	Cell cycle genes significantly (p =&lt; 0.05) changed in fibroblast cells at 24 h after exposure to ionizing radiation.	33	1.083741e-2	1.000000e+0	1.000000e+0	9.227296e+1	1.083741e-2	1	1.083741e-2	1.000000e+0	32	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	MAD2L1
MSigDB Perturbation	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	Up-regulated genes in MDA-MB-435 cells (breast cancer) undergoing G2/M arrest after treatment with 2-methoxyestradiol (2ME2)[PubChem=1573].	34	1.139239e-2	1.000000e+0	1.000000e+0	8.777787e+1	1.139239e-2	1	1.139239e-2	1.000000e+0	33	1.380970e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	125	5.000000e-1	8.000000e-3	unnamed	MAD2L1
MSigDB Perturbation	BENPORATH_PROLIFERATION	Set 'Proliferation Cluster': genes defined in human breast tumor expression data.	35	1.146571e-2	1.000000e+0	1.000000e+0	8.721655e+1	1.146571e-2	1	1.146571e-2	1.000000e+0	40	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	MAD2L1
MSigDB Perturbation	WHITEFORD_PEDIATRIC_CANCER_MARKERS	Differentially expressed genes in a panel of xenografts representing 8 common pediatric tumors compared to the normal tissues.	36	1.184154e-2	1.000000e+0	1.000000e+0	8.444848e+1	1.184154e-2	1	1.184154e-2	1.000000e+0	34	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	MAD2L1
MSigDB Perturbation	CHANG_CYCLING_GENES	Fibroblast serum response genes showing periodic expression during the cell cycle; excluded from the core serum response signature.	37	1.263702e-2	1.000000e+0	1.000000e+0	7.913256e+1	1.263702e-2	1	1.263702e-2	1.000000e+0	37	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	MAD2L1
MSigDB Perturbation	SERVITJA_LIVER_HNF1A_TARGETS_UP	Genes up-regulated in liver tissue upon knockout of HNF1A [GeneID=6927].	38	1.396256e-2	1.000000e+0	1.000000e+0	7.162009e+1	1.396256e-2	1	1.396256e-2	1.000000e+0	35	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	MAD2L1
MSigDB Perturbation	LE_EGR2_TARGETS_UP	Genes up-regulated in P14 nerves of transgenic mice having hypomorhic (reduced function) allele of EGR2 [GeneID=1959].	39	1.431208e-2	1.000000e+0	1.000000e+0	6.987106e+1	1.431208e-2	1	1.431208e-2	1.000000e+0	29	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	MAD2L1
MSigDB Perturbation	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	Cluster 7: genes up-regulated in B493-6 cells (B lymphocytes) by MYC [GeneID=4609] and down-regulated by the combination of MYC and serum.	40	1.454324e-2	1.000000e+0	1.000000e+0	6.876045e+1	1.454324e-2	1	1.454324e-2	1.000000e+0	41	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	MAD2L1
MSigDB Perturbation	VANTVEER_BREAST_CANCER_METASTASIS_DN	Genes whose expression is significantly and negatively correlated with poor breast cancer clinical outcome (defined as developing distant metastases in less than 5 years).	41	1.498648e-2	1.000000e+0	1.000000e+0	6.672679e+1	1.498648e-2	1	1.498648e-2	1.000000e+0	31	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	MAD2L1
MSigDB Perturbation	PENG_GLUCOSE_DEPRIVATION_DN	Genes down-regulated in BJAB cells (B-lymphoma) after glucose [PubChem=206] deprivation.	42	1.502966e-2	1.000000e+0	1.000000e+0	6.653511e+1	1.502966e-2	1	1.502966e-2	1.000000e+0	45	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	MAD2L1
MSigDB Perturbation	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	Genes down-regulated in Wilm's tumor samples compared to fetal  kidney.	43	1.583386e-2	1.000000e+0	1.000000e+0	6.315578e+1	1.583386e-2	1	1.583386e-2	1.000000e+0	43	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	MAD2L1
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_G2	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G2 phase of cell cycle.	44	1.585683e-2	1.000000e+0	1.000000e+0	6.306431e+1	1.585683e-2	1	1.585683e-2	1.000000e+0	48	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	MAD2L1
MSigDB Perturbation	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.	45	1.595697e-2	1.000000e+0	1.000000e+0	6.266855e+1	1.595697e-2	1	1.595697e-2	1.000000e+0	49	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	MAD2L1
MSigDB Perturbation	PUJANA_XPRSS_INT_NETWORK	Genes constituting the XPRSS-Int network: intersection of genes whose expression correlates with BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200] in a compendium of normal tissues.	46	1.610988e-2	1.000000e+0	1.000000e+0	6.207372e+1	1.610988e-2	1	1.610988e-2	1.000000e+0	45	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	MAD2L1
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	Marker genes down-regulated in the 'unannotated' subclass of hepatocellular carcinoma (HCC) samples.	47	1.636872e-2	1.000000e+0	1.000000e+0	6.109215e+1	1.636872e-2	1	1.636872e-2	1.000000e+0	55	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	MAD2L1
MSigDB Perturbation	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	Genes differentially expressed in hereditary breast cancer tumors with mutated BRCA1 [GeneID=672] compared to those with mutated BRCA2 [GeneID=675].	48	1.653298e-2	1.000000e+0	1.000000e+0	6.048516e+1	1.653298e-2	1	1.653298e-2	1.000000e+0	43	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	MAD2L1
MSigDB Perturbation	RUIZ_TNC_TARGETS_DN	Genes down-regulated in T98G cells (glioblastoma) by TNC [GeneID=3371].	49	1.700761e-2	1.000000e+0	1.000000e+0	5.879722e+1	1.700761e-2	1	1.700761e-2	1.000000e+0	39	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	MAD2L1
MSigDB Perturbation	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	Up-regulated genes in hepatocellular carcinoma (HCC) subclass G3, defined by unsupervised clustering.	50	1.709912e-2	1.000000e+0	1.000000e+0	5.848255e+1	1.709912e-2	1	1.709912e-2	1.000000e+0	54	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	MAD2L1
MSigDB Perturbation	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	Genes up-regulated in fibroblasts with defective XPC [GeneID=7508] in response to cisplatin [PubChem=2767].	51	1.771781e-2	1.000000e+0	1.000000e+0	5.644040e+1	1.771781e-2	1	1.771781e-2	1.000000e+0	58	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MAD2L1
MSigDB Perturbation	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	52	1.771869e-2	1.000000e+0	1.000000e+0	5.643757e+1	1.771869e-2	1	1.771869e-2	1.000000e+0	56	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MAD2L1
MSigDB Perturbation	BIDUS_METASTASIS_UP	Genes up-regulated in endometroid endometrial tumors from patients with lymph node metastases compared to those without the metastases.	53	1.803475e-2	1.000000e+0	1.000000e+0	5.544850e+1	1.803475e-2	1	1.803475e-2	1.000000e+0	59	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	MAD2L1
MSigDB Perturbation	FUJII_YBX1_TARGETS_DN	Genes down-regulated in MCF-7 cells (breast cancer) after knockdown of YBX1 [GeneID=4904] by RNAi.	54	1.831262e-2	1.000000e+0	1.000000e+0	5.460716e+1	1.831262e-2	1	1.831262e-2	1.000000e+0	57	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MAD2L1
MSigDB Perturbation	KAUFFMANN_DNA_REPAIR_GENES	Genes involved in DNA repair, compiled manually by the authors.	55	1.883782e-2	1.000000e+0	1.000000e+0	5.308469e+1	1.883782e-2	1	1.883782e-2	1.000000e+0	60	2.467884e-2	1.000000e+0	1.000000e+0	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	MAD2L1
MSigDB Perturbation	MANALO_HYPOXIA_DN	Genes down-regulated in response to both hypoxia and overexpression of an active form of HIF1A [GeneID=3091].	56	1.907423e-2	1.000000e+0	1.000000e+0	5.242677e+1	1.907423e-2	1	1.907423e-2	1.000000e+0	67	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	MAD2L1
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	Top 200 marker genes up-regulated in the 'proliferation' subclass of hepatocellular carcinoma (HCC); characterized by increased proliferation, high levels of serum AFP [GeneID=174], and chromosomal instability.	57	1.975809e-2	1.000000e+0	1.000000e+0	5.061219e+1	1.975809e-2	1	1.975809e-2	1.000000e+0	52	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	MAD2L1
MSigDB Perturbation	BROWNE_HCMV_INFECTION_48HR_UP	Genes up-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not up-regulated at the previous time point, 24 h.	58	1.990267e-2	1.000000e+0	1.000000e+0	5.024451e+1	1.990267e-2	1	1.990267e-2	1.000000e+0	47	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	MAD2L1
MSigDB Perturbation	MARKEY_RB1_ACUTE_LOF_DN	Genes down-regulated in adult fibroblasts with inactivated RB1 [GeneID=5925] by Cre-lox: acute loss of function (LOF) of RB1.	59	2.024542e-2	1.000000e+0	1.000000e+0	4.939388e+1	2.024542e-2	1	2.024542e-2	1.000000e+0	61	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	MAD2L1
MSigDB Perturbation	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	Genes down-regulated in acute myeloid leukemia (AML) with respect to cellular localization of NPM1 [GeneID=4869]: cytoplasmic vs. nucleolar.	60	2.108944e-2	1.000000e+0	1.000000e+0	4.741710e+1	2.108944e-2	1	2.108944e-2	1.000000e+0	50	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	MAD2L1
MSigDB Perturbation	SASAKI_ADULT_T_CELL_LEUKEMIA	Genes up-regulated in adult T-cell leukemia (ATL) cells compared to T lymphocytes from healthy controls.	61	2.133045e-2	1.000000e+0	1.000000e+0	4.688133e+1	2.133045e-2	1	2.133045e-2	1.000000e+0	53	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	MAD2L1
MSigDB Perturbation	KOBAYASHI_EGFR_SIGNALING_24HR_DN	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	62	2.179460e-2	1.000000e+0	1.000000e+0	4.588292e+1	2.179460e-2	1	2.179460e-2	1.000000e+0	64	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	MAD2L1
MSigDB Perturbation	AFFAR_YY1_TARGETS_DN	Genes down-regulated in MEF cells (embryonic fibroblast) expressing ~25% of YY1 [GeneID=7528].	63	2.386809e-2	1.000000e+0	1.000000e+0	4.189694e+1	2.386809e-2	1	2.386809e-2	1.000000e+0	62	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	MAD2L1
MSigDB Perturbation	WONG_EMBRYONIC_STEM_CELL_CORE	The 'core ESC-like gene module': genes coordinately up-regulated in a compendium of mouse embryonic stem cells (ESC) which are shared with the human ESC-like module.	64	2.401219e-2	1.000000e+0	1.000000e+0	4.164551e+1	2.401219e-2	1	2.401219e-2	1.000000e+0	75	3.701143e-2	1.000000e+0	1.000000e+0	2.676706e+1	3.735935e-2	1	337	5.000000e-1	2.967359e-3	unnamed	MAD2L1
MSigDB Perturbation	BASAKI_YBX1_TARGETS_UP	Genes up-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	65	2.464082e-2	1.000000e+0	1.000000e+0	4.058307e+1	2.464082e-2	1	2.464082e-2	1.000000e+0	69	3.134601e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	MAD2L1
MSigDB Perturbation	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	Genes down-regulated in mature plasma cells compared with plasmablastic B lymphocytes.	66	2.473198e-2	1.000000e+0	1.000000e+0	4.043348e+1	2.473198e-2	1	2.473198e-2	1.000000e+0	72	3.407184e-2	1.000000e+0	1.000000e+0	2.909839e+1	3.436617e-2	1	310	5.000000e-1	3.225806e-3	unnamed	MAD2L1
MSigDB Perturbation	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	Genes down-regulated in SH-SY5Y cells (neuroblastoma) after treatment with epoxomicin [PubChem=3035402], a protease inhibitor causing apoptosis.	67	2.505742e-2	1.000000e+0	1.000000e+0	3.990833e+1	2.505742e-2	1	2.505742e-2	1.000000e+0	50	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	MAD2L1
MSigDB Perturbation	RIZKI_TUMOR_INVASIVENESS_3D_DN	Genes down-regulated in three-dimentional (3D) cultures of preinvasive (S3-C) vs invasive (T4-2) breast cancer cells.	68	2.565942e-2	1.000000e+0	1.000000e+0	3.897205e+1	2.565942e-2	1	2.565942e-2	1.000000e+0	65	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	MAD2L1
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	69	2.574991e-2	1.000000e+0	1.000000e+0	3.883509e+1	2.574991e-2	1	2.574991e-2	1.000000e+0	74	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	MAD2L1
MSigDB Perturbation	HORIUCHI_WTAP_TARGETS_DN	Genes down-regulated in primary endothelial cells (HUVEC) after knockdown of WTAP [GeneID=9589] by RNAi.	70	2.665398e-2	1.000000e+0	1.000000e+0	3.751785e+1	2.665398e-2	1	2.665398e-2	1.000000e+0	73	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	MAD2L1
MSigDB Perturbation	GOLDRATH_ANTIGEN_RESPONSE	Genes up-regulated at the peak of an antigen response of naive CD8+ [GeneID=925;926] T-cells.	71	2.675801e-2	1.000000e+0	1.000000e+0	3.737199e+1	2.675801e-2	1	2.675801e-2	1.000000e+0	77	3.755531e-2	1.000000e+0	1.000000e+0	2.637573e+1	3.791364e-2	1	342	5.000000e-1	2.923977e-3	unnamed	MAD2L1
MSigDB Perturbation	POOLA_INVASIVE_BREAST_CANCER_UP	Genes up-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH).	72	2.677237e-2	1.000000e+0	1.000000e+0	3.735195e+1	2.677237e-2	1	2.677237e-2	1.000000e+0	66	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	MAD2L1
MSigDB Perturbation	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	Genes up-regulated in biphasic (mixed) vs epithelial subtypes of malignant peritoneal mesothelioma.	73	2.747149e-2	1.000000e+0	1.000000e+0	3.640137e+1	2.747149e-2	1	2.747149e-2	1.000000e+0	70	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	MAD2L1
MSigDB Perturbation	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	74	2.928641e-2	1.000000e+0	1.000000e+0	3.414553e+1	2.928641e-2	1	2.928641e-2	1.000000e+0	80	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	MAD2L1
MSigDB Perturbation	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	The glioblastoma multiforme (GBM) plasticity signature: genes up-regulated in neural stem cells (NSC) with double knockout of TP53 and PTEN [GeneID=7157;5728] vs those with knockout of TP53 alone.	75	3.204692e-2	1.000000e+0	1.000000e+0	3.120425e+1	3.204692e-2	1	3.204692e-2	1.000000e+0	63	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	MAD2L1
MSigDB Perturbation	VECCHI_GASTRIC_CANCER_EARLY_UP	Up-regulated genes distinguishing between early gastric cancer (EGC) and normal tissue samples.	76	3.247479e-2	1.000000e+0	1.000000e+0	3.079312e+1	3.247479e-2	1	3.247479e-2	1.000000e+0	82	4.352782e-2	1.000000e+0	1.000000e+0	2.272166e+1	4.401086e-2	1	397	5.000000e-1	2.518892e-3	unnamed	MAD2L1
MSigDB Perturbation	BLUM_RESPONSE_TO_SALIRASIB_DN	Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	77	3.335018e-2	1.000000e+0	1.000000e+0	2.998484e+1	3.335018e-2	1	3.335018e-2	1.000000e+0	76	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	MAD2L1
MSigDB Perturbation	BRUINS_UVC_RESPONSE_EARLY_LATE	Early-late response genes: differentially expressed in the first 3 h and after 12 h following UV-C irradiation of MEF cells (embryonic fibroblast).	78	3.354868e-2	1.000000e+0	1.000000e+0	2.980743e+1	3.354868e-2	1	3.354868e-2	1.000000e+0	71	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	PRDM5
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nsopharyngeal carcinoma relative to the normal tissue.	79	3.539566e-2	1.000000e+0	1.000000e+0	2.825205e+1	3.539566e-2	1	3.539566e-2	1.000000e+0	68	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	MAD2L1
MSigDB Perturbation	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	Genes down-regulated in ALL (acute lymphoblastic leukemia) blasts after 1 week of treatment with glucocorticoids.	80	3.771906e-2	1.000000e+0	1.000000e+0	2.651180e+1	3.771906e-2	1	3.771906e-2	1.000000e+0	79	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	MAD2L1
MSigDB Perturbation	MARTENS_TRETINOIN_RESPONSE_DN	Genes down-regulated in NB4 cells (acute promyelocytic leukemia, APL) in response to tretinoin [PubChem=444795]; based on Chip-seq data.	81	3.772631e-2	1.000000e+0	1.000000e+0	2.650670e+1	3.772631e-2	1	3.772631e-2	1.000000e+0	99	8.449668e-2	1.000000e+0	1.000000e+0	1.157959e+1	8.635885e-2	1	779	5.000000e-1	1.283697e-3	unnamed	MAD2L1
MSigDB Perturbation	PUJANA_BRCA2_PCC_NETWORK	Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.	82	3.791785e-2	1.000000e+0	1.000000e+0	2.637280e+1	3.791785e-2	1	3.791785e-2	1.000000e+0	83	4.569503e-2	1.000000e+0	1.000000e+0	2.163189e+1	4.622804e-2	1	417	5.000000e-1	2.398082e-3	unnamed	MAD2L1
MSigDB Perturbation	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	Cluster 6 of method A: up-regulation of these genes in patients with non-small cell lung cancer (NSCLC) predicts poor survival outcome.	83	3.969311e-2	1.000000e+0	1.000000e+0	2.519329e+1	3.969311e-2	1	3.969311e-2	1.000000e+0	85	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	MAD2L1
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_CLASSES_UP	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	84	3.989950e-2	1.000000e+0	1.000000e+0	2.506297e+1	3.989950e-2	1	3.989950e-2	1.000000e+0	90	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	MAD2L1
MSigDB Perturbation	KUMAR_TARGETS_OF_MLL_AF9_FUSION	Myeloid leukemia model in mice with germ-line MLL-AF9 fusion knock-in [GeneID=4297;4300]: genes changed in comparison among the leukemic, preleukemic and wild-type animals.	85	4.113256e-2	1.000000e+0	1.000000e+0	2.431164e+1	4.113256e-2	1	4.113256e-2	1.000000e+0	81	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	PRDM5
MSigDB Perturbation	MARSON_BOUND_BY_E2F4_UNSTIMULATED	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	86	4.167922e-2	1.000000e+0	1.000000e+0	2.399277e+1	4.167922e-2	1	4.167922e-2	1.000000e+0	94	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	MAD2L1
MSigDB Perturbation	WANG_SMARCE1_TARGETS_DN	Genes down-regulated in BT549 cells (breast cancer) by expression of SMARCE1 [GeneID=6605] off a retroviral vector.	87	4.334967e-2	1.000000e+0	1.000000e+0	2.306822e+1	4.334967e-2	1	4.334967e-2	1.000000e+0	78	3.918602e-2	1.000000e+0	1.000000e+0	2.526751e+1	3.957652e-2	1	357	5.000000e-1	2.801120e-3	unnamed	MAD2L1
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_24HR_UP	Genes up-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 24h.	88	4.577476e-2	1.000000e+0	1.000000e+0	2.184610e+1	4.577476e-2	1	4.577476e-2	1.000000e+0	89	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	MAD2L1
MSigDB Perturbation	KIM_WT1_TARGETS_DN	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	89	4.691887e-2	1.000000e+0	1.000000e+0	2.131339e+1	4.691887e-2	1	4.691887e-2	1.000000e+0	84	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	MAD2L1
MSigDB Perturbation	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	Genes up-regulated during later stage of differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	90	4.971953e-2	1.000000e+0	1.000000e+0	2.011282e+1	4.971953e-2	1	4.971953e-2	1.000000e+0	88	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	MAD2L1
MSigDB Perturbation	BERENJENO_TRANSFORMED_BY_RHOA_UP	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	91	5.123973e-2	1.000000e+0	1.000000e+0	1.951611e+1	5.123973e-2	1	5.123973e-2	1.000000e+0	87	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	MAD2L1
MSigDB Perturbation	BENPORATH_MYC_MAX_TARGETS	Set 'Myc targets2': targets of c-Myc [GeneID=4609] and Max [GeneID=4149] identified by ChIP on chip in a Burkitt's lymphoma cell line; overlap set.	92	5.249114e-2	1.000000e+0	1.000000e+0	1.905083e+1	5.249114e-2	1	5.249114e-2	1.000000e+0	100	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	MAD2L1
MSigDB Perturbation	ENK_UV_RESPONSE_KERATINOCYTE_DN	Genes down-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.	93	5.492266e-2	1.000000e+0	1.000000e+0	1.820742e+1	5.492266e-2	1	5.492266e-2	1.000000e+0	86	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	MAD2L1
MSigDB Perturbation	BENPORATH_CYCLING_GENES	Genes showing cell-cycle stage-specific expression [PMID=12058064].	94	5.607900e-2	1.000000e+0	1.000000e+0	1.783199e+1	5.607900e-2	1	5.607900e-2	1.000000e+0	92	7.022751e-2	1.000000e+0	1.000000e+0	1.398527e+1	7.150380e-2	1	645	5.000000e-1	1.550388e-3	unnamed	MAD2L1
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	Genes up-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to normal thyroid tissue.	95	5.883486e-2	1.000000e+0	1.000000e+0	1.699673e+1	5.883486e-2	1	5.883486e-2	1.000000e+0	91	6.680363e-2	1.000000e+0	1.000000e+0	1.471533e+1	6.795632e-2	1	613	5.000000e-1	1.631321e-3	unnamed	MAD2L1
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	96	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	101	8.608710e-2	1.000000e+0	1.000000e+0	1.136083e+1	8.802173e-2	1	794	5.000000e-1	1.259446e-3	unnamed	MAD2L1
MSigDB Perturbation	PATIL_LIVER_CANCER	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	97	5.982431e-2	1.000000e+0	1.000000e+0	1.671561e+1	5.982431e-2	1	5.982431e-2	1.000000e+0	97	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	MAD2L1
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	98	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	104	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	MAD2L1
MSigDB Perturbation	WEI_MYCN_TARGETS_WITH_E_BOX	Genes whose promoters contain E-box motifs and whose expression changed in MYCN-3 cells (neuroblastoma) upon induction of MYCN [GeneID=4613].	99	6.806111e-2	1.000000e+0	1.000000e+0	1.469268e+1	6.806111e-2	1	6.806111e-2	1.000000e+0	98	8.343562e-2	1.000000e+0	1.000000e+0	1.173017e+1	8.525026e-2	1	769	5.000000e-1	1.300390e-3	unnamed	MAD2L1
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	Genes in the expression cluster 'HSC and Progenitors Shared': up-regulated in hematopoietic stem cells (HSC) and progenitors from adult bone marrow and fetal liver.	100	7.135492e-2	1.000000e+0	1.000000e+0	1.401445e+1	7.135492e-2	1	7.135492e-2	1.000000e+0	93	7.054818e-2	1.000000e+0	1.000000e+0	1.392052e+1	7.183637e-2	1	648	5.000000e-1	1.543210e-3	unnamed	PRDM5
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	Genes up-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	101	7.606396e-2	1.000000e+0	1.000000e+0	1.314683e+1	7.606396e-2	1	7.606396e-2	1.000000e+0	95	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	MAD2L1
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	102	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	106	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	MAD2L1
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	103	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	107	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	MAD2L1
MSigDB Perturbation	LEE_BMP2_TARGETS_DN	Genes down-regulated in uterus upon knockout of BMP2 [GeneID=650].	104	8.052857e-2	1.000000e+0	1.000000e+0	1.241795e+1	8.052857e-2	1	8.052857e-2	1.000000e+0	103	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	MAD2L1
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	105	8.753961e-2	1.000000e+0	1.000000e+0	1.142340e+1	8.753961e-2	1	8.753961e-2	1.000000e+0	105	9.317413e-2	1.000000e+0	1.000000e+0	1.047677e+1	9.544925e-2	1	861	5.000000e-1	1.161440e-3	unnamed	MAD2L1
MSigDB Perturbation	GEORGES_TARGETS_OF_MIR192_AND_MIR215	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	106	9.671084e-2	1.000000e+0	1.000000e+0	1.034010e+1	9.671084e-2	1	9.671084e-2	1.000000e+0	102	9.137854e-2	1.000000e+0	1.000000e+0	1.068780e+1	9.356466e-2	1	844	5.000000e-1	1.184834e-3	unnamed	MAD2L1
MSigDB Perturbation	WONG_ADULT_TISSUE_STEM_MODULE	The 'adult tissue stem' module: genes coordinately up-regulated in a compendium of adult tissue stem cells.	107	1.017240e-1	1.000000e+0	1.000000e+0	9.830524e+0	1.017240e-1	1	1.017240e-1	1.000000e+0	96	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	PRDM5
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	108	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	108	1.314014e-1	1.000000e+0	1.000000e+0	7.351671e+0	1.360235e-1	1	1227	5.000000e-1	8.149959e-4	unnamed	MAD2L1
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	109	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	110	1.472401e-1	1.000000e+0	1.000000e+0	6.531861e+0	1.530957e-1	1	1381	5.000000e-1	7.241130e-4	unnamed	MAD2L1
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	110	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	111	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	MAD2L1
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	111	1.258050e-1	1.000000e+0	1.000000e+0	7.948812e+0	1.258050e-1	1	1.258050e-1	1.000000e+0	109	1.382073e-1	1.000000e+0	1.000000e+0	6.976411e+0	1.433402e-1	1	1293	5.000000e-1	7.733952e-4	unnamed	MAD2L1
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	112	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	112	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	MAD2L1
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	113	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	113	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	MAD2L1
MSigDB Predicted Promoter Motifs	V$ELF1_Q6	Motif RNWMBAGGAART matches ELF1: E74-like factor 1 (ets domain transcription factor)	1	2.494870e-2	1.000000e+0	1.000000e+0	4.008225e+1	2.494870e-2	1	2.494870e-2	1.000000e+0	2	2.621103e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	PRDM5
MSigDB Predicted Promoter Motifs	V$MZF1_01	Motif NGNGGGGA (no known TF)	2	2.543803e-2	1.000000e+0	1.000000e+0	3.931122e+1	2.543803e-2	1	2.543803e-2	1.000000e+0	1	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	PRDM5
MSigDB Predicted Promoter Motifs	V$NFY_01	Motif NNNRRCCAATSRGNNN (no known TF)	3	2.703791e-2	1.000000e+0	1.000000e+0	3.698511e+1	2.703791e-2	1	2.703791e-2	1.000000e+0	3	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	PRDM5
MSigDB Predicted Promoter Motifs	GCTNWTTGK_UNKNOWN	Motif GCTNWTTGK (no known TF)	4	3.983645e-2	1.000000e+0	1.000000e+0	2.510264e+1	3.983645e-2	1	3.983645e-2	1.000000e+0	4	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	PRDM5
MSigDB Predicted Promoter Motifs	RGAGGAARY_V$PU1_Q6	Motif RGAGGAARY matches SPI1: spleen focus forming virus (SFFV) proviral integration oncogene spi1	5	5.221701e-2	1.000000e+0	1.000000e+0	1.915085e+1	5.221701e-2	1	5.221701e-2	1.000000e+0	5	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	PRDM5
MSigDB Predicted Promoter Motifs	RCGCANGCGY_V$NRF1_Q6	Motif RCGCANGCGY matches NRF1: nuclear respiratory factor 1	6	6.425044e-2	1.000000e+0	1.000000e+0	1.556410e+1	6.425044e-2	1	6.425044e-2	1.000000e+0	6	9.486248e-2	1.000000e+0	1.000000e+0	1.028563e+1	9.722299e-2	1	877	5.000000e-1	1.140251e-3	unnamed	MAD2L1
MSigDB Predicted Promoter Motifs	GATTGGY_V$NFY_Q6_01	Motif GATTGGY (no known TF)	7	1.117321e-1	1.000000e+0	1.000000e+0	8.949976e+0	1.117321e-1	1	1.117321e-1	1.000000e+0	7	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	PRDM5
InterPro	IPR017125	PR-domain zinc finger protein PRDM5	1	3.492912e-4	1.000000e+0	1.000000e+0	2.862941e+3	3.492912e-4	1	3.492912e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PRDM5
InterPro	IPR027097	Mitotic spindle checkpoint protein Mad2	2	4.500877e-4	1.000000e+0	1.000000e+0	2.221789e+3	4.500877e-4	1	4.500877e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MAD2L1
InterPro	IPR003511	DNA-binding HORMA	3	6.095079e-4	1.000000e+0	1.000000e+0	1.640668e+3	6.095079e-4	1	6.095079e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MAD2L1
InterPro	IPR022755	Zinc finger, double-stranded RNA binding	4	2.929668e-3	1.000000e+0	1.000000e+0	3.413356e+2	2.929668e-3	1	2.929668e-3	1.000000e+0	4	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PRDM5
InterPro	IPR001214	SET domain	5	6.263614e-3	1.000000e+0	1.000000e+0	1.596522e+2	6.263614e-3	1	6.263614e-3	1.000000e+0	5	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PRDM5
InterPro	IPR013087	Zinc finger C2H2-type/integrase DNA-binding domain	6	4.898426e-2	1.000000e+0	1.000000e+0	2.041472e+1	4.898426e-2	1	4.898426e-2	1.000000e+0	6	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	PRDM5
InterPro	IPR007087	Zinc finger, C2H2	7	6.057290e-2	1.000000e+0	1.000000e+0	1.650903e+1	6.057290e-2	1	6.057290e-2	1.000000e+0	7	8.449668e-2	1.000000e+0	1.000000e+0	1.157959e+1	8.635885e-2	1	779	5.000000e-1	1.283697e-3	unnamed	PRDM5
InterPro	IPR015880	Zinc finger, C2H2-like	8	6.445125e-2	1.000000e+0	1.000000e+0	1.551560e+1	6.445125e-2	1	6.445125e-2	1.000000e+0	8	8.884057e-2	1.000000e+0	1.000000e+0	1.100061e+1	9.090405e-2	1	820	5.000000e-1	1.219512e-3	unnamed	PRDM5
TreeFam	TF106478	PR domain containing 5	1	3.492912e-4	1.000000e+0	1.000000e+0	2.862941e+3	3.492912e-4	1	3.492912e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PRDM5
TreeFam	TF101084	MAD2 mitotic arrest deficient-like 1 (yeast)	2	4.500877e-4	1.000000e+0	1.000000e+0	2.221789e+3	4.500877e-4	1	4.500877e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MAD2L1
HGNC Gene Families	ZNF	ZNF	1	2.464893e-2	1.000000e+0	1.000000e+0	4.056971e+1	2.464893e-2	1	2.464893e-2	1.000000e+0	1	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	PRDM5
Ensembl Genes	14811	PRDM5	1	3.492912e-4	1.000000e+0	1.000000e+0	2.862941e+3	3.492912e-4	1	3.492912e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PRDM5
Ensembl Genes	14810	MAD2L1	2	4.500877e-4	1.000000e+0	1.000000e+0	2.221789e+3	4.500877e-4	1	4.500877e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MAD2L1
MSigDB Oncogenic Signatures	RB_P107_DN.V1_UP	Genes up-regulated in primary keratinocytes from RB1 and RBL1 [Gene ID=5925, 5933] skin specific knockout mice.	1	1.211958e-2	1.000000e+0	1.000000e+0	8.251110e+1	1.211958e-2	1	1.211958e-2	1.000000e+0	1	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	MAD2L1
MSigDB Oncogenic Signatures	CAMP_UP.V1_UP	Genes up-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).	2	1.223246e-2	1.000000e+0	1.000000e+0	8.174970e+1	1.223246e-2	1	1.223246e-2	1.000000e+0	2	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MAD2L1
MSigDB Oncogenic Signatures	ERB2_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	3	2.349699e-2	1.000000e+0	1.000000e+0	4.255865e+1	2.349699e-2	1	2.349699e-2	1.000000e+0	3	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MAD2L1
MSigDB Oncogenic Signatures	VEGF_A_UP.V1_DN	Genes down-regulated in HUVEC cells (endothelium) by treatment with VEGFA [Gene ID=7422].	4	2.493383e-2	1.000000e+0	1.000000e+0	4.010616e+1	2.493383e-2	1	2.493383e-2	1.000000e+0	3	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 48 h.	1	1.168167e-2	1.000000e+0	1.000000e+0	8.560422e+1	1.168167e-2	1	1.168167e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN	Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3600] at 16 h.	2	1.308014e-2	1.000000e+0	1.000000e+0	7.645178e+1	1.308014e-2	1	1.308014e-2	1.000000e+0	77	2.215906e-2	1.000000e+0	5.496598e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 24 h.	3	1.322845e-2	1.000000e+0	1.000000e+0	7.559462e+1	1.322845e-2	1	1.322845e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 24 h after stimulation with antigen-B7-1.	4	1.348943e-2	1.000000e+0	1.000000e+0	7.413209e+1	1.348943e-2	1	1.348943e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE11924_TH1_VS_TH2_CD4_TCELL_UP	Genes up-regulated in comparison of Th1 cells versus Th17 cells.	5	1.360185e-2	1.000000e+0	1.000000e+0	7.351944e+1	1.360185e-2	1	1.360185e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 24 h after stimulation with IL12 .	6	1.364545e-2	1.000000e+0	1.000000e+0	7.328448e+1	1.364545e-2	1	1.364545e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.	7	1.368185e-2	1.000000e+0	1.000000e+0	7.308953e+1	1.368185e-2	1	1.368185e-2	1.000000e+0	81	2.237830e-2	1.000000e+0	5.276858e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 1 h versus the untreated cells at 72 h.	8	1.381429e-2	1.000000e+0	1.000000e+0	7.238879e+1	1.381429e-2	1	1.381429e-2	1.000000e+0	9	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h.	9	1.381457e-2	1.000000e+0	1.000000e+0	7.238736e+1	1.381457e-2	1	1.381457e-2	1.000000e+0	10	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] CXCR5+ [GeneID=643] T cells.	10	1.426556e-2	1.000000e+0	1.000000e+0	7.009892e+1	1.426556e-2	1	1.426556e-2	1.000000e+0	5	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h.	11	1.439686e-2	1.000000e+0	1.000000e+0	6.945959e+1	1.439686e-2	1	1.439686e-2	1.000000e+0	50	2.172051e-2	1.000000e+0	8.297235e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 12 h.	12	1.464114e-2	1.000000e+0	1.000000e+0	6.830071e+1	1.464114e-2	1	1.464114e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN	Genes down-regulated in comparison of IgD+ B cells versus IgD- B cells.	13	1.478087e-2	1.000000e+0	1.000000e+0	6.765500e+1	1.478087e-2	1	1.478087e-2	1.000000e+0	7	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 T cells KLRG1 Int [GeneID=10219].	14	1.507722e-2	1.000000e+0	1.000000e+0	6.632521e+1	1.507722e-2	1	1.507722e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after stimulation with antigen-B7-1.	15	1.508606e-2	1.000000e+0	1.000000e+0	6.628636e+1	1.508606e-2	1	1.508606e-2	1.000000e+0	75	2.204943e-2	1.000000e+0	5.615255e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 48 h after stimulation with IL12.	16	1.510333e-2	1.000000e+0	1.000000e+0	6.621059e+1	1.510333e-2	1	1.510333e-2	1.000000e+0	75	2.204943e-2	1.000000e+0	5.615255e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after treatment with trichostatin A (TSA) [PubChem=5562].	17	1.520805e-2	1.000000e+0	1.000000e+0	6.575466e+1	1.520805e-2	1	1.520805e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those  from mice defficient for TRAF6 [GeneID=7189] at day 10.	18	1.571267e-2	1.000000e+0	1.000000e+0	6.364290e+1	1.571267e-2	1	1.571267e-2	1.000000e+0	50	2.172051e-2	1.000000e+0	8.297235e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with poly(I:C) (TLR3 agonist) at 1 h.	19	1.606339e-2	1.000000e+0	1.000000e+0	6.225335e+1	1.606339e-2	1	1.606339e-2	1.000000e+0	29	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	20	1.608243e-2	1.000000e+0	1.000000e+0	6.217967e+1	1.608243e-2	1	1.608243e-2	1.000000e+0	85	2.347414e-2	1.000000e+0	5.274777e-1	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after stimulation with IL12.	21	1.611774e-2	1.000000e+0	1.000000e+0	6.204344e+1	1.611774e-2	1	1.611774e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP	Genes up-regulated in comparison of ex vivo CD4 [GeneID=920] dendritic cells (DC) versus cultured CD4 [GeneID=920] DCs.	22	1.634222e-2	1.000000e+0	1.000000e+0	6.119121e+1	1.634222e-2	1	1.634222e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those at day 10.	23	1.635850e-2	1.000000e+0	1.000000e+0	6.113031e+1	1.635850e-2	1	1.635850e-2	1.000000e+0	29	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN	Genes down-regulated in comparison of regulatory T cell (Treg) from IL2RB [GeneID=3560] defficient mice versus effector T cells from IL2RB [GeneID=3560] defficient mice.	24	1.641504e-2	1.000000e+0	1.000000e+0	6.091975e+1	1.641504e-2	1	1.641504e-2	1.000000e+0	29	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of naive versus memory CD8 T cells (day 40+ following LCMV-Armstrong infection).	25	1.646202e-2	1.000000e+0	1.000000e+0	6.074588e+1	1.646202e-2	1	1.646202e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP	Genes up-regulated in comparison of CD8 T cells at 0 h versus those at 72 h.	26	1.649144e-2	1.000000e+0	1.000000e+0	6.063751e+1	1.649144e-2	1	1.649144e-2	1.000000e+0	29	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 T cells versus memory CD8 T cells.	27	1.654411e-2	1.000000e+0	1.000000e+0	6.044446e+1	1.654411e-2	1	1.654411e-2	1.000000e+0	79	2.226868e-2	1.000000e+0	5.383947e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	28	1.678214e-2	1.000000e+0	1.000000e+0	5.958715e+1	1.678214e-2	1	1.678214e-2	1.000000e+0	77	2.215906e-2	1.000000e+0	5.496598e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of nave CD8 T cells versus effector CD8 T cells.	29	1.689214e-2	1.000000e+0	1.000000e+0	5.919913e+1	1.689214e-2	1	1.689214e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_4H_VS_24H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus those stimulated at 24 h.	30	1.690970e-2	1.000000e+0	1.000000e+0	5.913764e+1	1.690970e-2	1	1.690970e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_CD8_TCELL_UP	Genes up-regulated in comparison of B cells versus CD8 T cells.	31	1.697980e-2	1.000000e+0	1.000000e+0	5.889350e+1	1.697980e-2	1	1.697980e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN	Genes down-regulated in comparison of naive B cells versus blood plasma cells.	32	1.703464e-2	1.000000e+0	1.000000e+0	5.870393e+1	1.703464e-2	1	1.703464e-2	1.000000e+0	12	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP	Genes up-regulated in comparison of Th1 cells versus naive CD4 [GeneID=920] T cells.	33	1.713505e-2	1.000000e+0	9.917559e-1	5.835993e+1	1.713505e-2	1	1.713505e-2	1.000000e+0	29	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 5 versus untreated CD25- T cells at day 5.	34	1.714712e-2	1.000000e+0	9.632647e-1	5.831884e+1	1.714712e-2	1	1.714712e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_24H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 24 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 24 h.	35	1.723646e-2	1.000000e+0	9.406182e-1	5.801654e+1	1.723646e-2	1	1.723646e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 24 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 24 h.	36	1.771441e-2	1.000000e+0	9.398479e-1	5.645121e+1	1.771441e-2	1	1.771441e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN	Genes down-regulated in comparison of adult thymic progenitors versus adult DN2 thymocytes.	37	1.786462e-2	1.000000e+0	9.222007e-1	5.597656e+1	1.786462e-2	1	1.786462e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 3 days after stimulation with YF17D vaccine.	38	1.788357e-2	1.000000e+0	8.988847e-1	5.591723e+1	1.788357e-2	1	1.788357e-2	1.000000e+0	2	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell	39	1.821527e-2	1.000000e+0	8.920812e-1	5.489899e+1	1.821527e-2	1	1.821527e-2	1.000000e+0	79	2.226868e-2	1.000000e+0	5.383947e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE2826_WT_VS_BTK_KO_BCELL_UP	Genes up-regulated in comparison of primary splenic B cells from wild type mice versus those from BTK [GeneID=695] knockout mice.	40	1.832401e-2	1.000000e+0	8.749715e-1	5.457322e+1	1.832401e-2	1	1.832401e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP	Genes up-regulated in comparison of CD4+ [GeneID=920] CD8+ thymocytes versus CD4- [GeneID=920] CD8+ thymocytes.	41	1.833871e-2	1.000000e+0	8.543155e-1	5.452946e+1	1.833871e-2	1	1.833871e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP	Genes up-regulated in comparison of CD8 T cells at 0 h versus those at 24 h after stimulation with antigen-B7-1.	42	1.843221e-2	1.000000e+0	8.382267e-1	5.425286e+1	1.843221e-2	1	1.843221e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 T cells KLRG1 high [GeneID=10219].	43	1.845901e-2	1.000000e+0	8.199235e-1	5.417409e+1	1.845901e-2	1	1.845901e-2	1.000000e+0	50	2.172051e-2	1.000000e+0	8.297235e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.	44	1.848083e-2	1.000000e+0	8.022360e-1	5.411012e+1	1.848083e-2	1	1.848083e-2	1.000000e+0	50	2.172051e-2	1.000000e+0	8.297235e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 T cells.	45	1.864793e-2	1.000000e+0	7.915010e-1	5.362527e+1	1.864793e-2	1	1.864793e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	Genes up-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.	46	1.865788e-2	1.000000e+0	7.747076e-1	5.359667e+1	1.865788e-2	1	1.865788e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	47	1.874321e-2	1.000000e+0	7.616922e-1	5.335266e+1	1.874321e-2	1	1.874321e-2	1.000000e+0	1	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.	48	1.876123e-2	1.000000e+0	7.465406e-1	5.330142e+1	1.876123e-2	1	1.876123e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.	49	1.883374e-2	1.000000e+0	7.341315e-1	5.309620e+1	1.883374e-2	1	1.883374e-2	1.000000e+0	84	2.336458e-2	1.000000e+0	5.312660e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_MAC_UP	Genes up-regulated in comparison of eosinophils versus macrophages.	50	1.885392e-2	1.000000e+0	7.202197e-1	5.303937e+1	1.885392e-2	1	1.885392e-2	1.000000e+0	8	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	51	1.891202e-2	1.000000e+0	7.082737e-1	5.287643e+1	1.891202e-2	1	1.891202e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP	Genes up-regulated in comparison of ex vivo CD4- [GeneID=920] CD8- dendritic cells (DC) versus cultured CD4- [GeneID=920] CD8- DCs.	52	1.895237e-2	1.000000e+0	6.961351e-1	5.276384e+1	1.895237e-2	1	1.895237e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 24 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 24 h.	53	1.897418e-2	1.000000e+0	6.837865e-1	5.270320e+1	1.897418e-2	1	1.897418e-2	1.000000e+0	50	2.172051e-2	1.000000e+0	8.297235e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.	54	1.927061e-2	1.000000e+0	6.816086e-1	5.189250e+1	1.927061e-2	1	1.927061e-2	1.000000e+0	83	2.303588e-2	1.000000e+0	5.301028e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	Genes down-regulated in comparison of CD8 dendritic cells (DC) versus CD4- [GeneID=920] CD8- DCs.	55	1.939348e-2	1.000000e+0	6.734827e-1	5.156373e+1	1.939348e-2	1	1.939348e-2	1.000000e+0	34	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP	Genes up-regulated in comparison of adult thymic progenitors versus adult DN3 thymocytes.	56	1.942686e-2	1.000000e+0	6.625947e-1	5.147514e+1	1.942686e-2	1	1.942686e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 16 h.	57	1.943857e-2	1.000000e+0	6.513626e-1	5.144411e+1	1.943857e-2	1	1.943857e-2	1.000000e+0	12	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_16H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	58	1.945462e-2	1.000000e+0	6.406608e-1	5.140168e+1	1.945462e-2	1	1.945462e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN	Genes down-regulated in comparison of adult thymic progenitors versus fetal thymic progenitors.	59	1.949204e-2	1.000000e+0	6.310135e-1	5.130300e+1	1.949204e-2	1	1.949204e-2	1.000000e+0	82	2.281671e-2	1.000000e+0	5.314624e-1	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	60	1.980860e-2	1.000000e+0	6.305738e-1	5.048313e+1	1.980860e-2	1	1.980860e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] thymocytes.	61	1.991617e-2	1.000000e+0	6.236047e-1	5.021045e+1	1.991617e-2	1	1.991617e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_TH1_UP	Genes up-regulated in comparison of eosinophils versus Th1 cells.	62	2.005436e-2	1.000000e+0	6.178037e-1	4.986447e+1	2.005436e-2	1	2.005436e-2	1.000000e+0	34	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE13306_TREG_VS_TCONV_UP	Genes up-regulated in regulatory T cell (Treg) versus conventional T cells.	63	2.026116e-2	1.000000e+0	6.142669e-1	4.935552e+1	2.026116e-2	1	2.026116e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP	Genes up-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	64	2.035031e-2	1.000000e+0	6.073296e-1	4.913931e+1	2.035031e-2	1	2.035031e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP	Genes up-regulated in comparison of regulatory T cell (Treg) from mice infected with S. mansoni versus T effector cells from the infected mice.	65	2.057634e-2	1.000000e+0	6.046278e-1	4.859951e+1	2.057634e-2	1	2.057634e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	66	2.066372e-2	1.000000e+0	5.979955e-1	4.839399e+1	2.066372e-2	1	2.066372e-2	1.000000e+0	3	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN	Genes down-regulated in comparison of untreated CD8 T cells versus CD8 T cells treated with leukocyte costimulatory blockade antibodies.	67	2.095124e-2	1.000000e+0	5.972667e-1	4.772988e+1	2.095124e-2	1	2.095124e-2	1.000000e+0	12	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	Genes up-regulated in comparison of untreated macrophages versus those treated with IL6 [GeneID=3569].	68	2.095804e-2	1.000000e+0	5.886744e-1	4.771439e+1	2.095804e-2	1	2.095804e-2	1.000000e+0	12	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.	69	2.099420e-2	1.000000e+0	5.811438e-1	4.763220e+1	2.099420e-2	1	2.099420e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	Genes up-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	70	2.126595e-2	1.000000e+0	5.802566e-1	4.702352e+1	2.126595e-2	1	2.126595e-2	1.000000e+0	6	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h.	71	2.127653e-2	1.000000e+0	5.723686e-1	4.700014e+1	2.127653e-2	1	2.127653e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.	72	2.147521e-2	1.000000e+0	5.696896e-1	4.656532e+1	2.147521e-2	1	2.147521e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.	73	2.178263e-2	1.000000e+0	5.699291e-1	4.590815e+1	2.178263e-2	1	2.178263e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	Genes down-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	74	2.181198e-2	1.000000e+0	5.629849e-1	4.584637e+1	2.181198e-2	1	2.181198e-2	1.000000e+0	86	2.369323e-2	1.000000e+0	5.262101e-1	4.195581e+1	2.383460e-2	1	215	5.000000e-1	4.651163e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE13306_RA_VS_UNTREATED_TCONV_DN	Genes down-regulated in comparison of conventional T cells treated with retinoic acid (tretinoin) [PubChem=444795] versus untreated conventional T cells.	75	2.211565e-2	1.000000e+0	5.632119e-1	4.521685e+1	2.211565e-2	1	2.211565e-2	1.000000e+0	10	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP	Genes up-regulated in comparison of thymic progenitors versus fetal DN3 thymocytes.	76	2.224626e-2	1.000000e+0	5.590836e-1	4.495138e+1	2.224626e-2	1	2.224626e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	77	2.225685e-2	1.000000e+0	5.520855e-1	4.492999e+1	2.225685e-2	1	2.225685e-2	1.000000e+0	56	2.183015e-2	1.000000e+0	7.445640e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 6 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 6 h.	78	2.262574e-2	1.000000e+0	5.540406e-1	4.419744e+1	2.262574e-2	1	2.262574e-2	1.000000e+0	50	2.172051e-2	1.000000e+0	8.297235e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	79	2.282006e-2	1.000000e+0	5.517255e-1	4.382110e+1	2.282006e-2	1	2.282006e-2	1.000000e+0	12	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_2H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 2 h.	80	2.288378e-2	1.000000e+0	5.463502e-1	4.369906e+1	2.288378e-2	1	2.288378e-2	1.000000e+0	34	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP	Genes up-regulated in comparison of adult DN3 thymocytes versus fetal DN3 thymocytes.	81	2.372238e-2	1.000000e+0	5.593796e-1	4.215429e+1	2.372238e-2	1	2.372238e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN	Genes down-regulated in comparison of splenic primary CD8 effector T cells at day 8 post-acute infection versus splenic primary CD8 effector T cells at day 8 post-chronic infection.	82	2.374266e-2	1.000000e+0	5.530303e-1	4.211827e+1	2.374266e-2	1	2.374266e-2	1.000000e+0	24	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in naive CD4 [GeneID=920] T cells from adult blood versus thymic stromal cells.	83	2.479311e-2	1.000000e+0	5.705402e-1	4.033378e+1	2.479311e-2	1	2.479311e-2	1.000000e+0	63	2.193980e-2	1.000000e+0	6.651590e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MAD2L1
MSigDB Immunologic Signatures	GSE13306_TREG_VS_TCONV_SPLEEN_UP	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	84	2.508038e-2	1.000000e+0	5.702801e-1	3.987180e+1	2.508038e-2	1	2.508038e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.	85	2.588933e-2	1.000000e+0	5.817485e-1	3.862596e+1	2.588933e-2	1	2.588933e-2	1.000000e+0	4	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PRDM5
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP	Genes up-regulated in comparison of adult thymic progenitors versus adult DN2 thymocytes.	86	2.621064e-2	1.000000e+0	5.821200e-1	3.815245e+1	2.621064e-2	1	2.621064e-2	1.000000e+0	17	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PRDM5
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
